<!DOCTYPE html>
<html lang="en" dir="ltr" 
  xmlns="http://www.w3.org/1999/xhtml"
  xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#" >
    <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="dns-prefetch" href="//journals.asm.org" />
<link rel="dns-prefetch" href="//www.googletagservices.com" />
<link rel="dns-prefetch" href="//scholar.google.com" />
<link rel="dns-prefetch" href="//stats.g.doubleclick.net" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//www.google.com" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes" />
<link rel="shortcut icon" href="https://aac.asm.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="canonical" href="https://aac.asm.org/content/47/3/923" />
<meta name="Generator" content="Drupal 7 (http://drupal.org)" />
<link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/47/3/923.full.pdf" />
<link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/47/3/923.full.txt" />
<link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/47/3/923.ppt" />
<meta name="issue_cover_image" content="https://aac.asm.org/sites/default/files/highwire/default/covers/AAC_Cover_0.jpg" />
<meta name="type" content="article" />
<meta name="category" content="research-article" />
<meta name="HW.identifier" content="/aac/47/3/923.atom" />
<meta name="HW.pisa" content="aac;47/3/923" />
<meta name="DC.Format" content="text/html" />
<meta name="DC.Language" content="en" />
<meta name="DC.Title" content="In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci" />
<meta name="DC.Identifier" content="10.1128/AAC.47.3.923-931.2003" />
<meta name="DC.Date" content="2003-03-01" />
<meta name="DC.Publisher" content="American Society for Microbiology Journals" />
<meta name="DC.Rights" content="Copyright В© 2003 American Society for Microbiology" />
<meta name="DC.AccessRights" content="restricted" />
<meta name="DC.Description" content="The in vitro antibacterial activity of S-3578, a new parenteral cephalosporin, against clinical isolates was evaluated. The MICs of the drug at which 90% of the isolates were inhibited were 4 Ојg/ml for methicillin-resistant Staphylococcus aureus (MRSA) and 2 Ојg/ml for methicillin-resistant Staphylococcus epidermidis , which were fourfold higher than and equal to those of vancomycin, respectively. The anti-MRSA activity of S-3578 was considered to be due to its high affinity for penicillin-binding protein 2a (50% inhibitory concentration, 4.5 Ојg/ml). In time-kill studies with 10 strains each of MRSA and methicillin-susceptible S. aureus , S-3578 caused more than a 4-log10 decrease of viable cells on the average at twice the MIC after 24 h of exposure, indicating that it had potent bactericidal activity. Furthermore, in population analysis of MRSA strains with heterogeneous or homogeneous resistance to imipenem, no colonies emerged from about 109 cells on agar plates containing twice the MIC of S-3578, suggesting the low frequency of emergence of S-3578-resistant strains from MRSA. S-3578 was also highly active against penicillin-resistant Streptococcus pneumoniae (PRSP), with a MIC90 of 1 Ојg/ml, which was comparable to that of ceftriaxone. S-3578 also had antibacterial activity against a variety of gram-negative bacteria including Pseudomonas aeruginosa , though its activity was not superior to that of cefepime. In conclusion, S-3578 exhibited a broad antibacterial spectrum and, particularly, had excellent activity against gram-positive bacteria including methicillin-resistant staphylococci and PRSP. Thus, S-3578 was considered to be worthy of further evaluation." />
<meta name="DC.Contributor" content="Takaji Fujimura" />
<meta name="DC.Contributor" content="Yoshinori Yamano" />
<meta name="DC.Contributor" content="Isamu Yoshida" />
<meta name="DC.Contributor" content="Jingoro Shimada" />
<meta name="DC.Contributor" content="Shogo Kuwahara" />
<meta name="article:published_time" content="2003-03-01" />
<meta name="article:section" content="SUSCEPTIBILITY" />
<meta name="citation_title" content="In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci" />
<meta name="citation_abstract" lang="en" content="&lt;h3&gt;ABSTRACT&lt;/h3&gt;
&lt;p&gt;The in vitro antibacterial activity of S-3578, a new parenteral cephalosporin, against clinical isolates was evaluated. The MICs of the drug at which 90% of the isolates were inhibited were 4 Ојg/ml for methicillin-resistant &lt;i&gt;Staphylococcus aureus&lt;/i&gt; (MRSA) and 2 Ојg/ml for methicillin-resistant &lt;i&gt;Staphylococcus epidermidis&lt;/i&gt;, which were fourfold higher than and equal to those of vancomycin, respectively. The anti-MRSA activity of S-3578 was considered to be due to its high affinity for penicillin-binding protein 2a (50% inhibitory concentration, 4.5 Ојg/ml). In time-kill studies with 10 strains each of MRSA and methicillin-susceptible &lt;i&gt;S. aureus&lt;/i&gt;, S-3578 caused more than a 4-log&lt;sub&gt;10&lt;/sub&gt; decrease of viable cells on the average at twice the MIC after 24 h of exposure, indicating that it had potent bactericidal activity. Furthermore, in population analysis of MRSA strains with heterogeneous or homogeneous resistance to imipenem, no colonies emerged from about 10&lt;sup&gt;9&lt;/sup&gt; cells on agar plates containing twice the MIC of S-3578, suggesting the low frequency of emergence of S-3578-resistant strains from MRSA. S-3578 was also highly active against penicillin-resistant &lt;i&gt;Streptococcus pneumoniae&lt;/i&gt; (PRSP), with a MIC&lt;sub&gt;90&lt;/sub&gt; of 1 Ојg/ml, which was comparable to that of ceftriaxone. S-3578 also had antibacterial activity against a variety of gram-negative bacteria including &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt;, though its activity was not superior to that of cefepime. In conclusion, S-3578 exhibited a broad antibacterial spectrum and, particularly, had excellent activity against gram-positive bacteria including methicillin-resistant staphylococci and PRSP. Thus, S-3578 was considered to be worthy of further evaluation.&lt;/p&gt;" />
<meta name="citation_journal_title" content="Antimicrobial Agents and Chemotherapy" />
<meta name="citation_publisher" content="American Society for Microbiology Journals" />
<meta name="citation_publication_date" content="2003/03/01" />
<meta name="citation_mjid" content="aac;47/3/923" />
<meta name="citation_id" content="47/3/923" />
<meta name="citation_public_url" content="https://aac.asm.org/content/47/3/923" />
<meta name="citation_abstract_html_url" content="https://aac.asm.org/content/47/3/923.abstract" />
<meta name="citation_full_html_url" content="https://aac.asm.org/content/47/3/923.full" />
<meta name="citation_pdf_url" content="https://aac.asm.org/content/aac/47/3/923.full.pdf" />
<meta name="citation_issn" content="0066-4804" />
<meta name="citation_issn" content="1098-6596" />
<meta name="citation_doi" content="10.1128/AAC.47.3.923-931.2003" />
<meta name="citation_pmid" content="12604523" />
<meta name="citation_volume" content="47" />
<meta name="citation_issue" content="3" />
<meta name="citation_article_type" content="Research Article" />
<meta name="citation_section" content="SUSCEPTIBILITY" />
<meta name="citation_firstpage" content="923" />
<meta name="citation_lastpage" content="931" />
<meta name="citation_author" content="Takaji Fujimura" />
<meta name="citation_author_institution" content="Discovery Research Laboratories, Shionogi &amp; Co., Ltd., Toyonaka, Osaka 561-0825" />
<meta name="citation_author_email" content="takaji.fujimura@shionogi.co.jp" />
<meta name="citation_author" content="Yoshinori Yamano" />
<meta name="citation_author_institution" content="Discovery Research Laboratories, Shionogi &amp; Co., Ltd., Toyonaka, Osaka 561-0825" />
<meta name="citation_author" content="Isamu Yoshida" />
<meta name="citation_author_institution" content="Discovery Research Laboratories, Shionogi &amp; Co., Ltd., Toyonaka, Osaka 561-0825" />
<meta name="citation_author" content="Jingoro Shimada" />
<meta name="citation_author_institution" content="St. Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511" />
<meta name="citation_author" content="Shogo Kuwahara" />
<meta name="citation_author_institution" content="Department of Microbiology, Toho University School of Medicine, Ota-ku, Tokyo 143-8540, Japan" />
<meta name="citation_reference" content="Antony, S. J., E. Diaz-Vasquez, and C. Stratton. 2001. Clinical experience with linezolid in the treatment of resistant gram-positive infections. J. Natl. Med. Assoc.93:386-391." />
<meta name="citation_reference" content="Chambers, H. F., and M. Sachdeva. 1990. Binding of ОІ-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus. J. Infect. Dis.161:1170-1176." />
<meta name="citation_reference" content="Chambers, H. F. 1995. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a. Antimicrob. Agents Chemother.39:462-466." />
<meta name="citation_reference" content="Cho, A., T. W. Glinka, M. Ludwikow, A. T. Fan, M. Wang, and S. J. Hecker. 2001. New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position. Bioorg. Med. Chem. Lett.11:137-140." />
<meta name="citation_reference" content="Diekema, D. J., M. A. Pfaller, J. Turnidge, J. Verhoef, J. Bell, A. C. Fluit, G. V. Doern, R. N. Jones, and the SENTRY Participants Group. 2000. Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY antimicrobial resistance surveillance centers worldwide, 1998. Microb. Drug Resist.6:213-221." />
<meta name="citation_reference" content="Drew, R. H., J. R. Perfect, L. Srinath, E. Kurkimilis, M. Dowzicky, and G. H. Talbot. 2000. Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. J. Antimicrob. Chem.46:775-784." />
<meta name="citation_reference" content="Fung-Tomc, J. C., J. Clark, B. Minassian, M. Pucci, Y. Tsai, E. Gradelski, L. Lamb, I. Media, E. Huczko, B. Kolek, S. Chaniewski, C. Ferraro, T. Washo, and D. P. Bonner. 2002. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and susceptible staphylococci. Antimicrob. Agents Chemother.46:971-976." />
<meta name="citation_reference" content="Hartman, B. J., and A. Tomasz. 1984. Low-affinity penicillin-binding protein associated with ОІ-lactam resistance in Staphylococcus aureus. J. Bacteriol.158:513-516." />
<meta name="citation_reference" content="Hebeisen, P., I. Heinze-Krauss, P. Angehrn, P. Hohl, M. G. P. Page, and R. L. Then. 2001. In vitro and in vivo properties of Ro63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrob. Agents Chemother.45:825-836." />
<meta name="citation_reference" content="Heinze-Krauss, I., P. Angehrn, P. Guerry, P. Hebeisen, C. Hubschwerlen, I. Kompis, M. G. P. Page, H. G. F. Richter, V. Runtz, H. Stalder, U. Weiss, and C. Wei. 1996. Synthesis and structure-activity relationship of (lactamylvinyl)cephalosporins exhibiting activity against staphylococci, pneumococci, and enterococci. J. Med. Chem.39:1864-1871." />
<meta name="citation_reference" content="Higashi, Y., A. Wakabayashi, Y. Matsumoto, Y. Watanabe, and A. Ohno. 1999. Role of inhibition of penicillin binding proteins and cell wall cross-linking by beta-lactam antibiotics in low- and high-level methicillin resistance of Staphylococcus aureus. Chemotherapy45:37-47." />
<meta name="citation_reference" content="Ishikawa, T., K. Kamiyama, Y. Nakayama, Y. Iizawa, K. Okonogi, and A. Miyake. 2001. Studies on anti-MRSA parenteral cephalosporins. III. Synthesis and antibacterial activity of 7ОІ-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-[(E)-2-(1-alkylimidazo[1,2-b]pyridazinium-6-yl)thiovinyl]-3-cephem-4-carboxylates and related compounds. J. Antibiot.54:257-277." />
<meta name="citation_reference" content="Johnson, A. P., M. Warner, M. Carter, and D. M. Livermore. 2002. In vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocci. Antimicrob. Agents Chemother.46:321-326." />
<meta name="citation_reference" content="Lowy, F. 1998. Staphylococcus aureus infections. N. Engl. J. Med.339:520-532." />
<meta name="citation_reference" content="Matsumoto, M., H. Tamaoka, H. Ishikawa, and M. Kikuchi. 1998. In vitro and in vivo antibacterial activities of OPC-20011, a novel parenteral broad-spectrum 2-oxaisocephem antibiotic. Antimicrob. Agents Chemother.42:2943-2949." />
<meta name="citation_reference" content="Murakami, K., and T. Yoshida. 1985. Covalent binding of moxalactam to cephalosporinase of Citrobacter freundii. Antimicrob. Agents Chemother.27:727-732." />
<meta name="citation_reference" content="Murakami, K., K. Nomura, M. Doi, and T. Yoshida. 1987. Production of low-affinity penicillin-binding protein by low-and high-resistance groups of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother.31:1307-1311." />
<meta name="citation_reference" content="Murakami, K., K. Nomura, M. Doi, and T. Yoshida. 1987. Increased susceptibility to cephamycin-type antibiotics of methicillin-resistant Staphylococcus aureus defective in penicillin-binding protein 2. Antimicrob. Agents Chemother.31:1423-1425." />
<meta name="citation_reference" content="National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. M26-A. National Committee for Clinical Laboratory Standards, Wayne, Pa." />
<meta name="citation_reference" content="National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard, 5th ed. M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa." />
<meta name="citation_reference" content="O'Callaghan, C. H., P. W. Muggleton, and G. W. Ross. 1969. Effects of ОІ-lactamase from gram-negative organisms on cephalosporins and penicillins, p. 57-63. Antimicrob. Agents Chemother. 1968." />
<meta name="citation_reference" content="Sawai, T., S. Yamagishi, and S. Mitsuhashi. 1973. Penicillinases of Klebsiella pneumoniae and their phylogenetic relationship to penicillinases mediated by R factors. J. Bacteriol.115:1045-1054." />
<meta name="citation_reference" content="Spratt, B. G. 1977. Properties of the penicillin-binding proteins of Escherichia coli K12. Eur. J. Biochem.72:341-352." />
<meta name="citation_reference" content="Springer, D. M., B. Luh, and J. J. Bronson. 2001. Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives. Bioorg. Med. Chem. Lett.11:797-801." />
<meta name="citation_reference" content="Witte, W. 1999. Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. J. Antimicrob. Chemother.44:A1-A9." />
<meta name="citation_reference" content="Yoshizawa, H., H. Itani, K. Ishikura, T. Irie, K. Yokoo, T. Kubota, K. Minami, T. Iwaki, H. Miwa and Y. Nishitani. 2002. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa: synthesis and structure-activity relationships. J. Antibiot., 55:975-992." />
<meta name="twitter:title" content="In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:image" content="https://aac.asm.org/sites/default/files/highwire/default/covers/AAC_Cover_0.jpg" />
<meta name="twitter:description" content="The in vitro antibacterial activity of S-3578, a new parenteral cephalosporin, against clinical isolates was evaluated. The MICs of the drug at which 90% of the isolates were inhibited were 4 Ојg/ml for methicillin-resistant Staphylococcus aureus (MRSA) and 2 Ојg/ml for methicillin-resistant Staphylococcus epidermidis , which were fourfold higher than and equal to those of vancomycin, respectively. The anti-MRSA activity of S-3578 was considered to be due to its high affinity for penicillin-binding protein 2a (50% inhibitory concentration, 4.5 Ојg/ml). In time-kill studies with 10 strains each of MRSA and methicillin-susceptible S. aureus , S-3578 caused more than a 4-log10 decrease of viable cells on the average at twice the MIC after 24 h of exposure, indicating that it had potent bactericidal activity. Furthermore, in population analysis of MRSA strains with heterogeneous or homogeneous resistance to imipenem, no colonies emerged from about 109 cells on agar plates containing twice the MIC of S-3578, suggesting the low frequency of emergence of S-3578-resistant strains from MRSA. S-3578 was also highly active against penicillin-resistant Streptococcus pneumoniae (PRSP), with a MIC90 of 1 Ојg/ml, which was comparable to that of ceftriaxone. S-3578 also had antibacterial activity against a variety of gram-negative bacteria including Pseudomonas aeruginosa , though its activity was not superior to that of cefepime. In conclusion, S-3578 exhibited a broad antibacterial spectrum and, particularly, had excellent activity against gram-positive bacteria including methicillin-resistant staphylococci and PRSP. Thus, S-3578 was considered to be worthy of further evaluation." />
<meta name="og-title" property="og:title" content="In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci" />
<meta name="og-url" property="og:url" content="https://aac.asm.org/content/47/3/923" />
<meta name="og-site-name" property="og:site_name" content="Antimicrobial Agents and Chemotherapy" />
<meta name="og-description" property="og:description" content="The in vitro antibacterial activity of S-3578, a new parenteral cephalosporin, against clinical isolates was evaluated. The MICs of the drug at which 90% of the isolates were inhibited were 4 Ојg/ml for methicillin-resistant Staphylococcus aureus (MRSA) and 2 Ојg/ml for methicillin-resistant Staphylococcus epidermidis , which were fourfold higher than and equal to those of vancomycin, respectively. The anti-MRSA activity of S-3578 was considered to be due to its high affinity for penicillin-binding protein 2a (50% inhibitory concentration, 4.5 Ојg/ml). In time-kill studies with 10 strains each of MRSA and methicillin-susceptible S. aureus , S-3578 caused more than a 4-log10 decrease of viable cells on the average at twice the MIC after 24 h of exposure, indicating that it had potent bactericidal activity. Furthermore, in population analysis of MRSA strains with heterogeneous or homogeneous resistance to imipenem, no colonies emerged from about 109 cells on agar plates containing twice the MIC of S-3578, suggesting the low frequency of emergence of S-3578-resistant strains from MRSA. S-3578 was also highly active against penicillin-resistant Streptococcus pneumoniae (PRSP), with a MIC90 of 1 Ојg/ml, which was comparable to that of ceftriaxone. S-3578 also had antibacterial activity against a variety of gram-negative bacteria including Pseudomonas aeruginosa , though its activity was not superior to that of cefepime. In conclusion, S-3578 exhibited a broad antibacterial spectrum and, particularly, had excellent activity against gram-positive bacteria including methicillin-resistant staphylococci and PRSP. Thus, S-3578 was considered to be worthy of further evaluation." />
<meta name="og-type" property="og:type" content="article" />
<meta name="og-image" property="og:image" content="https://aac.asm.org/sites/default/files/highwire/default/covers/AAC_Cover_0.jpg" />
    <title>In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci | Antimicrobial Agents and Chemotherapy</title>  
    <link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__kTVyDAOL5NkNO3djn2rimjhdkOw28Y0e-6AJ2ClHgfU__2T2VYhFSTHiMKD_qnEoA-dRink7GcnC3XqIduXK87Lw__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/all/modules/highwire/highwire/highwire.style.highwire.css?qjdf71" media="all" />
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__BX3nCkChknRoE-aDbdxprlFaypp4fXWeczbX7JvfqrM__g-t84A-r74kQSXvr21Rgbefb9LKqLm96c9xLvHou54w__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__LAPMf2_D41coKgF9GMvNabGOxgOc_VLT-xXm2EsAliA__2jNUX6ja6sF12c6BfrluuTZt_7EDEMHSb2LyUdWuTXA__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
.panels-flexible-region{padding:0}.panels-flexible-region-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-region-inside-first{padding-left:0}.panels-flexible-region-inside-last{padding-right:0}.panels-flexible-column{padding:0}.panels-flexible-column-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-column-inside-first{padding-left:0}.panels-flexible-column-inside-last{padding-right:0}.panels-flexible-row{padding:0 0 .5em 0;margin:0}.panels-flexible-row-last{padding-bottom:0}.panels-flexible-column-new-main{float:left;width:99.0000%}.panels-flexible-new-inside{padding-right:0}.panels-flexible-new{width:auto}.panels-flexible-region-new-center{float:left;width:99.0000%}.panels-flexible-row-new-main-row-inside{padding-right:0}
/* ]]> */
</style>
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__PnFOUU3wwEeMc-3uTp-rJi3xEd6b9xBIOyZ99akvv-4__xNoeDncIFLwvGXSGvArCoLrv5_DoXvtueK4yDbpLy4U__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
.user-menu-dropdown-logo>.menubar-nav>.nice-menu>.menuparent a:first-child{background:url('https://aac.asm.org/sites/default/files/uber-ASMJournals.png') transparent no-repeat left center;padding-left:106px}
/* ]]> */
</style>
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__7CYEtfDxMu3CEBZ53TQrEfMpO7duR_XdIuTLye9W7Cc__CzzPXev2zJRWVry4kyDAKuuERTizWaGzrN8gCp2auaE__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:#000}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]> */
</style>

<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__ElJr3PIJEvw3qLXc1cnYiLj2G4KgDPSXFOfm6Phf8hw__JdWGm15cDWjsK6KrFlQVXQix9YgNeYysf22XZHj-Y-c__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__vP96nkAt3EeLU62QRdHXKZuS9tqQ1EMDJC_PSKd7hEk__tdZg4qOJpqrCbkbGYbpNeWgJZN-ltlK3uYdisQZuHX0__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__WTIsRlLrkKgFz0Dd4Y-MRkV_8c933CL255PlZPb2RqI__uBvc03D0c_E7-EfMZ-LlXTnA0SGx13NNJeQaFUTS0Yc__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />

<!--[if (lt IE 9)&(!IEMobile)]>
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__XH6bpcI0f2dImc-p674DLCZtWBGb-QwxJK1YexVGtno__vUceGprdo5nIhV6DH93X7fI3r8RcTJbChbas9TQXeW4__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<![endif]-->

<!--[if gte IE 9]><!-->
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<!--<![endif]-->
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__jC-UM4y5ea0GptlS8YSVWKZyyOO1Cqf3MmlsxANgy3Y__BK4cyZQdrIENRK8aL8B6_rAV69WxBtzchyITAvs6YHg__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://journals.asm.org/sites/default/files/additional_assets/journals-advpages.css" media="all" />
    <script type="text/javascript">
<!--//--><![CDATA[//><!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i<a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&&h(j,l);else Object(a)===a&&h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&&b.addEventListener&&(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&&g(k.readyState)&&(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/all/libraries/modernizr/modernizr.min.js?qjdf71"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__wH8myWXKi4A-QKdUKDXzJAnGs-FRS1A2ZzTTNzjRAdI__4MCtOZK_Ov0QKyRlXNLGQ2LRlYRGWj9ArT-NpFox3QA__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var googletag = googletag || {};
googletag.cmd = googletag.cmd || [];
googletag.slots = googletag.slots || {};
//--><!]]>
</script>
<script type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__9rXDBIhVBkP0BsyHk1wbescXWFIxRy4CVuUwfiESLj4__F1JmUI65uDfzw6swVIdx2_0bzIaKP9u0qg-RNYe3m3s__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
googletag.slots["asm_box"] = googletag.defineSlot("/13678947/asm_box", [300, 250], "dfp-ad-asm_box")
  .addService(googletag.pubads())
  .setTargeting("asmjournals", "aac");
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__bQc6kyz_Gw2afC1F6wguCBh8Z8nev-hxX6F2Tw4bq6k__CO2faEsYCquY82rVj6as9HScSnogGHeR-oh5fSQydG0__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var mapping = googletag.sizeMapping()
  .addSize([980, 1], [728, 90])
  .addSize([1, 1], [320, 50])
  .build();
googletag.slots["asm_leader_mob"] = googletag.defineSlot("/13678947/asm_leader-mob", [[728, 90], [320, 50]], "dfp-ad-asm_leader_mob")
  .addService(googletag.pubads())
  .setTargeting("asmjournals", "aac")
  .defineSizeMapping(mapping);
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__dpHWPO8-QXPRsQXkx2RcUYOOrnCKh7SfUDVV0G48YII__-_Atd1qh6XaeX6cPmbvx5CNihEYhVDjwEQrkcRWbbk8__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
document.createElement( "picture" );
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__UK1ygaa8bCfT-jsjqYRdRLDZ5N17950T7K5WPC9XtpI__NqLYT1T1SMBsKukLWIe82VgCZYYCMHZX_f609-a1rj8__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
googletag.cmd.push(function() {
  googletag.pubads().enableAsyncRendering();
  googletag.pubads().enableSingleRequest();
  googletag.pubads().collapseEmptyDivs();
  googletag.pubads().addEventListener("slotRenderEnded", function (event) {
    if (event.isEmpty) {
      var id = event.slot.getSlotElementId();
      var x = document.getElementById(id);
      if (x.parentElement.classList.contains("dfp-tag-wrapper")) {
        x.parentElement.style.display = "none";
      }
    }
  });
});

googletag.enableServices();
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__3vwOA0BwlnyBkt9H4CLg6FgNyKAh--OmfOxFOIu_5S4__EXTgktcHbQ7BQfelY6CnrqgPRc4i4eD6XcZ4i3xs5RU__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" defer="defer" async="async" src="//cdn.foxycart.com/asm.ecommerce.highwire.org/loader.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__IBM5LrU6V_9IHDow9uvaTZj6hSk8OauPIL06zKFXP9E__sSVK9Wk1leVNQSDhpslSC7eHBDkvUkwvqpqFBoR55fE__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__3uCzzYE5jr6ly9nvsM8PRBRkhh4p0NWCMDja4EKBy4M__dmGGVYcB8LhnbR2iAmVW0ZyXI6QuFVYFRORa5XxglXs__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__yiXGyyzC1oV2sZBtAUN2DFoM2mAH5KP0iYCqS1dmafE__UiTPqZo1iNHqhqhx1lKGu2xkUGpxmin5ny6_22C53JA__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__9cszWACvqfgGHxZ9cYu77EmgUl5PS06bWWNMHQWXAzs__r43EInI51Aw344uPml6V9wbOCwCPY3JUCv0myrWhWJ8__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" src="https://www.google.com/recaptcha/api.js?hl=en&amp;render=explicit&amp;onload=drupalRecaptchaOnload"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__wv9tKCDrA0z5A6V5iIUk8KuqnrSwkhwD8xBY49vTnGw__XpJxKcSFHszUXwo83u22u-X8Nm3hRoKB-ZRewjwMTwk__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-5821458-3", {"cookieDomain":"auto"});ga("set", "anonymizeIp", true);ga("send", "pageview");ga('create', 'UA-189672-34', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__o0sqMT5Ga6hDKg0ZzJ2O7bLSX1bhj6Edl5UUgbwRffM__gX3BEX_JCocmWnJuIrEZ-5f80gTLiRTdLwiABEY_Aq8__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
  setTimeout(function(){var a=document.createElement("script");
  var b=document.getElementsByTagName("script")[0];
  a.src=document.location.protocol+"//script.crazyegg.com/pages/scripts/0043/7461.js?"+Math.floor(new Date().getTime()/3600000);
  a.async=true;a.type="text/javascript";b.parentNode.insertBefore(a,b)}, 1);
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__zZf2JqHvQzUqy4IxpDf7IpgqVlzNZCKiFz1EjRjvrVo___zmTm_XlL04QiV3YGJI8uAySe9z0WRlaXXOFu3pDumE__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-PZPCQN5');
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"SIzhjsj9MirQQgf2rYD6Fw-D_wABzGYmuEXzBXHdFK4","jquery_version":"1.8","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"misc\/ui\/jquery.ui.button.css":1,"misc\/ui\/jquery.ui.resizable.css":1,"misc\/ui\/jquery.ui.dialog.css":1,"misc\/ui\/jquery.ui.tooltip.css":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/themes\/base\/minified\/jquery.ui.accordion.min.css":1,"sites\/all\/modules\/contrib\/date\/date_api\/date.css":1,"sites\/all\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_draw\/css\/highwire-draw.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_folders\/highwire_folders.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_foxycart\/highwire_foxycart.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/css\/highwire-responsive.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_saved_searches\/highwire_saved_searches.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/highwire_user.css":1,"sites\/all\/modules\/shared\/jnl_asm_styles\/css\/shared-styles.css":1,"modules\/node\/node.css":1,"sites\/all\/modules\/contrib\/picture\/picture_wysiwyg.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/contrib\/foxycart\/foxycart.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.highwire.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/nlm-elements.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"public:\/\/ctools\/css\/263bfdb18936424f0ade19d6bd885f37.css":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/css\/panels_ajax_tab.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_corrections.css":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/css\/highwire_collapsible_supplemental.css":1,"sites\/all\/libraries\/iToggle\/src\/engage.itoggle.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.markup.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/layouts\/highwire_2col_stacked\/highwire-2col-stacked.css":1,"sites\/all\/modules\/contrib\/forward\/forward.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_share_link.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_copy_permalink.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/plugins\/styles\/highwire_responsive_toggle\/highwire_responsive_toggle.css.less":1,"sites\/all\/modules\/contrib\/nice_menus\/css\/nice_menus.css":1,"sites\/all\/modules\/contrib\/nice_menus\/css\/nice_menus_default.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/flexible\/flexible.css":1,"0":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/css\/eu_cookie_compliance.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/userbar-dropdown-menu.css":1,"2":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons-glyphs.css":1,"1":1,"sites\/all\/themes\/highwire\/jcore_1\/eu_cookie_compliance.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome-ie7.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-reset.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-mobile.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-alpha.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/formalize.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-text.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-branding.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-menu.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-forms.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire-forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/mobile-reset.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/global.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/jquery-ui-elements.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/text.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/colors.css.less":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-narrow.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/narrow\/jcore-default-narrow-30.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-wide.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/wide\/jcore-default-wide-30.css":1,"sites\/all\/modules\/shared\/jnl_asm_styles\/css\/jnl_asm_styles.css.less":1,"https:\/\/journals.asm.org\/sites\/default\/files\/additional_assets\/journals-advpages.css":1},"js":{"sites\/all\/libraries\/enquire.js\/enquire.min.js":1,"sites\/all\/modules\/contrib\/picture\/picturefill2\/picturefill.min.js":1,"sites\/all\/modules\/contrib\/picture\/picture.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_google_scholar_sprinkle.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_tables.js":1,"sites\/all\/libraries\/lazysizes\/lazysizes.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_figures.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_article_trendmd.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/plugins\/content_types\/js\/highwire_user_salutation.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_foxycart\/highwire_foxycart.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/eu_cookie_compliance.js":1,"sites\/all\/libraries\/modernizr\/modernizr.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.8\/jquery.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery.once.js":1,"https:\/\/www.googletagservices.com\/tag\/js\/gpt.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/libraries\/iToggle\/src\/engage.itoggle.1.8.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.button.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.mouse.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.draggable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.resizable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.dialog.min.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/jquery.cookie-1.4.1.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/misc\/jquery.form.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.tooltip.min.js":1,"sites\/all\/libraries\/jquery.bgiframe\/jquery.bgiframe.js":1,"sites\/all\/libraries\/jquery.hoverIntent\/jquery.hoverIntent.js":1,"sites\/all\/libraries\/superfish\/superfish.js":1,"sites\/all\/modules\/contrib\/nice_menus\/js\/nice_menus.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.accordion.min.js":1,"misc\/ajax.js":1,"sites\/all\/modules\/contrib\/jquery_update\/js\/jquery_update.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.equal-heights.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.panels-ajax-tab.js":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"\/\/cdn.foxycart.com\/asm.ecommerce.highwire.org\/loader.js":1,"sites\/all\/modules\/contrib\/foxycart\/foxycart.js":1,"https:\/\/scholar.google.com\/scholar_js\/casa.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_log\/highwire_log.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_nps_survey\/js\/nps_survey.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/js\/highwire_user_meta.js":1,"sites\/all\/modules\/contrib\/panels\/js\/panels.js":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/js\/panels_ajax_tab.js":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_collapsible_supplemental.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_citation\/plugins\/content_types\/js\/highwire_citation_export.js":1,"misc\/progress.js":1,"sites\/all\/modules\/contrib\/captcha\/captcha.js":1,"misc\/textarea.js":1,"sites\/all\/modules\/contrib\/recaptcha\/js\/recaptcha.js":1,"https:\/\/www.google.com\/recaptcha\/api.js?hl=en\u0026render=explicit\u0026onload=drupalRecaptchaOnload":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/minipanel_dialog_link.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_share_dialog.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/clipboard.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_clipboard.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_article_nav.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_nav_float.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/plugins\/styles\/highwire_responsive_toggle\/highwire_responsive_toggle.js":1,"sites\/all\/modules\/contrib\/google_analytics\/googleanalytics.js":1,"sites\/all\/modules\/contrib\/panels_ajax_pane\/panels_ajax_pane.js":1,"sites\/all\/modules\/contrib\/panels_accordion\/js\/panels_accordion.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.article-citation-author-tooltip.js":1,"sites\/all\/themes\/highwire\/jcore_1\/js\/theme-scripts.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/jquery.formalize.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-mediaqueries.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-equalheights.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/js\/highwire-mediaqueries.js":1,"sites\/all\/modules\/shared\/jnl_asm_styles\/js\/asm_gtm_scripts.js":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"81053","apath":"\/aac\/47\/3\/923.atom","pisa":"aac;47\/3\/923","ac":{"\/aac\/47\/3\/923.atom":{"access":{"full":true},"pisa_id":"","apath":"\/aac\/47\/3\/923.atom","jcode":"aac"}},"processed":["highwire_math"],"collapsible_supplemental":{"title_expand":"\u003Ca href=\u0022#nogo\u0022 class=\u0022link-icon\u0022\u003E\u003Ci class=\u0022icon-plus\u0022\u003E\u003C\/i\u003E \u003Cspan class=\u0022title\u0022\u003EExpand view\u003C\/span\u003E\u003C\/a\u003E","title_collapse":"\u003Ca href=\u0022#nogo\u0022 class=\u0022link-icon\u0022\u003E\u003Ci class=\u0022icon-minus\u0022\u003E\u003C\/i\u003E \u003Cspan class=\u0022title\u0022\u003ECollapse view\u003C\/span\u003E\u003C\/a\u003E","title_all":"Expand all view","title_subtitle":0,"expand_all":1},"markup":[{"requested":"full-text","variant":"full-text","view":"full","pisa":"aac;47\/3\/923"},{"requested":"full-text","variant":"full-text","view":"full","pisa":"aac;47\/3\/923"}],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article","trendmd":{"trendmd-suggestions":"{\u0022element\u0022:\u0022#trendmd-suggestions\u0022,\u0022track_id\u0022:\u0022null\u0022}"}},"user_uid":0,"foxycart_subdomain":"asm.ecommerce.highwire.org","foxycart_always_show_cart_link":true,"hw_fc_cookie_domain":".asm.org","jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"highwire_panel_tabs":[{"panel_name":"jnl_asm_tab_pdf","panel_ajax_tab":"jnl_asm_tab_pdf"}],"panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","highwire_foxycart_add_to_cart_link":{"apath":"\/aac\/47\/3\/923.atom","text":"Add to Cart (%short-price)","type":"link"},"panels_ajax_pane":{"new-20":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022oUyQQWMMUTpa7Kv3Xy+Kymn0dRYaQAYE+2j\\\\\\\/DtgaHikP8cetSPUEOrQBy9YEHoxCpDUGS\\\\\\\/vd5gzMQdiarbgsrNKJn7vViAOnlYHaYq3StmQWEAf3+cf0Bcsaa+LMkXXPqvIwqe56hS2EWg4gSq5zowN\\\\\\\/Vf6jyhZWzBVDzXjCmMIvuqdMPCBulwfohDhFoc1BHC8fpwguy9KH\\\\\\\/ImCAEdNkpWP8a12f80WaFp8\\\\\\\/\\\\\\\/GvdhQExF4NENasYKiQaOvWcFejvAzfSDS46J+3r50vzUs8WOwjkJNyfjfVsRU3966wdGW6O8oosrQVtdMo9JJnfeAHsf0adSj8DTWkQfB+JXQudHFOMe8XRgBBAPGQvVvncwFHAYeJx4QBIVo4\\\\\\\/SShd4Ep5lT1XYOe3prgY7Dncrrexh0iBMFzfwDkJdw3cRMqyTB26guLMHMLG+OlBmU2TRPZhEbYkclk5wq4d2LqlthlqCovMHT+brqKPxATEKpZVoiTvsmGYQYbEK3KrkqQbSgmwLz26GgTWTE\\\\\\\/7ho5a7qcrKkpiDx3ryHInFDGioKkYJ6hLGhhlIgb8hL7tv0EWC2F\\\\\\\/osFoMX0jA+ICt47OVMn8yyg81fPF+f0oRA10WTSZ\\\\\\\/MS0tcPEOW7mlAaIw+3NK6gLarTW+XjYuGqrLgsoiZ5V5QcuUyPETRxViYhAbup8Sc71nKapDa8HtUt9fK2fu1kmWU41FG\\\\\\\/X8Udab3ApXCORRAjOu33RR1wDZhHnW700sMLJ3fpyYbwCPEzvVZNdTQklzEBm7pJ7NyNfROQcMIjqkTTaIgtLTewRauDuYA5bngHTZnw0KwjBDUD+bTzWJHFrV560t4TSsUtA8xSDj7dfRPOKSlq1xJoajxKpPTYBftjkWRv\\\\\\\/xblIsEeP0Znh5c53V70smVHdpeGAgffpiIyhu2gmeJYm1++FBdNtIHx+hckN\\\\\\\/T2emZ0BB2b0049iZtZD\\\\\\\/I7VnpvBbJQukrew1qQfnPH6Mv504d8\\\\\\\/XngsrAUm0CejkFQdPh300rp3fkNjHA18B5qRw4syjIStO9rZHDGc5nmgaCfI\\\\\\\/eWLMf46Z+2wp75WB7Kwxri0SpxqMDlCKj5FmmGNvAMVUy+3VIED6XrHVsfGoOO39e1mGL6Dioj57YXmWgEkk2sQCx3ciysoIEvt1mAt1V7XLIXy2XZC0i3UTO+tWCreW86r2HO5wgILKvoz6PpPBjongdtBQwfQsl5VUMOi890fQWxFR4TMJ6hsuUvl89iJ2R7\\\\\\\/7S2\\\\\\\/3ckYIfAQGwE3m1EqEKu7kMMbyOSYjVnVsnXTBOexHhcMRx94CUiDTAwGh8MbHwWQWW4fg9K1sAH7ZZ3BDKRCEkgoAsFb6+V6UCIivGniUvXJX5ylWD+oucgK6YFBueVIM3QyaIa0AffUcB9q4p4mM5Trs6PJQLPFYFf4KToONCskQLLvRkfZXWZjSXxE\\\\\\\/OgpJulk4tXRO5EoPvL3eYgshxjgJZyPwz0mDESsx1dovGBSgg+H3zLbw2GH5kyrXsFBoBtHqe6CgkFOpwwtUzGPsxC5V6EfZivZSt11wkP8ozGuGO+WR544Kzhx82NAA9NK7n8LKRQCGENDrQFQhX\\\\\\\/0KLGtcWxNewFz8Qb5isF4D0Wxk46sptWGtE0A15xbUOgAYaK8AbqnutN4fkqlFTneWLYsCkraphdW5q911liPfu1j63FVb80uOe8eoAG71BZS0SJ\\\\\\\/nK0rsV9kO3+i4BGT76PJN2j1TiSau5+puwva3pQ8FHAhb6OUl2MP6xEJPLunkUbIsYDtFI0cf8nasYRjUCONSmluCfJiKdnSledJjfaAwiIHJ2EzCXAw5LyxP2DFJfsh9cDKqMMUX9yatXd\\\\\\\/ZfuOn6ZVLKSdlhMkOau\\\\\\\/rHAqjSnCv6sNRcTiGMzWE1bUP88FQgSLyBm5KnCKvKtaLQTso+3wTWP80gCyj6ClHAOwSL3oCsm5tF8bYN0yjvuogZp8o6eLTyeAUtOIEbSEuiihtcX\\\\\\\/SEKCxJof31+11FXIRw+uNjmXPpNgy03lmPCuXEPVoRjRrRhzpmwxzm4Y76+\\\\\\\/HM\\\\\\\/Pjt6XrFTHJ\\\\\\\/8kx+3r5sRjVE5pDkAIqLbk8pRHbND+XXfSXBw4miR4g+GGKA4McTceslnCnbSiTdVAJbBb+hnxpvKlv\\\\\\\/U8GvL+wtdyPuA5hTM7sO3\\\\\\\/Xpo6ZNS\\\\\\\/Ac+Ptgw95oI\\\\\\\/H4Lu6Z5+DttGCaQDEK4mRxLDgIgBflmfJITwvGiWyHna+NVTmnmP2H27inGM1YI6F6lmPXECotwykP+KA+LaAyosQDD00geMxVbDXktZggfcrNWFbZJ5BAOCxIj\\\u0022,\\\u0022iv\\\u0022:\\\u0022mJA9DUBlM8eOCxASTeX4xQ==\\\u0022,\\\u0022salt\\\u0022:\\\u0022c61521e99d992105f48078da3e31e17d\\\u0022}\u0022,\u0022hmac\u0022:\u00222552203666ab24e1d9eb2c8c4282106a159e4ae6263e7c4cceb465ffbe3b133e\u0022}","new-1":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022n3Xz\\\\\\\/y02+Y\\\\\\\/krLdApwYu+VJ6b3j3+\\\\\\\/R8BQvQ9X5Ymdhy0TtIMEK0d7hi7EoTstSecLJcLW7XpAqYRoWfjVWbM7PIvluU6Ob7UJVuWy7+pCtbEL\\\\\\\/\\\\\\\/IooC1RM\\\\\\\/DqyC4Dspf1H28G2FkkDV9gJDWYgCVACFeRPq\\\\\\\/6O7UNqrYRJYea2MteHkq60kY321K0V+JdXH\\\\\\\/MRI1oqaV6Gn3kl9byxBzsdINzkRWzjXISl827Y36uLj26eXrBEHRTyIXEo4Zm8Tlq3pLvCfQz20\\\\\\\/xBxLUjg\\\\\\\/Hca+xLFW32jLI4bWN3jwndvlfby\\\\\\\/u+m3cy1Nh6aViZefLMyABZcAfz+jxd95GAVg58kutPm10sKpjf9xAEJxoSb0lfKHPwrQAGnZKfzxc7NTLjS+yd9kO05h7iR9NApdf0rovEFqK7JQRnP26zLKY\\\\\\\/Xs\\\\\\\/o3qrubymNROTRmK5qJNktH4mfLrf+q5Zut1wCRdiRk8E2jHoWsVrEW6R+RzeLmBeVsdZNAfXAKXhDNDhIQuJzYohL\\\\\\\/zduaJGoX08HbZgtjeVHU\\\\\\\/sO0\\\\\\\/Si9ksZuBSQZ5Jrm3LSXiDG\\\\\\\/Ejh4qFdzw9PzsxrnSbEZlyRazD4J26qrdfYbzDLZ\\\\\\\/cu1usy31V3Pic6z7guIWSvl7DM0gAhJAj9KgpPd8hDh05OQ3ze6YZfdO+su8mDr14OKnfOI508XQgFme0WtP+c7m1CfI\\\\\\\/Av50PpnlUb94B3e\\\\\\\/MoARE7kkVNTTBBkSDktQ8MJjHPKpYjvmV8CnBV9jnR1i2Ni0RCOLWD1kJapTjltw49awT5zS9ymF5RgWgi852sqY3\\\\\\\/PSHIweJAiYReFqsug9U4\\\\\\\/AkFrduYX6Fz7TqMQgCiJd\\\\\\\/Aa+4ZLHkJF8EpzqYElk5M26BHbijGXHz3WbpVh5faXWuUPTv5vWvqrmdGnITPiymRPG8WrsAnT38OHUC7UzTonLKogB7ObI7ViSnw3vmO+GzKWxMryrJJPyzuPxLASI9\\\\\\\/wVID1UPtt1ltWR3JEg5gOaK3QvsxE28BmkUMwYtyhVAcSxlrp9SQ2koLL25i7uFSM9P5ybTDLwKVmAHsnL1YIuClSKCgfCPq0FY1O1f8KFgbcDPiHWRiRMbjxDK3yrcN4D3RSSPO\\\\\\\/RPmAaS8PCodpwpPXJe7bHHYLYzl0hr2QnxlmP5WEKMq46klfPelP2AN\\\\\\\/QnYm5oY\\\\\\\/FDS2vDWQ9RqAcaQ\\\\\\\/5+HmAbYmNoYUnK0yLOHSRQLGwCAJeOkdZFoeImVqgjR5kH5rmtxnNZ+wXPDpl9Ut4GBFKjudTdfw5ShH6O5C7J1GZpdODC9EhGwNAuy0lssP9vjrh8jyH+g8DpoS0+ruCJEfPhB2JOHssr1oopmIlnbCGmh9Lyk2lDk+gN8mTGe7RJzl3ytYIObSlwBBW8sILI7X4z1LgbsSVuPUd3U99n5Je1fc2XCsS4VJ2QAqYbAGaEU65GrqSZlBEoHKTL+FptWlCGxih31PkRJO5iztCozmc\\\\\\\/GZiRc8C08B0KJLQafwqNnN9RNF8vVYdbsbHezfagowFdhAKi0dTj76qadZV\\\\\\\/wiKnzCat4K9LaGdv8b2WFQ8B2v57X6trsoz+hW7pwLTL\\\\\\\/QZeaHEh2q2BVM9KNvdAacE0S7NvC8TQYKDFAyGKDyIh0iFll89p6lOYWMqcvQlXKZK11utKjo4eVinE8tQdcfLqGaHYURhPvC3NMTxP5G\\\\\\\/+xlcjSPgcDDjYXN\\\\\\\/ZaqtcY0+Rn55KzT9pRi0NfMe+NSka+\\\\\\\/WhdgHRyd+HvGNmfP7lhPC3EIC8aEhwQM0edJpXP7VgcICrhlL3LPRbULiqU9ghyJWU2Ezs6p6kIQIcyAVobGWE\\\\\\\/LGwC8tvZbaEB4QT\\\\\\\/5kRFWzqZrgtUK5jm7YSyTDjKCzFp1\\\\\\\/HzlKxQwlCYojcualSvRdlRAUGxmXNaCKgI0tHCMHWevN\\\\\\\/4AjPknwRwOkOl\\\\\\\/K8DxaKjq+zRHJrYj4He2JjE58dqjWeYpojrXOT69q6FJLwfM+bXf4XmXkxMGypQnw4x+GS5BP\\\\\\\/G\\\\\\\/Cm\\\\\\\/hWrj22l9Jfe3BIHr1Fq84ev0iC36o7KD26zRy6mbSvbhjAAzSdC7nxBzY+UD7HE8VDUnA2hTDXCVealM\\\\\\\/MyLDdiIvfjx9jyOJ9\\\\\\\/mmeosvChT9uvdTSkaMTrsDsVV2KiujbwbP7qCJHMHLq6dV8VvnUiFHPpLqqLS1sxKRGKjfOIVPYgUNHRMvx5V2vaarwxqCMjfMr+iJ00UYxNFiG9fGm\\\\\\\/xRMVleRyfdd+U7sG43cJttlwPjPOLUTek+kjVt3IVZVxwx3Ke1c3vrh+ouWtIYigLQc+DUbT5rbv6ulD+Xs62FghExpaZ9zzta01XQ9osO94Zvhmv\\\\\\\/yRfpfN+w4kTP+\\\\\\\/F1Rhty\\\\\\\/ydFJhN8fYNobT\\\\\\\/\\\\\\\/iC4\\\\\\\/puBgNDQ3+pMZiTkP6AeCT3\\\\\\\/xIsnn6wuaf6jk1Gw0aGis9Lx8A0Yttj7KhKe1c3c3IVklE9B0syTTAxQC4wppgHjoQIt88YSpsm79o7rOdE2sTZW3ksNnj7Lue8XlH\\\\\\\/S2JrDeVhKjTq2LjVq8aka8ErBJaiZmOH0Vfdonpmawc4uPvvm3B2e3yFl2JAve+PCHk6h8heA9GDACqUrhAAi\\\\\\\/g6jbxFkfhwrv9KFpAa8ULkt2hzdKBrlLSmbcz2xh2smogn9N2ksnRLTntOKNQCG4deWuul9S0634BfhRkm7PYONIzMsaNxFcaG2NrC8B+LfApNfDuAS9mCc4RVG2p7Hpr2NibLG9D\\\\\\\/mOqsM+j6O2spV5Hi13bZ7kPwD7meU3OD96coJnb4VVpRYzf1z8wKZa+mxV3qdKiLJb7YjUnfaVklDOUnoTQSvtGbnqm6KB17GedJs50\\\\\\\/Rb7oZhiXhlgknPmJYLmZ\\\\\\\/nmOIU74m2v8\\\\\\\/Ouvx\\\\\\\/JMogEf8tO3aGWyXzDmn+85LNQip40kU\\\\\\\/FCh9Sh8MCcln4VGZ3KXSC8heeZPRccU5Wx\\\\\\\/PTM26vU6ium+8ptGkbYHUXPUlTCcBEYvDk9cdWsEcKkCYfsEp51SkpdbpngvdApsgikI5OBi9J3FC7Uzr40jEDfCBzgLrkOy86wzzgSR8aK+PwzUa67S6QdWbcs4xDPgYrZQ+77O3Y9bFLCak+VEZaEvHpxB9vwNqiz93Eq+lKWKYw4ezGHN665ST4ATog0W+EK0iZzYrlzjgSo9EtBhzJDk\\\\\\\/xEZocy0QHGiC1kym\\\\\\\/qCcl\\\\\\\/3J5XqTp1kW6cxbPfrHfeCoD2\\\\\\\/sLMk8jEXU8GFEL+bb0qaZ8MhXJztlLRmX1lo4PCa2GSfO9LUirAL2E7+T1jArhuGtC9yhahNkdBeUP4nY1OXTnrF\\\\\\\/NWmn0EezGSWMoE9zXYqGPvltS8W6a+Zbc5uIgCBziz3wYEqgdzG3jLNJkeS0c\\\\\\\/YDTu+Awzosspl4szx6sTqOzPgJjo4xqNEODGPnb1zrF8ydRKPqNCuVpGM7vyyaObZk2wzyx2weBBgLB0atp9F0R1jI1hoio2NyhYZM8vAVCN6DAraRyf6ozYurzfV7teGhUtUC69t23flQceh4YaaZSi8jCYlJa8NzgQICq+et1n8KiRYMPbfL2dd0cB1UkUUKOJyTbXHpBaZw3hEDpmkMWPMmiBKsySlLihz89bMwYpfytrUDI0Y6ffAn\\\\\\\/H9QRqnzro9VMbI2D5MKa1YuPZrroke5nGarzSrH2oz6E3FHIirzOYl40attCT4Ct3j65SDsblpqFOV9ebCZkbf4GW6fnFMVkccJIFMnDXDUMAWsMPZO3oIc3402sm6MB2frwiiu5YP6vNtNHoXREDb2D9pqmjOu8jNB\\\\\\\/Sv00arQFDcZfhC9VYEirzZ8cziN5OvLinnK1sNhLszFxsq6qToX0c1yGvEPBmarrw3ujbkTJOxVWGs4SbRTrL83ySM\\\\\\\/dtv3FJy1Ni4ZwRV3JRvlUtPlL2rOIkF9VC+\\\\\\\/7BTPVWXaQA0ina5W\\\\\\\/UbIZQqZP9K1Z6gZRhMBZOk\\\\\\\/hniOWAkOzvl3mQdTF+e6uo1jKAp40nTcq47thJx0QMeSylakfyjNb2jPYAufsssZjIP5bOPoG4mDO9tMai6JDxRJJTumeBbWdAl1ihJAzv4uNfAjlDL7EsoBZLkSVv7LFT7qllgCm2n3vD9AXE4Pa2X1h7FKeNcfSIaONGcsBLq1oLx76YZVy+ESqM9YqsK4gDLlYfT9QNY59wPBRUYwKwUdyd1x760XJUwoLgl7+wmLgrJbSiyF6BeUZE93P87mWNtZAUC936VSUFUX1O7t1fqr7G2vWZ0erqzTMx9E4I0qqSjVbjAVdEZ1t920bAbVKQj4P85SPmMbypT1OCkG5NZCWopugN0Y8Rwwmp+79grcM29p5mk\\\\\\\/FLrCb6ytyjdpApiR6OxlCxhiXdv+B2dDgSK3eQXJdVik6Syml4FZOjDVgJe5ZKoU\\\\\\\/vYsoGU7CFPFkWSmaQxckBQUAHyH6mzGSvHyRIqYWOKDlb3+qfKgv4+tXEWSdwBvzXbJnT4tSZdeLjZtp724ugUdfUC7RMBu4KktpYZKPNgl+QmBPOIf\\\\\\\/0+M7M9WCSa46PVI8nq4uuLtQ7OuJ5NUpwWaZLuXkb2mpAVcdfBNPMwb+IDPoXvkpnGMOnetlMxWiyyVzarazWd2yTLSg0LlJtqIkGNAmzTZBAojrcN4J4oYMrXZ3kR2t77k1uPfyA9y31giRDrMV6gy+bjGYgPULfvUyHB9klpU4ZGhgZZLdfMzi\\\\\\\/r9iS8eB0HBm8PzXlP5mZOcB59ozfnwWVp1hYnSBF7rwLT3euqgjICol+ua4CCRq\\\\\\\/iyJqjY\\\\\\\/q1csBBX2cZGHNtMzxq9vGrpZG2jgg9CNZzVviQ1osfca8Su2\\\\\\\/u3YKBwa1DyLe0ybKt5QXmRuqV8bmdU3Oa5ug8i6optaIC3389nxf4gl5hynl3cbqK32hvuoO\\\\\\\/s\\\\\\\/HKeOYmEQmq\\\\\\\/U59RIPOXYATDx1lJbtENK54L4gTrtnIAz9GoBGBfl2MDa29AvyNflAfEyXy50dvJMwJE4CERhVfqL1xw1RbZ04RcJfS+W750YtaJCvviaFEW+8wAg5PdPJxiazrrKj3gvb4SNdLzSduMrRVVaJV0z9QXWJL2yeKUXzpIEEDt5K68LdvZCZA1Wp6wr3vXxh9a6CoX5uBF8s4MjS3P43lhfsAgIJ7G2w0W3y\\\\\\\/CLPJ3ccgSAOQ2Rjh2ucAll9apDGF8JfSdhxt5Ok3EeFDmsvnwDf\\\\\\\/0bYcTrgRXkrnsRpFN2yAYcXl6DQyJBILe1ClUkkjs92FtaHIUk0HL6+IV9t6MSVjVNspjLQu2wPNRovz\\\\\\\/gK3P0LZlorJFPj4I4HOdHREP55j9YZK8zVzi63O2FJ2iOzjxtkoMH\\\\\\\/7S90yGXj9HnZlzwIs4Im5XDsdfH3wmY3\\\\\\\/DYGmv7bBJq58T3gVw8VjcAAHOFDGkAxPzFa5JBygsJeczF5MtspsML5efraqxcN8Cs9IQqnI2GARSXgmK3KoF9lHX5fjKNKVElBGzrqjLXEQXPQN8E4FcSXvM60d8w7FKM3vRaa0Yu51O+gk38RPQ+ryZjXxxZk647zUmBeQrvIJvVVlc4d+\\\\\\\/Eg6M1v0TR\\\\\\\/R5MT\\\\\\\/cqP8qtdxYAUgnjbxQXMV+QSaiGZfZhuAZpRIrAZvSWT1ZQYQ\\\\\\\/U3+Ev9C6bqFp9ZfTT7PC5JTn9wHx6g9aqIgr3UX5tFv\\\\\\\/LhSCN\\\\\\\/VqOY+Q8uk8KWR1crHivFrjfCR5vZpq2V\\\\\\\/L97Vdkg9O0dtRarFFrZCp0dVWJelPWq7Uj1sblJgIdNGf9+zff0fWOdg0HVWfwzKUIA\\\\\\\/CDZYsgh4\\\\\\\/esUUf3lCTAwVCWjxCibVqdyoHkiS2FnI5nhSObQgDLmEinpPhw9VCQcB24ogBS1yYqq00xnT39L314X1ziWOjH+P6reOUyJk8Jdwj8b8+NKEsCGXsSXkxFaMgixpcm0wtlh1SqKxA1oBJUW9Vn5W9fuLbPP\\\\\\\/3deLNFZszXe8Nd63X7rPq4KC7Lp+kJp+IIgITRobIOYzrxHNrw2ACNJVPHEwWjdCknob2kTXIckMLQiu3KXZGYrVwQxRjcOD\\\\\\\/Uua8bYtAXh4Gq2\\\\\\\/z3fZDmkV8AUxoKPQMSfW5edb7vPha883r0q1U0xvqMVMoSR9eRc33OALCo0kpSuEIpfD73Hzw6pZIzXFB1Lxa1G1WYh+gRpT4XSLPj8qVVNcrmwya8IxXS0s691baCNHr1nzVaizqbKOHUN663p5eVcDsIf\\\\\\\/FXqQ81a0dqzfb+ypd5rubTGptPYz6TQ6DbszWT63hBGOzv5oYsxu2ZmzEAtbR1FF+08uzupQ61H\\\\\\\/jw5L1\\\\\\\/PN\\\\\\\/C5RZhHyLcPykvzj4bMeaJM6npRCMxHyOJy5aIKJ2WbdeWSt7g7av0YYfgE4ps5xqKryiHE6UdaRhX9mABAHsueKHQCcgSl+ownMLXN9x023PbBqvxAVZxTcmdsp3jRb47oxqQT+uknTRyxMHStXe3OWT+m9eBQeK\\\\\\\/UVtIdGZsJp4acUcw4zS7c774FPR2esjdYjf\\\\\\\/PQsnEXfyn\\\\\\\/D0B5VyalmmF5SHEw8Jm1myh\\\\\\\/mOuWnjC6rB2n8xx1g1eQ23+\\\\\\\/+tKWTuO3+M3vHkn1TIlCQ\\\\\\\/a6jSll7m7+mpmbQepRL0ysrZIG+Hp6u3OI2tAydIEGBBMyJSz+ORTD\\\\\\\/xIB8M6dGxhH8\\\\\\\/EuWI7V5whDg7qFn2Tn1JD\\\\\\\/T4JJZlPfRbPtVuZAf\\\\\\\/fqCs+sy\\\\\\\/nC53BNHhFEUJvDDBCql\\\\\\\/8hu9fjKBuJyLWG8UjeLIaHddU5hVhPOh4s2X9y+Zwr+sUzqjqkMPikuWtOF+xf\\\\\\\/qjfXLPvCpxgVE9uC8tNU4leZ++sijF0qdmcDv2fTqGfAs2aUgOs7GlLUNJ8nhEmqYULvbLLFVP+UO4+hg\\\\\\\/mSEIpkBflvmMvg6H54wPqFcEM\\\\\\\/bDb9yhrOHviAft8JfAd4cQxx+9GWmvyEnMcb\\\\\\\/JlssCjQp9TB9c5sz07u1TlHegwWZF3fmWwcXN7Pcb\\\\\\\/ZBlrdioOYQol119jqwsdT6OUunJmCiIAfcB1XFR5f1N2kTwhC7Z6kB1wJPJyiKD3ffyN9x67sozwBUyLuoF5X3fjRtfZk0ceFSklhLBqvpco0Cjk2xN8bQDCR7W1b6NPqBAsB12mqfGmCW3t2LelweXBwGcAu1DoOZDAOXQTKRv290HK5rUhv9FgHZ6N3M2fHUge80KXrl\\\\\\\/3+xAc5aVnE79sn9Ds4601ckw9tNnna6JxKznnFwwe7mTrN3u0mwqd6zWS\\\\\\\/IqRinMeUAdeV6AChqWmMXyvbz7u4nuM\\\\\\\/JSkFbSp2EfZOLRPTf9ANtDFnhaF+jFavxuFAsT6nAraP7uaKA1Qjz9nTSIW2CodOKsQvFY\\\\\\\/sb4uSXEukZLrcBj2CnWG5RrzWq6Wy1xWyihCpIIJ3BtwQXBbY+CP0rcAQrvd7AowWtJgKWJ9a2O6RiAOyKxkveWGCxUkuebNxTvnfCxCnT+7qD9jd\\\\\\\/MV9P1jqdEBZYv1Z22QMKN4P7WRVw3UJNFLLBW6ELH9+Cvv0mgJIyR3TZxaUgZbfPOK9wyz5Fry3xrjRHHshXOS9lp7wgutMVccuTh32kYCtaMDG9vZqNFIbcDFDFJDRnXEUlRlSxM91eVADGZXz7wOunYxUmuQYUACWUnzSUbkaVG28dl03J\\\\\\\/7JEzLCKwEVC7kg3EazNV90uAefc9CfQ5h0Duj20ARrg\\\\\\\/vVi6Jkn7mB+Dg7VmCpCk9L\\\\\\\/EOH5BkXOLZBxjcdn9nxX6TV\\\\\\\/FLcIGbzMT2JjpdcmUf9flmq\\\\\\\/9VgJ+qQ9FmVTY7ieg70Fm3ZdSIGHfyVgxnWLsnWFPGEAzva3DtDt5U1wh7azFrvcbXH9CTPVurt64RYBVdCazO8oeqezBJb+RZSa7xb5\\\\\\\/WLgA+yuDXWDpQOnoKGeSxVGLWCZ+ZfOOv0+H7wzWwrP265Mb6yJIeRJxF0S0hM8+8gWMAEfGsLFGT1ckXgGv6\\\\\\\/fBMaGq540IE+f\\\\\\\/I194HDDCUSfM7u1VCyaF3CIyVJhC1grnVtC5hVAhorAtljM8ynD6bz3a+qubT3o9qYlVB4joMJflq3Le2i0B9lMqtmz36Dii0tmj6uYwlNn7E0WDwxA6+8JJkeerNranyYZi1gnEnd89SmsplQGhqyXV\\\\\\\/8IlMy7a2OVVdlT3dBM\\\\\\\/kcTOkWG2rY+fk9zAjRNsEOQWMlSS9DkQ2yKYfRvuIBKp0YNVsYXo\\\\\\\/g+WljPeLAYvQfX4jXtnE\\\\\\\/\\\\\\\/6sfpZze8BIOiTvXygNzVX0FBdGpN8xNeT2Selu1oXHhRuF16mokfs1n+zf0I9XlEtYfPkfdf3LuQVT4CprgV4nCiYVafeb\\\\\\\/k6KtulCs+TDcTNzH1xOkQjWMKxOT19o8lD7nnYBedbqhIoFoIic6ylMVCSon8tdEaRoL1EULaGE1UdHwda9mSK0YD8pfOxKAct4JGrPmeVKE\\\\\\\/+UoxApZY8RZ5WPg0L5mZY+y1TsifEAmFVzH6CSJpQU2WhHxHUVtFMrKEuc9PafSYbNbdj6KwBdVUvsI5oOfAWtzx6YUpsA4AKW0CCIcv1IPjLVAIzW9aMjsNlG1GPLeF5eMFbjNcdvW6XA+5dTzvshh+BF7i0i5hrK9FdOhOifGjvjdr+WwKl0Wxagop0\\\\\\\/Rtx\\\\\\\/jTme98M\\\\\\\/UP8uAerMwd6PdawV5nEKOsdvZIBX6pb8fLiUUUOl6wlYK9h\\\\\\\/tzOnH6hSyOrOwoc1b3IXzEl5aZR7LmprLE+599R85Iz1hsbETzM+dY2d\\\\\\\/kpnS7BUo8BPYWoUtQOCPVcqBFHAWh3lsDWIzotmIeWRt0NIyeFS3xKUSb30f+Ig8h84n\\\\\\\/fm+Kf3TL+9YUhSUt2z032nEDoYYxS2NrFKFpO3iHd1ccy5i5fllUp56iBDrTReZ1Xy0BvX1+3Df0Kk88+1Rh7RqNbbvHhkq1j6lj4eYUwh7ADooMO3c2k3Rr1ksoqsFYKJo4rzRh1jgfrtX6dT4vfCSGwYMFiVc+kN6sYEMMHcDjoG7Kp7oMaxTDRcxmxV9laK8ewpm4RZAkMPBip3fwAoib99ssCawaFmcZBnyGk2PEvpKNqTSx+xbUpLN0\\\\\\\/K4FUGnHPJmrfFLlXLX8JMpISFl78eVmkulOWJhGhDe4BizJ4s3mC6K8z42MgtFYymks3abmrm0OXN76YhNH86Kw16+Zxlk1J7OkXQc2Si666bWHN3eOX3wtqOZz8aemEqTOSykMA+6bLIHSZ9IeABH01l7gwGi18qH7ETeSKimDk2BTNujg3uTqEMi2BtuYa6osW5kP90qKx2E6o4VC00T3bKPICqGzHZToS6eeBk8Lkdd+ka3Axs9odFoCOSAqopaeQ2YHgHUVkekdTwuhJoKVEc31rl6+fj7K2AySUx2G633Hu5jcBzzbNOhSxLcV8KjaBKLusuDNVFhqUct5bgJhP+PRRe\\\\\\\/cbsXvi0W8lGqFJbMjNHsXuNdSlNO9s8BMSgNfim1r5IwEbpOdXOXvIKn8vs5sE0akG\\\\\\\/VsRr7Xto3pT5ZMImaEf67c1ntLkyofLDHINoYK6PnAk2zsr0FqFmmP\\\\\\\/lGCsO1C6HX5euax5u7kxKIc1VBBzWgWGo8M+CnKjfyAnEwScnCq7mkkH1ympeG+X\\\\\\\/GRKUivwPLNS4bt5LzNQ014oG0U0kopUSRify\\\\\\\/25yjnBliogQ\\\\\\\/R2HjntGfmEpigWw5MF2wv0ID7A9LZjnihK7lo4xP3E71nFxST4ihigu8tx0MMafmFlAuvpbACuAP8V0JMnd8ZmAWwskCHPetdW+X3PxrW7\\\\\\\/uKVnFkRnmZP16UdI16dPgHfQZHKUA\\\\\\\/Wul1gxdMXyyiTIspwSlNem2W69mYt+9Sww1NlmLZmrOY5Cx36hs589nC5pFbO5JQspWZVfGR8nY+zR0kgDmp0Xuhz4+WilOnMg0sE3\\\\\\\/U3ptuxWfjC7kMLRHr1Yt2CD3wVhvws8EoIsjTjdh26A3MJtZfNb0IjMNEVLXOAx6wmR6j0IM5oHw4u9p6tQYU8y1dM2EkftYShvevHkIRKipPej2UJk1EaQ6UKiznZwusviyjNy3j+l0i6M\\\\\\\/yUox8gZNhamKIGfl3lSQfmnSqlTp66iP0q49aP63+Mfe0kB0IdDbrGYgOfWR21vaHnRs0mue+qaQRlbaWUrqZVTxly4xJWPGUPF3SD5ZPo3F5USljzUqqX1RULQhXoVgZizOmNswrANh3iKJGA3MG538AQ9mHG5rZ9ZpX2VkMbh5A0zbKSCIQIZnDPLSxu1zLQc25zIy0+3n1rmbLSiBjANa54NNMgeiGTHKTN8JlOK7TTC+I58AZAAwC5pJ3rnwR9j8f5\\\\\\\/0VuablnULaMOPiRGzorxAXHPsZorHbHG+YOrBxCB\\\\\\\/tie6qGSj1dU36QXOI7yDcOy3uaZOt2MsB+CYeKLaiPqvgYUthqUN\\\\\\\/xtLC0jHoSJvGxo9kHS4SPiM2yOffL1EcajOYDLb0MyOkdgObe8sBOiq48fFKgKJlmNeN86eFh44rcqc9vzXu4qbgH4yLM7FJLk5n6+4riSzzSk9FE3sE9DhVNmcphQKudxbl+RR9eKuTMzrqN8JHpUG9MgsNCl02ZtJ2wqQJyKmNmf8VjT\\\\\\\/c48hm62FnyQGb3tdZ3Y8bTYzbTiqAIK+o1ENHw\\\\\\\/LS\\\\\\\/HBSSPWpLW0iQK+R4uFKYbxxypJIqed+0DyWCCa6rEzsPL4Ttal8szCnewwlwXNSYp2xHGXLSIF2VobWqMDqnL\\\\\\\/S\\\\\\\/r5oBq\\\\\\\/3iKBP9b8W8yDUcxVUe5zksrCFkgLKZiq+b4OGB4yxxFeIQYA\\\\\\\/UvJnM1WVMQE6PC1epeKwD\\\\\\\/wkrhk\\\\\\\/SOY26EMdpL5MzuITrOROLp4TVZCLWJ8jjZg5TIkuqhGC\\\\\\\/oX6oLWJP5Y12wwAfVt3KLs2InEGjGMhCLCrK0Jn8VLxAJUAyNrPbk4YEZswv4Y6nu5TFmSLyBWK4LL5eVM9SmRdWaHn5i3\\\\\\\/Sm9vpIYBhKG1mYBJqti1FpBy3MCtB9uZnFl1LhYikEmoQjwVetbC2omtbX0r5sKGc5loWx1vUgUvSjBchYUaXg5FnRCu8tekWqcRQCt5IgozhM+lEovJp1tBfM4BwLp4S11KqrEJhnyU+pnrZmyE9Twasi067h7Z8LB8tzFIjbQJSSXSpNn3WWobt04pS999QJxlV+JmeSJp5IVg\\\\\\\/WCHq1WbZOyF5bc8N4rJdfzaQhc9ALqUKQ\\\\\\\/BB5EA0eSQA4CSCU49PNm6cx+1GIInSNxFaE1Ovcyt64LYTkqbtZv1HkILha6dIHIh1JK6eWeLeuf7Adjf1fO8NyMt0jcQy9zfxlVBT1Z+93EJrYZnT5fxlOVFS9DgRTyyLej6cmOP\\\\\\\/IKdRollTig7oAov84DfB\\\\\\\/hRgjkiz4m\\\\\\\/stXRm6DNoE6rIORUtdZbYJkZzjez5DVaiAsBomA+SDUMT+WE837ULBe2XcBbvNFSHVCc2jgnB\\\\\\\/C8iMgZ2PS3cFv40gSpdxXndzrkYXzhxlcZ\\\\\\\/yiia4meo92+VT\\\\\\\/lGR9yMuGgRBmyEpSjoP\\\\\\\/fltOb1zxJuCgtGW18nSFAewZ3iRtYQHm74WOZSh4IHty5qhBxMKTwrv0VV40UazFSu6GrgfFUr9\\\\\\\/u1fLQ7BdVfEonyfR1QUU1BLMb7abdlogr9A4pWg4TC3GozLEYEH56Md21lqyIqowRoPBmgKgpB\\\\\\\/upR4vIMfRQVi\\\\\\\/Hy2cv1R8cUPKZTE6rAwi6ibGOSZr3ytL3fOidbYXLEsyUABW2bdkjCpbD9hindCYrMw+O\\\\\\\/eQAXkF2JpPiu8BmAELgN0liGrFwqlRuzdqiQ8HioIpexkaE8Av14ZOLOsDs4A6Z4BscsiFMBWedrg8D4BNw7UZRXFP9kFORqPYqYnXBSKJnb+W2FzMxqkyMh0Izw06IVrGdS9rLCptnDhrJD4cT+Ob5gtFM4kpuw0LFlw3Mx5qKS4RhmKdZsNychwk+3Nmp7EQ9DxNEIGl2qSi5dWTy0vrdm\\\\\\\/QDnuzIun1gdee79+pYCe9l\\\\\\\/YOJ6iJhC2nSMwKrrg0Ujwf6pv6H\\\\\\\/KR0xEuSasnFE0RXczhA\\\\\\\/9bEExmBu\\\\\\\/AxQ3YhkFqtoxePWY24ZXgkZTpsyq0w8gbmRuGpwk8sndfy8EpVIPyE9JH7OcM+3B2VlqUHoGOdftmwIGj+5nFLfsAIwvXVPrJprruSeJYVGn3HNSLThGIV6YGXj3g5Vb8u0fCwZTmVsiUNXzKcCIOaqYcSz+CMEbmJFvPcS3JXlnKrhOhr1NkoXx4WVBEG4ycAiixSLpmVjGOXdduwBip8+uAwPWAMfmZDXoCTXogtwuxUcfFXZdkJ7A2tndLttn16epwvhjFwEoS9ABRpMBdDUkLLefFKU9fnSb23y+eQRnc2l9f5pL4R4Vdmzk2nYBmggcr6Qke+nwkhUG\\\\\\\/OPPiEyAjAK7cZEM+9y7Msu0Fx6UJgWZaoUVcLtl8HqHTefzmW2vGlQSLA2vsFztPEvUouMWkDg6InQZAH6frgQSc\\\\\\\/WgU0hDF1z\\\\\\\/ToHkr3A3kTD0TGxMSdM8FbmPSxdu5QjTmVBMsJVflMtDzbC2ATphG81JtcoyMabBi9K6TvP0ScMAtajS9ScrMwBzOIVp\\\\\\\/8Np1HmGAxQMy0nZd4zrrVOobs6k+ww0dEb97GgDqBG07UeitsRMMlBh3jjLLGL0sG2y\\\\\\\/jx57o6A2sNjqfVMlBZbyPxK8tKKW482U1EAAgfPw7I7SH9EIaLRFHCxIp4EY7WbZXLY1tfacvdpMUNTPP5xj6IHCXPy23JlqHa1vjRuUE7gKg3QYV5mRNlUCTmxPkWh01lZwmmefvR6M1dZEeCm1Y13ujGzgKbVjv8HoebUXM8c4Yd6tftAOvQ9vSEBHj\\\\\\\/s8+jEFJKqfreFJ+z0Nk\\\\\\\/0Zj7rzKKOb51ul9Gj7Ozp9FmqR8Il0c\\\\\\\/s7eISN4fxynJMkTU96HeB2Wxd9ahieWfmBjwAg1Axt5lmiOivkS1Y\\\\\\\/1qNSeUsp4YonfRQgQX5nAM5XfOhyf7mOD6QlYb1UE22MxhYcjBY\\\\\\\/Zy9z4iqVMjcNMvg7jFtjQIK1fSVBBoDNvDt9y5zJoBuY5D9XBodpT3JfRLb0FkwzoOQBXNQkB3nlfhAbJEl2wNb+RknYxsC9PJiFu7FERx+1VX5gAVYDoTKY\\\\\\\/elGHezsF1r87H4xmMZRBQyK2GuXWnX5Judr02sRyDbnm9uPevXy9j9o6UcaK\\\\\\\/0JauZQWTaPtq8CbOE\\\\\\\/dTLZr0rLDtt1PNtHQcKiRe1+GA7mPZal1rf\\\\\\\/gI9566g6Z+GbY3KDyqftbDpM9crm8ZRTxAt3OJUB\\\\\\\/x\\\\\\\/djTfndLPg1ri2RshYHmN7i2sYxcCa3s+kGGnBZJxIWoKnCCMSw+J4kKpZLe8sXqR9VGRmhkfI\\\\\\\/jZYz7lMcY7tXIeo1b5i+vIMR+K2Hzw8OJcI8bJBo7vOZ561r5i55ogy6SHKX5aNu78obUHwBpzwKhX7T9XUryiY4f1Zfis2+ERczQHUuOHQw\\\\\\\/+KSAC5LtCrdyji6w0fiEyIEOL7H41cbVBaq2L4Gi0dXWgMk84PvT4VaS8gKxKParmnr3WQSAgZLYAt8\\\\\\\/C0+lUPyevzvwHeSRwqkcXuZ6hmMwSU79APno9aOkn+Af9aGdtWoN4\\\\\\\/khQ0rxaJNiPiact\\\\\\\/PGYCIxzRGM6hHa9LoYkWWYAeqI3sOPyvj73JYDQm25Ujxx6HHYoPiKwuGqko1xPPTLMkedpk3txpC2snxHhZW7VKLuoYr3YselKUXyh30T3eXXUQu7xXEF5nPULnmwxJtzntiM0zpkNUl\\\\\\\/Y8M7FHPY64mwdDfEB89DUvrCUmbOoR9FUIwDdX+xModFxiPuB+SO87QP0eNzzBD0gQW6IzXoZmXtFyPsLVrqEs0pkYuB8WRL2qdo7ODvE\\\\\\\/6y9pvjaozEIEU++yrBsF2cs1UGgFSJhIc7DI6nBdGlrbs0PjPbPD57aIdfGCng0tSmxfcrCyle9lfeXu7iJ8RoBGjWZj6RTXMYORZQfq3+vaymNBmXEi7J21521yWh56wWhHhD0\\\\\\\/DXyXNkkBjx3f1UpIJDlsCUVKt+ldb9qXt3zD5Tbvn7aaXZ3ac4CiQiNzIIVkAm8nFk78woYKpbsc4BNWVI3KOm5v+f+qIUsUr3DfXT+ugXcJe2iYe5V6IA6zWjaQZnejsxHBWjOshMNiDYLUWaj\\\\\\\/Evw72URpEjC1PKubWwvZBVyrALBs5itokQJyEAbGvfukH\\\\\\\/chM5BRjZdL6gka40DF4GDTjw9qxdzUbKhqBMH18zyJXZS\\\\\\\/7mDgaeptUTXVriSxcfR9KtSLVF95rKVZ40OMUwHStM1KJh8saqcKwvURp+z9fyEjHlTLItCuzuF66kwu7wla0wF3D36IHeGj7CMoC5ZtGaelJRc5NprrhUrrVo8LrswMHg632lG9ijTtyVbxvQtm6Kt7XphLzMnnKyCx8WKFSGk+MeeEhpow6KPa4g2lWw23LYmNRJ2isy7b3K1WnoKSF2RbHBiT1JznhXIr7a7sRkHVyVvQUkz4aS46CpsJINLG7nj9IK7E5\\\\\\\/BBIPq748gg\\\\\\\/RjSBU1rher4y9YEWz8NuPIoud4F4arBYzPe0OeuiIU1zS6jSiQSyliXJAgWfEgnFew1xGnbc3EQ1IXxUSjki5C\\\\\\\/Rc7UekP+pQ3JToFFewQ8dDvo256pvvIpADYD\\\\\\\/o2Z9rpNuTbCY\\\\\\\/bGffAXTf1s90L4y5koxRo4oQPC1OksmY2jv7GLg\\\\\\\/G9+LvG+GeqcIzgyittM7EBQH\\\\\\\/H0AaA17lTqigDaU55hzBKlUgmyHGRE15TtqtNik3UsGvAnZLlM68xwgRL\\\\\\\/NDUnsLYYtGSWLi9c0kT2bHWPKX3by2qdn8fsFB1j\\\\\\\/EZdoxSXLYxn3EIBfZ\\\\\\\/CRjBnjz+Dw9QTQULJ1O6L+73WA7iqUIdefshxAJERhTglIeVR8ZS4CxQwxui\\\\\\\/RzIuaKWJisaZmo\\\\\\\/xXyUeyoDYgr9c8DZ2zYO\\\\\\\/pjD+x3RgwxbJTEuazDSipQ3+M4PyJS4O4qDEHSI1PLB3s83WT5sw6lrNpVkdi57c\\\\\\\/3+iKRcEA6mX6uFFfc23Ee9cordYnH3Fqp4tpOScFTqy4YCK6UQMXR0eYTRdZZ9ew2aH2OEXuFb+FUtuF6P50n1kak+JICqe1SOLHhawtWcHc8qEcaevpZi7FPFYDX6\\\\\\\/xVoYROu+g4JxHBN4FDBrSxSymc06m4olxO1IKiraG3eOIuExve3IsHNyDP52uMXw2YLkcXOYjqVZUSQvjDb72VmuLfGpQC1jqPZYVZfkwQ21WlHjdSGL9cxRnRnskX3b1oUP0J+i1HZhq5soAxEMqQMUE8N+65VULtLpKh2oS88EFYk9SrFaDgf3PZ6ZKD6bO6huqBbu4MYcg4\\\\\\\/O30XFiLs0+VrJHFt8dlnB9\\\\\\\/S+vENr9nkK8b3UD3\\\\\\\/ylad8nkll2\\\\\\\/YftiLUM5mKWjkIgzTlX\\\\\\\/OSIhqWtaC4daXh4Sqn5L0TFWI985XLq9YRQZ4Ww6E3hgjPYhOEz\\\\\\\/InILITSI+jhcE2fKg76rfe073r9EWVuouec+5Z\\\\\\\/QpcULOweGe+yIF\\\\\\\/k1mh0rmbfD3Lrk2eoyeueVrETOJKW2NP397TuktVyrgLsuViMwtrQQ0oKAIizNl\\\\\\\/RQ+Vm7Sozk0NlNQ3vnBS0p\\\\\\\/a2FH1U\\\\\\\/2Jdlzefsod20wRUxKt8D4xtl2XzkZOEGQtZhN+1fEu\\\\\\\/\\\\\\\/14vge2tG6MooFcOmPUeu\\\\\\\/4YXOksaV8PXpm9J0zIPKQKBPmgx+NAekUrhEu4GQDK61aG91q\\\\\\\/ElxY4t9lSpTtbCc7bz4C3DaOOy0dOGxTyRLCyAkDZhE\\\\\\\/M5taN4bDQLTxwi+F2DQ6rCndBlplPMDY0ecH+htci1dsd4H9zQdchg6GKWvM5typPJanz5DLPDWRGQ8rRKn9BbD\\\\\\\/y30+f1Owt3nQfOyz6FfZxL+QFqnQaBn8GivuBMF32Mv9lAyWHoB+Ydu\\\\\\\/Omgy7wRy74D7FX4fjkejwWVoDsOIWqvSwBC4WW3OiQaAGlWBw9N+kZtBAy0CKKE+mdAz0Q47oNeRtR0x3UNWMzLZOEA9PFuPEfwzUp8MZYs5CO49hsKsvl0LehUrvU4lsEtzi5tNOtmfK\\\\\\\/9wsRp++tzuL\\\\\\\/HGAu7PW2PwACG1Czbxw52SK6DxBnXBA26N7wEAf+GixMIZ9+yDV\\\\\\\/tVyIsGgBA5gblkhKAVowDJxIDeW9aEG0DF\\\\\\\/Dgdcvf4eBlRrL+lndD+AzTucV7PmrbKJ2nYR7YNnm8dg6jVM7+U4oxUB+SqeE4OT+RdvZwWXXukc2jTLzu\\\\\\\/5QovLR1AlKTNCZL37q6uPqMSR2Qm7dgJ\\\\\\\/9KEBBcv12GHvoGk8EOvEypp+ycf\\\\\\\/Ye6dVyAaeG\\\\\\\/RaCjTL8fSgUe2WtOfeDxSIO8Yhi+t4qzGnWHWSmdRN4DuyNH9cBVyysm8tpAY9cFYHpQBiBjnSNvfcj4sUXuKBWicjFvpqw1EsYvcDqMAs1tE8yPbGm0yXITvxQIbuL1jyU0S\\\\\\\/Nno\\\\\\\/tACZ1xxRTBWdPTwhittUYaumgD8Oi1GMxiT6YqMkXhqzY3htwJIYbnxD85sms\\\\\\\/l4A0+uWcD1krpZGPMWbOOqL6FCb7V\\\\\\\/FCmwiMwU055Scm9waB1nP8csulsUBlE8rz40PRa4JM76s59Jq8A8CCn4JSxV\\\\\\\/\\\\\\\/cw7AdaFIHs\\\\\\\/rTzVRE\\\\\\\/vWDtC96dvgDGHAxzgq842XtDqJyLI3TtvqXlkxdnRU1AtIhwVD8aL5j2tu++UTfu+QcmmaxxWpM1mfB9hN2g9cn0kdnQANb6mzPGVX72LLDTCgq4PL\\\\\\\/1vexc1vCHOoRYtefkn7mr7Z3tq8ZmyK52sUE9topx7ZOKYEDKa5LBh0lAybGVuoQh2nEL5fs7aPWzFnKthTcButLlb4Kk7T5UjeRtg6g57BUfCALQOVwamqyPJy4fLTty1mzqG2kMz9JsgDRISzsyfFiW8Tr\\\\\\\/KN93DbTrmiMBayz5jWjimZd5KzpiY+4teLMB207+wSPw2sujEusHS9zEyOlyiTOVr4dob9gpV8vNBD7HFDEnFNUvIbRuKvx1ctlzrHJez9Q6tNkYAnPR+\\\\\\\/YsjE+rOK2kdIyyw9d4VLujDDZ1nAuSx1jnpV0CrpKv\\\\\\\/VDCv\\\\\\\/KSDTpSmah\\\\\\\/P7qjwSXutnmDdyMUhAREKHlgt\\\\\\\/cERA4uQRiusXkdypqFXsgtGuYptzGSw+4YW7SytYcxzMiVBnlVP3eHzfs+xDp0Mhj1AbWP9nq\\\\\\\/L0DclfCfseuwDNbBKUsli15hPhrm6LCvpNJHdoK0m\\\\\\\/q3MhzS756kik1SsjkuFM4Q2oP+O3ocFHNA1uexAD3IjI2noAU\\\\\\\/zb98fJUA0\\\\\\\/0mhAYy2VcnrF9taJsAEZNCkCpwjVti\\\\\\\/zcElVuSsEU820jJ2aoGh8JJovRIaIa8hNPrHX\\\\\\\/TrNYHvBMProUJCirF0oTULVmDBTaEfIYpAlcIGCdlwc54dxlHp6HTIVXV4VlyYUn7LOW7vM\\\\\\\/Yxqnq7LH+JlzbKcOXPVSffSetFEJEn21IEFFkVssZ4EUrAnQfqYQM4TBTIBRrvzQ5hq8h\\\\\\\/CtkTlpU5+r5wMLMAZSOuZ6k6nnI2XjPN3xZCDnatGaoEvL56oSU1astEXyXoppyBZl0FuSJH3t8qyBZGGXvfem8rkn+SJysDIhf3yoraScT+y9FbDOyi+45Rm6fCO1uAKPTpy4FckvrMBtVLd+PuoCfL+wtqTCj8O\\\\\\\/dDZzFLLyJ+MrZs4GWMHoBLMeP7O239G40wNbd7xJh317WhErKW+Px5a6a51MxqDh3Rlko3L1BicyYxoqX6zkiA+yU1FYEjaFkGyd1tSncf9cF0UhOLqM1574w1fErSlz8OtKL1XLbUHfOdPlOXRLoMgV\\\\\\\/3H9FnT+zl3UkAhdvqQ6u1zY2N9PsahZx4IvR\\\\\\\/WhZs\\\\\\\/N3uPeSbv67g1zXYZTFg0mL0wsOYnoQmJiheGHB9yGOQVjzW0GdERqzzQXT0Gf5CXSBAu9Q4EUVZNuXN\\\\\\\/BsBVrimpRnwVf5C\\\\\\\/Gs7P50AwA6dPLo578e10brl7JeB6e0hjf8hUWXkPkf3nnzwtyfEDXSqoPxnvpJzpUbjNvmHz\\\\\\\/6z4OsB7L9xrydftweVpM+Qt9hz2Egh1PNhym799oZlo1sJsULydXI6HzlEfL4Yp8lDi6YYY\\\\\\\/OrVbXO584SZfS7FaMuU2LNYD9cesoWqEOid8ISEo7P+nSEXerqjNp3kBo1bxQby1GzApYvje7McSazhfJ1qKu48CidV+6jKaI20Juiin1j66b\\\\\\\/+A7l49dVLkvD\\\\\\\/AMUpEA2XmE3DpHpc0aD8YgJ2EYsr4z85c+LeoAIaexVuPv2uHTq50AjjKGLs32tWzH4LY8QXJmjMR0ONPpwez\\\\\\\/VqfPTfbeo9FVubOKVAY6ceHQPIyrvQ7uGXg74G5EHBFGi61hpP5SU5GvvHNSCnVB+XGLtTQEmUwCIq9ywZ4Tq4qhYoj7PuzOmZY52P7Qd\\\\\\\/CVEUmpu9MQzZmDIoIhl8vq9JORTlY2vYUOr2VgKGhQ8+RLh21\\\\\\\/YkBIKORuXsHpNWDfgJ0MWrl5k7FvE8YXbbPvF09nY9e3vhlaH7Uu+otFuykyep40lEyngMB6fm6uHWsCOTi2245LUzds0KFFtekvHKxURG3UZ77FYl69SS9JyZmirY2i4Cprx8o5l3oLAdrnCiC90\\\\\\\/jDWK30cu2RVsqqBNtt9MUYuINP5btObl5r5wK1T+io\\\\\\\/iqB+R9pZHg4drzp33XDnWbXyKUn\\\\\\\/hnOVEsfpWsu3B00d6yr+OL2b6OSfuk6790fVS1bqLzXn0epBa1dIioiR+atvHazy0ysHfwrS5OMSQ47AjdmQN9OagJa5z71s7pXlxmRdfY2KPXdCqqqogE8x7Aymr+TJI+D5JEzsGYBkOZs\\\\\\\/KkM8VEjH6vytDg0c\\\\\\\/duLsHHFvMhunZHmtfYv4lU1GMdkCV\\\\\\\/SBfEmcdPM7dwFSqtke5Dxxw7LC9\\\\\\\/nbc+cnVvWp0qQRKfAvkCQElSfW3MUs3q0WvaJL25IZZsHSsT6wdeumD7gZ9uHCoH3CXCTTqPYyudiA97aUvyQBZDhFcCh3zEkGOt6iCh\\\\\\\/TT48OeG3ajtT7LLZqmaLu0OQm9Rdew4pE3vvrP6DdRQcRUvTDIPKRvDscFRmtCosS6Fi410hNR9AYLE0UJtaYlrIGFsGYWlYwFeh8mg9joG48YYKmOhhLsytJT7dcedduViHhTvE8iQQSUhppjJey23I7YRhEwhtAqJluuxCt9pcwiR2wewTEBEI0kCjV2vRvs3TwehBd9Y6Bi2uXZwjcHx4oFWgQfJkdglEudsOeAsIFYCAqC5jCj6p4i7JahtP9h7SXBnGdfMWjS0ApXESU+WRo208uO69yBBtnU381Mhq0zg5ZMnkND7GLi27ue\\\\\\\/Do\\\\\\\/wWCmy0HWZblvhjJ2DpWhsCcVR6R+TYq\\\\\\\/M+rJMpco4o46ulf1NzncBR3BijVrbTDG9+q90vR1lV6yOC2hVmWpjvxWcEys6vK2nSVuf1ZfxTe+N8iPwuSp3723FUCTN7xw3RsYTgpL8p1lyxshg+pnSYnYcY96q\\\\\\\/UPSLPJF+asDPgYZCKm0AQHydVmGPJzWdBlQZi4Hlh2MU44zuVKjVorriDGHD21CEVdGcqRC+09Cak2H5gXuyyiHE2LrvOe\\\\\\\/DEswKuyrdcD\\\\\\\/aroFUcd\\\\\\\/l3HcRlBMfXYTmlQWM+dbamseN7Cx\\\\\\\/mSK43Kcv2EoRJoW4fa7++rkRTg7XZVE3Axz44uAwFvVTlYcQGHDHy3OTeyCglN3ofrMFscttOsu4i0JP6n02KfKRLDwE98Se0dYVbll18b9oKojfPaFEIvh8T0ZtzvUDrle7fK5ik9zhpOmxK2RY4OWwTzvy4WkHQkFkhoEnXWzXOyMuDVOC7\\\\\\\/QTuXvFtDVD9Xzvew5ywqnJqjWLIc4EoCgzwLODOknmeps+4a7Wv9ja9gLfyvD6J6nbC14XlKQFfeLscrBnWclgDTnu6noJDeudtr\\\\\\\/Tj6YMAmYE1\\\\\\\/41BvKQ2nIXclOC\\\\\\\/4xBUEM0+hsIykKanSx118iMaUSWtrFog7GRRDChDv3p4KnkmgWOZ3SbtxvrL1JF5n2tCVALInRwbvNYDm8X1q9R3Dnsxv\\\\\\\/yXxGs+MgJkzmZneYnmdZvBt3ro0M+NULnTCBr7htJ9sZ3e6bMGmee44nvtDowUOJBHTA6EofZvx18Zkwbb3tcYkSPHMO7FA4vMvzoJqSMzNWnlN+IB5kIShLq1LmRgpm\\\\\\\/36cHo8ivJQWcWL9VGEj0qItUxLxMVencywv+FJPLGbr7CEVnVl5eT2P9hgbx26cPJ62xCwnJZPtGZ\\\\\\\/t08+kTkyw8PMCOCl\\\\\\\/j+1mrf8Cu8xpO7S\\\\\\\/O0+fWqHlXufVqBrFX5cuZ8fRo\\\\\\\/bY4G3mfg\\\\\\\/CKQslGDnTtLey1ltmez0tJ2HfAwnxSd5fhbDgFX\\\\\\\/PiNLeOIfgZ1bi7qIkpVGog+Qo7w\\\\\\\/uaESq0gAPO1Lf1HeB10H01jhTbanGjigvb+5jKQ\\\\\\\/mluPC1fVUHSe6FAGTtDQ\\\\\\\/RVF4zeu\\\\\\\/Bum\\\\\\\/z6aTfAQ36vQfDcB\\\\\\\/Hyl1WHHY5s5yCsQWp+ziDuwsSBbEq8AE7dID6DGk4NcvHYWJ8s\\\\\\\/yF7nQqbeb0Nj55Ub6gCdpRIiHThYAv8+NNqjPFh4+Evvt9Hzr45SxMnxBS16VJHkldjM0BuBqcWwd9sYlN6\\\\\\\/VXBR+00WJyXeJQKshVeKGsuSLvlWLBlFJNtNeAUVYHVB1NEx\\\\\\\/PlKfB8PlrTTvjYRYfa2yew\\\\\\\/0i07AiFGpGEl0e1xz1qxkxFP4xqykdGbmNr5HUagV\\\\\\\/GSF9OV25zrqGbuC\\\\\\\/w\\\\\\\/xt3O8qNxhoFehsXvMi769myhssQwRHvm9QJ0DRbvcO9EaTPUlN\\\\\\\/uICujDNi4fPL6DYHUk9+xLcw6MycegY8s2Tbu1XzqK229bSJk+66lmWyZCi8jJ+mzN0NUhGmrmpU5RZYdF7V87JvpCOtH9DPrp8DlbB10qrab6lrvuJ5Cn5JNTzhe384X1+8BDVVAUY\\\\\\\/E5SNlZj9apXzAxhyQKwGeTrZeSjIkacSO1s1VuOpdK5k9Y\\\\\\\/Zmh5j+mobMeZmEWQMySNbd9FK6gf\\\\\\\/734UStiIOTnKHdp4PexWXqz+rE+AZlGJ3gGQMTXPYoPg4Wu5bxMxltKTi\\\\\\\/hcNYs4Tqxoazr1r4wQ5Uo4bXVCCxcq+Gw5qsKiKe028SGAXUeolgBsOiufHCexH\\\\\\\/EGn7Famb8+3rpWp7rI1DGFIKBjYKQghvc5zn3DrCD2V3WIi7gA7ezGuTlrrdlhEyaFvGAXWyql3UG0mbDYDwKP\\\\\\\/RitSabvx5N+2kOHPGWEaHBRcICSxj3TZnrg80vsT8Y0sBLgZ9NUamEO5FJXybp5y19NHuW0+UyY+nshPZr9nDpNnijyXQtMwUU\\\\\\\/dwIyjGA9tPeLN+rZvHUWhWdTMg3jr8YCp3WzMgqX0eVx8j7WuA9mND69N3lANXwaDULqAMZpMeq0zISk97Qrf\\\\\\\/3JbFJ4QA+\\\\\\\/e8OU74mxdJDSa+JLZmGlOn+WzuF2qkGeGPQFk58ksVL6HDEDi\\\\\\\/pYI3GHM+xQqDm+JbHvjegDN6tH6W1GYKmnIardJ4+UNyqOgONDSq683GVGrL9UY9Ytzj9HclO96cTMZkwqU5sXtyi7FN8O++vrQvGdpbuGYnyWvQf52KZBBqLDtZm0mSxcV9TKWcYkf2c+wZrdyOBfFnWcMJy5imI3le13+KsErZPcVFnutHXX0HzQV\\\\\\\/XvtAoAtN6rDq22U2dfdvB8Bd88i1MMLep2jpNXsFvHogboHr5ng2UcvEBNxBEEWiEZC22EBF5SjhroIFOrJQDOxJtJDrPHvoSFh79lR1ynMwonZczR+s9BS5SK06HAxljoGKJbid8paldc4esNk23daFCkfJv30VAltM\\\\\\\/1f05CgA5hxs4GwtF4vMmvM+8kHgUAvU8h3WO0ru+Fg\\\\\\\/FY8zsSFoSO21SA\\\\\\\/wkBztbXVRVhIJN+ftA3U3QhgZJLNjt5wzhdAPiO1FzxUCISsVwnXvnkn3598vtAqg9F2f5lWYHq7lA9APgO9aW6W3SI38FJd95taTaeUdGd9Q\\\\\\\/Aww5Ggq09MpyzWeCH8o1jUc3sexwqKBJnxfwIkCi7vJQatLDTXO\\\\\\\/k+2guvB9Rfn86JEdVm1IiuNDPYr8S\\\\\\\/84ibOago9+EHeF6IvonbUDVhTorIxy0S3zw995DjPduSQ3NJCWiWM2ltJ3TXXII24JxUnckvZ9eOFBVVA6RcRm9SsgyUu40y68WxGIWVPSjyEItf2\\\\\\\/eYKMzitng8rlIWItQ1vm200UDK33D+\\\\\\\/7k0khN5+dhnaAlKHjq+Fk5KK3mc\\\\\\\/qRLDsvxXKaQAKaXX+kogbKmlrLWhNKCBWqh2JJZybI+jjdAoereZ7udMN+i\\\\\\\/adzwT1ncK1JZGnuDDL1KqGGMnWnO3opb7pbC1aqvd+9RUUWnKE34w6K+ghWLhCQa+US+J7RsrRkZfjNGE+VqAt5NaNnmSislkTIa4o20kuNFr8wJkkeItLH0D8X2hNtZQLfbJoISkejxi9TGXamD9s2h0T3ffVH\\\\\\\/lIn1QKWd4O0RmaSf1L4d\\\\\\\/06FlbK\\\\\\\/GaPSgj2HAU5NQ\\\\\\\/mmEkUNFMWDPCvLXZCXRvWD2boHnGqiU8gDV8KVvEERY41ntIcXEyNJ0o\\\\\\\/oUGQbDfPtmTpNZJYJCbmgvK6nAsPo1DcAYgRsf4Oa5w9eOSOHzvNoAyzhS1IJETdx4f8nRdbBcZKE+MHQyCPet2rhujoIxFc5gJ1Sg\\\\\\\/SLGz3tf2or30ALnR4wSRjoq2XuYFjVoGzfnabNJVjfthv94SIp5mbsbnyteiA5C843ulIoEyeyQ0rkhSp5jpwMP+UTssgLX4SpODHNgpZ7qLUODZp5nC794wBgS+0USh3ePU8v41ElPv9sogjlJ8qXHzWvyLxImfFfIw+lv8UCU6oocrG9b+zV1R0ksDoN2HuUxpxiqTakvuLl7XUeGBvaAg0rSXD93JEG0CgOOnQGfww9w2IaU4is0hDjb336TZY7w99gyj2nopgfLmxw\\\\\\\/XTNQrfSQNHjbu1zt3Gs3LtTz2B6OJ72DyBlm+jklUYNtTWm+j8uQQbWVbudlkDReBgbKfb+kos64B\\\\\\\/gtDEhVmMVbO45YCRKs\\\\\\\/T6BYBai5WJ\\\\\\\/RBhlmZUtMYj8\\\\\\\/8m28U352oopDoODZRJOfBPHOjBtZxcVBF+7QIoN1V0WiayoN1s5jsDcs6CJoes892mh0EruoKc8i6x7dKH7r7cdvTm\\\\\\\/2FBzP+GF0HIE0sqlUFiCJAaymK19zmfQMlyJcXJBl1ynDoD4WO4FNZzqmWUUHfkyfq2RuWgatDOrmL28tRYjVVQdMgUESNkhJMaxM2oeOYQV7OjDyk38p8y0TapVTvp3nAs\\\\\\\/XSPZ1UcjdCSqN4+zzTmvOQl+j3T4YHm3HP6dlfCI87sfpIDzJ+HSt\\\\\\\/GjPOngNz7ChlUhMBLD6lVvCEb50UbuiZ6NBiznqn6\\\\\\\/vyJuBKyvHGwM\\\\\\\/Nr0kCmrYIGvtTJlQnt4+udWZpQR247e0MTk3dB9YQwBP2f5UsUt\\\\\\\/8tokH+ZokUcomRu35pQxpWtfc227HOWxV8V+n9bLGMAX0uL0zIBuBnzdqG1alp+JMFeVEmJ06fRpg0HM0tYWRbLU4oWdqwzHgmh2c6ZzWMzPQcsRoZa4b2mHbf7YMA53TKDGoNVKCMiDKNBxCLpVuECqpFc82UR5VfKl6uFecap39DNX0lnfQU+meI4L99+\\\\\\\/O5nnCoZxUhZNtjG6vhCF8eKv6EMjfLljGJBxIaGYvMesMaLW9vuJOIQ+Q5IvUhtKmLkQIOc44QAIYNCbPdx+8+lkAttH8FdkKg+OlFws6qtAHb6g5J9A8a42vQdqSTl5CvvfDAqU8CkvSWBlde3d3Cf9dBsJMjVdjdlUCb69gM0c7dzSKbfzdt5Hf8eGRljvUZDHov8oXsU1JQwvE6vbw89E54HRPJoj799BgFPk+xRD3V5UuvtAggIQy1MBIeDodCAeRq5fg8b0jTmqt1hXlGwNZya3FCrO+a0sylwblwTk2vZJ9Z3+fonpWwMb397X\\\\\\\/7iPFPJ2J0\\\\\\\/5oXJlO5NBIWGb3oaUEerct3V2f37gGO283gPoYGOquKlExHeZ82HTXrGgMk5EkEqsHNsgh3EdmHiZDIE3D8uNeNv\\\\\\\/xnc0bSFN94b73enITxj0IvyUcSuaubTqdQJ9B3mzbcUsYldQ03jO+8I+MRtvf+dkrJG\\\\\\\/mTYkzF3TZtyjKuIBbtgxfgn8gdqFuQt4iFSEbC1qnVKmPKK355v\\\\\\\/yunzhBo8agLxioKiLlc\\\\\\\/ipX9idWhmAZRsuM0KYxvoHQCzasIVV9fr\\\\\\\/9XOsHhm985XktYLV4tgqHpSkWsI1L6\\\\\\\/kZs4hTiH7MehnuqkO1ZosqkblwEWKsgvDhBiXBgc9cMiTdm1QWhEImxQVg\\\\\\\/pg11HL602n+AzY1VubbeklvZwv9mj8KUeuD\\\\\\\/LWM9OFM9dcZqX\\\\\\\/b7qQiCHqeGdtUhTapt1ceE5OM4Y7Fn3kKr3HHtT5oBDCnZoLIq3jqyYFcIlHYyrKmIRyXBL1o4wE4Sqnd0Q2RfIjkb+eSFxFyzFKqYPwOkfGgxHJtWsw4bPsJfsxG3lp3LrHFbqYPlGanhk+KwLPt86A19WjNRmC9WtbRx2hzs2KlCJhRxN4aQh+pYxP429GtoJnUbmySKGgOAhG1XCRJOLT99F695ci4aTTpKaWjgM9E6h58In8C2A6kXdHp3m9upK14PTTSdRJyWkSd8Oa8pkavBFOwcZq+K+1o+H9m32tuvlX17sgIpBHQNe\\\\\\\/H8\\\\\\\/PGVoHMqoTFTeYycrRymFKTT8htjvNxOxCOWTko1xJrd30g1OFDC4oDFXWj1DpaN5dMOq3b8niy9cD7WdV3yH3IerPAaah5JPY0Uwcvp\\\\\\\/TB9lapTFKNg6simi2+yH\\\\\\\/TLIj9i5pwFYDDhyiM8ejryg2ry1pt7arYDpybs6WAwMlPlt51nAQYcsJtGl24RKl0mTvTRtDOLEUeA+8Et\\\\\\\/FwZJGeLxM3XtzgFw93HO48o3tBqdKORJ2Yf9NvdjSgiBzjXo9en6kVMTl4jOtqEV7iW5Eubn6461XEccWgk+jpHcZIUUGFDkY+lTLiTMYfpeCdZFt2rwRsVqipiP98wB3fZILYG2\\\\\\\/1VLv5xBTQ9Vf4ebvMbZaRVpp4k5YMGzn20vRYWCal+6Tn4j\\\\\\\/MOX7H6nJL\\\\\\\/4abLLSrOtrf2BpPZAyMYbdzATy\\\\\\\/KIYIaFMwCriXjoGj7KW7vqww78CO\\\\\\\/ON3d+6hEDRR3wsQn6faedS1+iiEVdj6zH5FLPH+M+njQZGyEZN010YvNxjM2KYFTRXQi1RETrJnof6EIyRehe8w9Ec5lUCoqIwtGDForxIxDzgUk\\\\\\\/Gw+LlX3dg10nVDc1GVI6nD9EofzEuoK1Dp6mU9r\\\\\\\/mQ\\\\\\\/zqsGAOPMfwaUjhvx091+8XJ+XpILzpHeQ+tFr4B78zL7Bp4qzDOFxVeBmUzJcuCrbkskI4n77V6m1zBYgPUhrvNYyT9BbXStfL4ySyKsN6+xzkPdENXI6arPThTHrNm6Qbzv7+96RbybfCTY2QBf5tkLTJpBU6KJ2fP5U4gF7GOWSVWBkzE+tIFJWPaJzCKquSlzD\\\\\\\/UfVq4bcor7JCjiWeW+WpMeh1A0STlynNuKQCOMDRZpMeLYiyyYhoTIRuq2E4j46vxAElSWdL0Jazc8vwuN9zmpaJS0pfEMP8MGxNdj37yQvrRU5lxXoERVVYoBvtEOYKmvwrdI8ekGWEexw3n5wH3FAZL8YyDMrYxV0eGfSnjZSgX2FxpTTmXk9u3VFbQNp8E4DOSHjPYKpb7yvV\\\\\\\/36zF850fPoxKg0w1dtanhxeoeLL\\\\\\\/8DHsevDGCErXHrcHHlYDA2s7mgET8\\\\\\\/boUW\\\\\\\/DKE4IVVffDH5bd58RhW1an9EZ+9N6D1JnSeGvc\\\\\\\/0bIkGJG5Z4QSRdvt8kBxVRonULEIKrcJTm4GU9Cjj5ybmPRUzSSjiaGaDPtrqfN+cNkV6lVXeFqmCcFeDT3rLldGkComJShRy3vghJtIcHTd2XdR2OrJLipF9+ZJ3V8KQH91bh\\\\\\\/1Y+kroGgYoD4sGB3jrOZMiXKax4\\\\\\\/8QL0U\\\\\\\/KZOC+nuOmcXT0FHlWS8Eoax\\\\\\\/reiE8Tc33RFrShgb8dJy0tcbH+CydCIHgPzHPIACFK4HyE4oxid1PrWTWHG0LMxtxPa3eAPADt85VPBF6z3F+F+VZTYek2JkZvy5\\\\\\\/bk4FVPTCi8E0v+GLaOW6rFJNj7adAcGkAO1nnJZuEoEb9ArMu+WWG46RyLlF58Wkud0IOt2E+FhefvmTGrbXC6j8FOpnniZDXPNZeMEoK6EM5JVqXMwRB2kMCRahk2DXZk+zU1DxD4xme7yHkarvD5wcNEU9Pa0MiaY976JopkVC3jGkyHKfAYDbEgbCmAsA9RbUGn\\\\\\\/mQvjFvZ\\\\\\\/pbF3tSfO2O3W2ccVwKPMABGTMCS2xTaqHrxg83UyD9VmGNVBgopax5ZYt0VZVgNIT1nzRkqNusXZ\\\\\\\/xfiaGaptdBKe7POyKl38ekt3tqChBnLEfoiSXGD15OHmfwQhYSjBvC4VRqibyOsoRHQLa3educ+5rQLAfpA2bXU2DQuqrv1Hc+Q+t7oL7AxNV0PdS3bdbe492Hka6UxuAXcefESID3WtHgBXKZsIDFJTuZWKqlmty7MWQHNGfPctGwMSAs7Sn6+DsrrVkVxslQ6gHgqAr\\\\\\\/p8uQv1JYc8j2U\\\\\\\/5VytSSGPmrVDvPmqd0ufHs6\\\\\\\/qUftg0V6Z\\\\\\\/QRyfp0Uadn7hU1m53YOKn9LDzpkBBSyMiTBeURnrVNkT4C0HBTlILO6mLrczdHGzCwYUge8DMOWEbSwt66qegZ6jvy1U3241FGmMk2iW1mOh8whPK6b4msmb5x68etCNAPbWV\\\\\\\/PrFALrwpgIgqnYZWQg2+v5PM2MjJzOM95aW88kkomttVjoxTecwBH1cSDnHR3u6c0gbFMskTLiseqwbFh3p1Ew2PysaTJByiLxwHUcZjv5ZnM3qiOTFkPv1w6TlQS\\\\\\\/NInE8k3+WzuhmJJ7bw9k6v6OQtTtMoKesZ4xA5WV6v1d6+F7jx8l00mZBnze2ywz0n7mxqP9LJd6gmW4mu4QKBoKtsrc6OOTOpQf91rBFf4afYQCi1w2ymaSr7gJOzdoRARvTludOR\\\\\\\/3fP0rI3YwojdJD4ZifQtn\\\\\\\/WujGf6QMoSQiplnHUu\\\\\\\/fBVgnYmcYUeTHHVnNQDwVkGKHNM90ku4tq7Jc+cefZXMtVr1V63N\\\\\\\/9yRtdFf4QWd8qlfAxztdK6NiUTjrCY8VHlVknCnaSZ7zi7J0np8WKuQf\\\\\\\/4czFZcF47la+i\\\\\\\/vbMgZiFvIjvYzuCfUrTx9sN7Lxw20VUrZBrTIedTpYV+ceDETwYArTCB80oy63dcsABtO9J+\\\\\\\/FXXR+h63sdvhKzg4xG6euTTn\\\\\\\/Z2o8nA3X3P82EdHIbLyKjaZpS6HSv60qd7mbia7nHsjDoXm0w6n+c9A7usOmpOT4SwzrJtYZyn1dlpjIDNHa7\\\\\\\/VUhu3dpFCCZJDWcjV7vZa+knB8aGAcUAjmlawXuGh31JMj6w3ZfBf68NQ5QnIBJ6wIS71Z3aRLIf9Iz1AwsGtgMxFAQqcJuxmJbr\\\\\\\/nNHSS1uwUpfso35+ljSr7Lp4TvN+Fe8IsL1YMxs1FH+m4Hj2MpyGL3SIhj37nwhbTIdOY8SVJrrEAxd8rrbqYHffCTt0VahPLxq0E+deZrQNl3TUFNn6YQE5aNzqyLMk3CzjVtp\\\\\\\/b8in\\\\\\\/eI1Nfjvjhy7Qj5gi2XMSBlFEM\\\\\\\/o3+lIQhsqzFfLbAEOCoWLQ7gtRRoAUBNwam3D0ntBdzutG+vnUwcR47BYHR7bvczhfr9PZa0fXJhd5S8ShWmysBn0wYsxce2ootK4\\\\\\\/fVDkuTceOivodUyg5urADcjBbA4zEOih0iNu5PoEG5ynopmXvHIt0AaTjjsC2awh+YrsYbKcOY9xf4DrLnTYtCmQDTmhXc7CwvF6dliyax9RrHkNJTR3wvefZbVBH\\\\\\\/dqYVb0sSqIRjXMdUCWrBkTCrLKuMYbLyLSCXW+0naNUd\\\\\\\/dPDzRhoNW2Cm\\\\\\\/qJgqDKQDxroJd643LEABkqupCer08kF+FXR4A60GX6zJtfAtPO3O2Vk+ozz2yK8MIcKJq81Hyop7UeZESZEzqBc4f\\\u0022,\\\u0022iv\\\u0022:\\\u0022Cg+zJ0Pfq5x3TGHX6ehJwg==\\\u0022,\\\u0022salt\\\u0022:\\\u0022c61521e99d992105f48078da3e31e17d\\\u0022}\u0022,\u0022hmac\u0022:\u00228313554d8bb5dfc280f751f2d1b656a5fdcb2bbcf0512be658af2e22588e8ade\u0022}","new-2":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022F7ZB\\\\\\\/ko81YnKEqzJgx5GLvF32FOes0DQGmHqq105P+WwBf7FSmoz7j3Rd8JHQNT2Sa0OWiPLleehc6XCvRr2RnhfgSLf+OgIP+asYZOVhFthQn7zTlQNldWk2ur74vcKWgYmQGyxT+v04D5\\\\\\\/DSvCVxDeGhHRtbKtkJiMI1D3u0bjJa7hlPJfRNTUGShH\\\\\\\/Sdypolphgy+2iRZiU\\\\\\\/27oeafB+BzvEh9OM6pGv\\\\\\\/4kdCUdAinSt5GKExDMp6qxUJq+7u7isDkJubS05Ny4uetJLxpzop7ajCqx\\\\\\\/NlDiEVz7Se8nctv59y3xTKh5P76205U6fEjXiAB0h+bGyHmxK6O3XmBm5J12n+cqBxmxxJJm6WSD8ndG8euqVa7vVo2q9T2lZo6w+G+EmEnVDJVcPf1mELMjtL+AEWANu\\\\\\\/Mn8L2ulkPg7sNPfWqDXiMpGD4gsEicF\\\\\\\/+ybRVc3fua8YCVB+Cb\\\\\\\/IAJRBfqdv15doREtLGoiZBHe9gv41j\\\\\\\/xqFF53i\\\\\\\/GZuH8Knc7RBWBzUDSj2jK\\\\\\\/l5uimd7DAPgXo3lGjkDxOe9Umsxl9txpfbsRLlTpbjzYjn9zV6ASCYcznJ0+4wuxplxu2ZnZ+6PbPyZoQTsgT3P\\\\\\\/QvREUMPIpmcyXV1qkYGjrlHSM++vRI7A35Y5WWbZle0FkPwWWjcT+cWcySSpAmuBcys3a1AQ9xwg0U0sSCUtvaqzkDF2uQoYfq7GIGJOvIFTcaM1lxo8l8BXAHe7DZDdP9LSTvw+8xORWy2stlMKJDuScA+qnXdwgD5GU8JgihmWU1\\\\\\\/Y0toZzqqOFoixMTqy5i6YsNIvvpdHMkNOY32825ak3luhgKaGCT79IZHjA13FixbkgO93Iou0MelVgRXH7220+ttFKdRQFEfM8j4eX8jHM0qFaHlUn2Ql\\\\\\\/\\\\\\\/7fOoqR2mestzubwBiKRUUw2AULLaPSifWdHkLhCReC\\\\\\\/8O2pEKKGc7TLVeMGUp\\\\\\\/MHE4p+zlxn9VXbSqeHenNsGkahrJJQSr0SZzUobxd1ng\\\\\\\/kx41wNgFSIbnSIXflILuYsbPPa39b09uv31+QMIdZDRZIRKdW9+ne4PMpwwxwaiVeBTNsRn4AzqY\\\\\\\/cZARtR2yTbGNZmtRZG78k8HHfbNd2LwD6juMK6AemV87YOlNZ2SNR0ESaPAHG8si3o+RYLzRrQOCqJTFigPlXT6H1zk16wvp\\\\\\\/S\\\\\\\/ur89jjyPMmdJ5qZhoGt6S+S3IonOX0kHQBl3mhIm++I+PmJynRj9w4hnBijEDMRdkDnsbu+ZJ9Zyrr8gyrpuy66zdk0+iwMbNMUKCY6UOIrhqfkvzjV+Ex0TAPmrlEml8dJOv7m8Hn1DBlP6gE24rNUGgRlY3F3n0fKzabpMGdgsawrXW3gEXIbz4NEisiwj\\\\\\\/b\\\\\\\/aeDlpLsFJAaS66CvycQA\\\\\\\/SpxqDbQrYDOoL78ZzHwX+dM4XkXyyDOCzvUIdYJuGKnr6u7RRO7CjP9grqMqmleLoFdnAc5oFIbblSQolncdAEGzmDhhtWKKMyywb4Jzy27fKSSXwb+V1xYDIu68\\\\\\\/QevyJoq3OqJ4bIFXAQVIGUKrzOJ7Bp1vbt3\\\\\\\/UuwLYbMKuxhRmzrnvv7z50H5v1K5rUvx12jyqILNLBib5vPkmEGjF9x4eYXIx3\\\\\\\/8Io7mDy0NhXeGZd0cz8pprVv0Oyl1aqnSNKe+\\\\\\\/1V8fgci13+Z2gzAK0ZFFwykEtaoLSh9cgqOYDS7Glfys16AfF7JEuj+wUMlxswynGANB4Ax11FPz7DXAsI1It+mSNKtoZMp2FBauY42Yj3H86snKSQ0OF6eDs3a9PVeyc7qCql7qSL0LWTgECHzVLAF7ba2WBE2az7glAlu15y8Wi5CpVxlCsFVAy6i0cETDpxiKks35NtW30ZbzNac8dc663pPBzcrQ94UQLxUe0UN1PhvmRiI3YwLoTfWg6J8YigNrDpb81JMLzxDcZHf82cvvaMy8v5ro9NNlwTrqMzq7YiFV\\\\\\\/w2xz5cUa1OmAp2DU2DSrWZ0cyVi0rFoWGVTXBN16JMptM9ShrptKrES4VWIzxBjqMviHGldqO9H5R6LrUCZ\\\\\\\/hg+8RqjQA==\\\u0022,\\\u0022iv\\\u0022:\\\u0022ueqcNitw7\\\\\\\/sTk8axLDav0g==\\\u0022,\\\u0022salt\\\u0022:\\\u0022c61521e99d992105f48078da3e31e17d\\\u0022}\u0022,\u0022hmac\u0022:\u00223df144de4aab1f15c0977bfdfd17d9839a44e711026c6e61009daed07a18aa5c\u0022}"},"ajax":{"edit-submit--3":{"callback":"highwire_alerts_login_form_submit","wrapper":"alerts-form-wrapper","event":"click","url":"\/system\/ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Submit"}}},"urlIsAjaxTrusted":{"\/system\/ajax":true,"\/content\/47\/3\/923.full":true},"panels_accordion":{"highwire_article_accordion_container":{"heightStyle":"content","autoHeight":false,"collapsible":0,"region_accordion_id":"highwire_article_accordion_container","active":0,"animated":"slide"}},"nice_menus_options":{"delay":800,"speed":"fast"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EThank you for accepting cookies. You can now hide this message or find out more about cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"https:\/\/www.asm.org\/index.php\/privacy-policy-and-terms-of-use","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1},"asmGTM":{"user_type":"Non-member","is_article":true,"date":"March 01 2003","date_split":{"year":"2003","month":"3","day":"1"}},"color":{"logo":null},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--><!]]>
</script>
    <!--[if lt IE 9]><script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  </head>
  <body class="html not-front not-logged-in page-node page-node- page-node-81053 node-type-highwire-article context-content hw-default-jcode-aac hw-article-type-research-article hw-article-category-susceptibility"><noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-PZPCQN5" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <div id="skip-link">
      <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    </div>
    <div class="region region-page-top" id="region-page-top">
  <div class="region-inner region-page-top-inner">
      </div>
</div>    <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
      <header id="section-header" class="section section-header">
  <div id="zone-user-wrapper" class="zone-wrapper zone-user-wrapper clearfix mobile-hidden print-hidden">  
  <div id="zone-user" class="zone zone-user clearfix equal-height-container mobile-hidden print-hidden container-30">    
  	    <div class="grid-10 region region-user-first equal-height-element" id="region-user-first">
  <div class="region-inner region-user-first-inner">
    <div class="block block-nice-menus block-2 block-nice-menus-2 odd block-without-title" id="block-nice-menus-2">
  <div class="block-inner clearfix">
                
    <div class="content clearfix user-menu-dropdown user-menu-dropdown-logo user-menu-dropdown-logo-only">
      <nav class="menubar-nav"><ul class="nice-menu nice-menu-down nice-menu-umbrella-menu" id="nice-menu-2" role="menu"><li class="menu-653 menuparent  menu-path-journalsasmorg- first odd last" role="menuitem"><a href="http://journals.asm.org/" data-hide-link-title="0" class="" data-icon-position="">ASM</a><ul role="menu"><li class="menu-654 menu-path-aacasmorg- first odd " role="menuitem"><a href="http://aac.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Antimicrobial Agents and Chemotherapy</span></a></li>
<li class="menu-765 menu-path-aemasmorg-  even " role="menuitem"><a href="http://aem.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Applied and Environmental Microbiology</span></a></li>
<li class="menu-767 menu-path-cmrasmorg-  odd " role="menuitem"><a href="http://cmr.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Clinical Microbiology Reviews</span></a></li>
<li class="menu-766 menu-path-cviasmorg-  even " role="menuitem"><a href="http://cvi.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Clinical and Vaccine Immunology</span></a></li>
<li class="menu-768 menu-path-asmscienceorg-content-journal-ecosalplus  odd " role="menuitem"><a href="http://www.asmscience.org/content/journal/ecosalplus" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">EcoSal Plus</span></a></li>
<li class="menu-1425 menu-path-ecasmorg-  even " role="menuitem"><a href="http://ec.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Eukaryotic Cell</span></a></li>
<li class="menu-770 menu-path-iaiasmorg-  odd " role="menuitem"><a href="http://iai.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Infection and Immunity</span></a></li>
<li class="menu-771 menu-path-jbasmorg-  even " role="menuitem"><a href="http://jb.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Bacteriology</span></a></li>
<li class="menu-772 menu-path-jcmasmorg-  odd " role="menuitem"><a href="http://jcm.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Clinical Microbiology</span></a></li>
<li class="menu-773 menu-path-asmscienceorg-content-journal-jmbe  even " role="menuitem"><a href="http://www.asmscience.org/content/journal/jmbe" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Microbiology &amp; Biology Education</span></a></li>
<li class="menu-774 menu-path-jviasmorg-  odd " role="menuitem"><a href="http://jvi.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Virology</span></a></li>
<li class="menu-775 menu-path-mbioasmorg-  even " role="menuitem"><a href="http://mbio.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mBio</span></a></li>
<li class="menu-776 menu-path-mmbrasmorg-  odd " role="menuitem"><a href="http://mmbr.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology and Molecular Biology Reviews</span></a></li>
<li class="menu-769 menu-path-mraasmorg-  even " role="menuitem"><a href="http://mra.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology Resource Announcements</span></a></li>
<li class="menu-777 menu-path-asmscienceorg-content-journal-microbiolspec  odd " role="menuitem"><a href="http://www.asmscience.org/content/journal/microbiolspec" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology Spectrum </span></a></li>
<li class="menu-778 menu-path-mcbasmorg-  even " role="menuitem"><a href="http://mcb.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Molecular and Cellular Biology</span></a></li>
<li class="menu-779 menu-path-msphereasmorg-  odd " role="menuitem"><a href="http://msphere.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mSphere</span></a></li>
<li class="menu-780 menu-path-msystemsasmorg-  even last" role="menuitem"><a href="http://msystems.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mSystems</span></a></li>
</ul></li>
</ul></nav>
    </div>
  </div>
</div>  </div>
</div><div class="grid-20 region region-user-second equal-height-element" id="region-user-second">
  <div class="region-inner region-user-second-inner">
    <div class="block block-panels-mini highwire-uid-string block-jnl-asm-uid-strng block-panels-mini-jnl-asm-uid-strng odd block-without-title" id="block-panels-mini-jnl-asm-uid-strng">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_uid_strng">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-user-identities" >
  
      
  
  <div class="pane-content">
    <div class="highwire-user-message" data-separator=" | "><span class="highwire-user-institution" data-id-type="institution" data-identity="a%3A2%3A%7Bs%3A4%3A%22show%22%3Bi%3A1%3Bs%3A7%3A%22message%22%3Bs%3A85%3A%22%3Cspan%20class%3D%22narrow-hidden%22%3EInstitution%3A%20%3C%2Fspan%3E%5Bidentity%3Ainstitutional_display_name%5D%22%3B%7D"></span></div>  </div>

  
  </div>
<div class="panel-pane pane-block pane-system-user-menu links inline pane-system" >
  
      
  
  <div class="pane-content">
    <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/user/login?destination=/content/47/3/923%3Fvariant%3Dfull-text" class="" data-icon-position="" data-hide-link-title="0">Log in</a></li>
<li class="leaf" role="menuitem"><a href="/alerts" class="" data-icon-position="" data-hide-link-title="0">My alerts</a></li>
<li class="last leaf" role="menuitem"><a href="/cart" class="link-icon-right link-icon"><span class="title">My Cart</span> <i class="icon-shopping-cart"></i></a></li>
</ul></nav>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
</div><div id="zone-advertising-top-wrapper" class="zone-wrapper zone-advertising-top-wrapper clearfix">  
  <div id="zone-advertising-top" class="zone zone-advertising-top clearfix container-30">
    <div class="grid-28 suffix-1 prefix-1 region region-ad-top" id="region-ad-top">
  <div class="region-inner region-ad-top-inner">
    <div class="block block-panels-mini block-home-page-top-banner-add block-panels-mini-home-page-top-banner-add odd block-without-title" id="block-panels-mini-home-page-top-banner-add">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-flexible panels-flexible-new clearfix" id="mini-panel-home_page_top_banner_add">
<div class="panel-flexible-inside panels-flexible-new-inside">
<div class="panels-flexible-region panels-flexible-region-new-center panels-flexible-region-first panels-flexible-region-last">
  <div class="inside panels-flexible-region-inside panels-flexible-region-new-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
<div class="panel-pane pane-dfp-pane rtecenter" >
  
      
  
  <div class="pane-content">
    <div id="dfp-ad-asm_leader_mob-wrapper" class="dfp-tag-wrapper">

<div  id="dfp-ad-asm_leader_mob" class="dfp-tag-wrapper">
  <script type="text/javascript">
    googletag.cmd.push(function() {
      googletag.display("dfp-ad-asm_leader_mob");
    });
  </script>
</div>
</div>  </div>

  
  </div>
  </div>
</div>
</div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
</div><div id="zone-superheader-wrapper" class="zone-wrapper zone-superheader-wrapper clearfix mobile-only print-hidden">  
  <div id="zone-superheader" class="zone zone-superheader clearfix mobile-only print-hidden container-30">
    <div class="grid-30 region region-superheader" id="region-superheader">
  <div class="region-inner region-superheader-inner">
    <div class="block block-panels-mini block-responsive-menu block-panels-mini-responsive-menu odd block-without-title" id="block-panels-mini-responsive-menu">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-responsive_menu">
  <div class="panel-panel panel-col">
    <div><div id="unique-id3" class="highwire-responsive-toggle-group"><div class="panel-pane pane-panels-mini pane-responsive-menu-main-menu" >
  
        <h2 class="pane-title"><i class="icon-reorder"></i><span class="element-invisible">Main menu</span></h2>
    
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-responsive_menu_main_menu">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-menu-tree pane-main-menu" >
  
      
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-ctools-main-menu-1 menu-name-main-menu parent-mlid-main-menu:0 menu-level-1">
  <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-862" role="menuitem"><a href="/" data-hide-link-title="0" class="" data-icon-position="">Home</a></li>
<li class="expanded menu-mlid-659" role="menuitem"><a href="/latest" data-hide-link-title="0" class="" data-icon-position="">Articles</a><nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-787" role="menuitem"><a href="/content/current" data-hide-link-title="0" class="" data-icon-position="">Current Issue</a></li>
<li class="leaf menu-mlid-1426" role="menuitem"><a href="/content/early/recent" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Accepted Manuscripts</a></li>
<li class="leaf menu-mlid-1517" role="menuitem"><a href="https://journals.asm.org/content/covid-19" data-hide-link-title="0" target="_blank" class="" data-icon-position="">COVID-19 Special Collection</a></li>
<li class="leaf menu-mlid-663" role="menuitem"><a href="/content/by/year" class="" data-icon-position="" data-hide-link-title="0">Archive</a></li>
<li class="last leaf menu-mlid-1424" role="menuitem"><a href="/content/by/section/Minireview" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Minireviews</a></li>
</ul></nav></li>
<li class="expanded menu-mlid-939" role="menuitem"><a href="/content/submit-manuscript" data-hide-link-title="0" class="" data-icon-position="">For Authors</a><nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-940" role="menuitem"><a href="/content/submit-manuscript" data-hide-link-title="0" class="" data-icon-position="">Submit a Manuscript</a></li>
<li class="leaf menu-mlid-666" role="menuitem"><a href="/content/scope" data-hide-link-title="0" class="" data-icon-position="">Scope</a></li>
<li class="leaf menu-mlid-667" role="menuitem"><a href="/content/editorial-policy" data-hide-link-title="0" class="" data-icon-position="">Editorial Policy</a></li>
<li class="leaf menu-mlid-668" role="menuitem"><a href="/content/submission-review-publication-processes" data-hide-link-title="0" class="" data-icon-position="">Submission, Review, &amp; Publication Processes</a></li>
<li class="leaf menu-mlid-669" role="menuitem"><a href="/content/organization-and-format" data-hide-link-title="0" class="" data-icon-position="">Organization and Format</a></li>
<li class="leaf menu-mlid-676" role="menuitem"><a href="/content/author-corrections-errata-retractions" data-hide-link-title="0" class="" data-icon-position="">Errata, Author Corrections, Retractions</a></li>
<li class="leaf menu-mlid-671" role="menuitem"><a href="/content/illustrations-and-tables" data-hide-link-title="0" class="" data-icon-position="">Illustrations and Tables</a></li>
<li class="leaf menu-mlid-678" role="menuitem"><a href="/content/nomenclature" data-hide-link-title="0" class="" data-icon-position="">Nomenclature</a></li>
<li class="leaf menu-mlid-672" role="menuitem"><a href="/content/abbreviations-and-conventions" data-hide-link-title="0" class="" data-icon-position="">Abbreviations and Conventions</a></li>
<li class="leaf menu-mlid-835" role="menuitem"><a href="/content/publication-fees" data-hide-link-title="0" class="" data-icon-position="">Publication Fees</a></li>
<li class="last leaf menu-mlid-948" role="menuitem"><a href="https://journals.asm.org/content/ethics-and-policies" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Ethics Resources and Policies </a></li>
</ul></nav></li>
<li class="expanded menu-mlid-664" role="menuitem"><a href="/content/about-aac" data-hide-link-title="0" class="" data-icon-position="">About the Journal</a><nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-1427" role="menuitem"><a href="/content/about-aac" data-hide-link-title="0" class="" data-icon-position="">About AAC</a></li>
<li class="leaf menu-mlid-823" role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" class="" data-icon-position="">Editor in Chief</a></li>
<li class="leaf menu-mlid-824" role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Editorial Board</a></li>
<li class="leaf menu-mlid-830" role="menuitem"><a href="https://journals.asm.org/content/reviewers" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Reviewers</a></li>
<li class="leaf menu-mlid-833" role="menuitem"><a href="https://www.asm.org/Newsroom" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For the Media</a></li>
<li class="leaf menu-mlid-831" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Librarians</a></li>
<li class="leaf menu-mlid-832" role="menuitem"><a href="https://journals.asm.org/content/advertising" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Advertisers</a></li>
<li class="leaf menu-mlid-677" role="menuitem"><a href="https://journals.asm.org/alerts" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Alerts</a></li>
<li class="leaf menu-mlid-1516" role="menuitem"><a href="https://www.youtube.com/playlist?list=PL1DFmJFZvefiidG0t8jEKTdITXxJrmdO5" data-hide-link-title="0" target="_blank" class="" data-icon-position="">AAC Podcast</a></li>
<li class="leaf menu-mlid-829" role="menuitem"><a href="/content/rss" data-hide-link-title="0" class="" data-icon-position="">RSS</a></li>
<li class="last leaf menu-mlid-828" role="menuitem"><a href="/content/faq" data-hide-link-title="0" class="" data-icon-position="">FAQ</a></li>
</ul></nav></li>
<li class="last expanded menu-mlid-1434" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Subscribe</a><nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-1435" role="menuitem"><a href="https://journals.asm.org/content/members" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Members</a></li>
<li class="last leaf menu-mlid-1436" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Institutions</a></li>
</ul></nav></li>
</ul></nav></div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-menu-tree pane-umbrella-menu" >
  
      
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-ctools-umbrella-menu-1 menu-name-umbrella-menu parent-mlid-umbrella-menu:0 menu-level-1">
  <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first last expanded menu-mlid-653" role="menuitem"><a href="http://journals.asm.org/" data-hide-link-title="0" class="" data-icon-position="">ASM</a><nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-654" role="menuitem"><a href="http://aac.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Antimicrobial Agents and Chemotherapy</span></a></li>
<li class="leaf menu-mlid-765" role="menuitem"><a href="http://aem.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Applied and Environmental Microbiology</span></a></li>
<li class="leaf menu-mlid-767" role="menuitem"><a href="http://cmr.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Clinical Microbiology Reviews</span></a></li>
<li class="leaf menu-mlid-766" role="menuitem"><a href="http://cvi.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Clinical and Vaccine Immunology</span></a></li>
<li class="leaf menu-mlid-768" role="menuitem"><a href="http://www.asmscience.org/content/journal/ecosalplus" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">EcoSal Plus</span></a></li>
<li class="leaf menu-mlid-1425" role="menuitem"><a href="http://ec.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Eukaryotic Cell</span></a></li>
<li class="leaf menu-mlid-770" role="menuitem"><a href="http://iai.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Infection and Immunity</span></a></li>
<li class="leaf menu-mlid-771" role="menuitem"><a href="http://jb.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Bacteriology</span></a></li>
<li class="leaf menu-mlid-772" role="menuitem"><a href="http://jcm.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Clinical Microbiology</span></a></li>
<li class="leaf menu-mlid-773" role="menuitem"><a href="http://www.asmscience.org/content/journal/jmbe" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Microbiology &amp; Biology Education</span></a></li>
<li class="leaf menu-mlid-774" role="menuitem"><a href="http://jvi.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Virology</span></a></li>
<li class="leaf menu-mlid-775" role="menuitem"><a href="http://mbio.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mBio</span></a></li>
<li class="leaf menu-mlid-776" role="menuitem"><a href="http://mmbr.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology and Molecular Biology Reviews</span></a></li>
<li class="leaf menu-mlid-769" role="menuitem"><a href="http://mra.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology Resource Announcements</span></a></li>
<li class="leaf menu-mlid-777" role="menuitem"><a href="http://www.asmscience.org/content/journal/microbiolspec" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology Spectrum </span></a></li>
<li class="leaf menu-mlid-778" role="menuitem"><a href="http://mcb.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Molecular and Cellular Biology</span></a></li>
<li class="leaf menu-mlid-779" role="menuitem"><a href="http://msphere.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mSphere</span></a></li>
<li class="last leaf menu-mlid-780" role="menuitem"><a href="http://msystems.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mSystems</span></a></li>
</ul></nav></li>
</ul></nav></div>
  </div>

  
  </div>
</div>
  </div>
</div>
  </div>

  
  </div>
<div class="panel-pane pane-panels-mini pane-responsive-menu-user-menu" >
  
        <h2 class="pane-title"><i class="icon-gear"></i><span class="element-invisible">User menu</span></h2>
    
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-responsive_menu_user_menu">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-menu-tree pane-user-menu" >
  
      
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-ctools-user-menu-1 menu-name-user-menu parent-mlid-user-menu:0 menu-level-1">
  <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-690" role="menuitem"><a href="/user/login?destination=/content/47/3/923%3Fvariant%3Dfull-text" class="" data-icon-position="" data-hide-link-title="0">Log in</a></li>
<li class="leaf menu-mlid-689" role="menuitem"><a href="/alerts" class="" data-icon-position="" data-hide-link-title="0">My alerts</a></li>
<li class="last leaf menu-mlid-1423" role="menuitem"><a href="/cart" class="link-icon-right link-icon"><span class="title">My Cart</span> <i class="icon-shopping-cart"></i></a></li>
</ul></nav></div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-user-identities" >
  
      
  
  <div class="pane-content">
    <div class="highwire-user-message" data-separator="|"><span class="highwire-user-institution" data-id-type="institution" data-identity="a%3A2%3A%7Bs%3A4%3A%22show%22%3Bi%3A1%3Bs%3A7%3A%22message%22%3Bs%3A50%3A%22Institution%3A%20%5Bidentity%3Ainstitutional_display_name%5D%22%3B%7D"></span></div>  </div>

  
  </div>
</div>
  </div>
</div>
  </div>

  
  </div>
<div class="panel-pane pane-panels-mini pane-responsive-menu-search" >
  
        <h2 class="pane-title"><i class="icon-search"></i><span class="element-invisible">Search</span></h2>
    
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-responsive_menu_search">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-qsearch-nocontext" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/47/3/923.full" method="post" id="highwire-search-qsearch-nocontext-form" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords">Search for this keyword </label>
 <input placeholder="Search..." type="text" id="edit-keywords" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><i class="icon-search"></i><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--5" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-nR8m8mGGzur6W-Qb1zd_k8j30ni7kZbq7Ei1LM8ofKg" />
<input type="hidden" name="form_id" value="highwire_search_qsearch_nocontext_form" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-2 highwire-responsive-advanced-search-link pane-menu-tree" >
  
      
  
  <div class="pane-content">
    <ul class="menu">
  <li><a href="/search" title="Advanced search">Advanced search</a></li>
  </ul>  </div>

  
  </div>
</div>
  </div>
</div>
  </div>

  
  </div>
</div></div>
  </div>
</div>
    </div>
  </div>
</div><div class="block block-panels-mini block-hw-small-logo block-panels-mini-hw-small-logo even block-without-title" id="block-panels-mini-hw-small-logo">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-hw_small_logo">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-small-logo" >
  
      
  
  <div class="pane-content">
    <a href="/" class="" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/default/files/logo-mobile-AAC.png" alt="Antimicrobial Agents and Chemotherapy" title="Antimicrobial Agents and Chemotherapy" /></a>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
</div>  
  <div id="zone-branding" class="zone zone-branding clearfix mobile-hidden print-display-block container-30">
    <div class="grid-19 prefix-1 region region-branding print-display-block" id="region-branding">
  <div class="region-inner region-branding-inner">
        <div class="block block-panels-mini block-banner-logo-image block-panels-mini-banner-logo-image odd block-without-title" id="block-panels-mini-banner-logo-image">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-banner_logo_image">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-snippet pane-logo-image-banner" >
  
      
  
  <div class="pane-content">
    <div class="snippet logo-image-banner" id="logo-image-banner">
  
      
  <div class="snippet-content">
    <div class="logo-imgs"><a class="publisher-link" href="https://www.asm.org/" rel="home"><img alt="publisher-logo" class="publisher-logo" src="/sites/default/files/additional_assets/Site_Logo/publisher-logo.png" /></a><a class="site-link" href="/" rel="home"><img alt="site-logo" class="site-logo" src="/sites/default/files/additional_assets/Site_Logo/site-logo.png" /></a></div>
  </div>

</div>
  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div><div class="grid-9 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
  <div class="region-inner region-branding-second-inner">
    <div class="block block-panels-mini highwire-inst-branding-block block-jnl-asm-inst-brand block-panels-mini-jnl-asm-inst-brand odd block-without-title" id="block-panels-mini-jnl-asm-inst-brand">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_inst_brand">
  <div class="panel-panel panel-col">
    <div></div>
  </div>
</div>
    </div>
  </div>
</div><div class="block block-panels-mini block-jnl-asm-search-box block-panels-mini-jnl-asm-search-box even block-without-title" id="block-panels-mini-jnl-asm-search-box">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_search_box">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-quicksearch no-margin-bottom" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/47/3/923.full" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords--2">Search for this keyword </label>
 <input placeholder="search" type="text" id="edit-keywords--2" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><i class="icon-search"></i><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--6" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-LC0pUJ5MROR5P_GGwueK7azlJaMJdR8VO2GjBPAhmR8" />
<input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-3" >
  
      
  
  <div class="pane-content">
    <p><a href="/search">Advanced Search</a></p>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-menu" class="zone zone-menu clearfix mobile-hidden container-30">
    <div class="grid-28 suffix-1 prefix-1 region region-menu main-menu-active-caret" id="region-menu">
  <div class="region-inner region-menu-inner">
        <div class="block block-nice-menus block-1 block-nice-menus-1 odd block-without-title" id="block-nice-menus-1">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="nice-menu nice-menu-down nice-menu-main-menu" id="nice-menu-1" role="menu"><li class="menu-862 menu-path-front first odd " role="menuitem"><a href="/" data-hide-link-title="0" class="" data-icon-position="">Home</a></li>
<li class="menu-659 menuparent  menu-path-latest  even " role="menuitem"><a href="/latest" data-hide-link-title="0" class="" data-icon-position="">Articles</a><ul role="menu"><li class="menu-787 menu-path-content-current first odd " role="menuitem"><a href="/content/current" data-hide-link-title="0" class="" data-icon-position="">Current Issue</a></li>
<li class="menu-1426 menu-path-content-early-recent  even " role="menuitem"><a href="/content/early/recent" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Accepted Manuscripts</a></li>
<li class="menu-1517 menu-path-sjournalsasmorg-content-covid-19  odd " role="menuitem"><a href="https://journals.asm.org/content/covid-19" data-hide-link-title="0" target="_blank" class="" data-icon-position="">COVID-19 Special Collection</a></li>
<li class="menu-663 menu-path-content-by-year  even " role="menuitem"><a href="/content/by/year" class="" data-icon-position="" data-hide-link-title="0">Archive</a></li>
<li class="menu-1424 menu-path-content-by-section-minireview  odd last" role="menuitem"><a href="/content/by/section/Minireview" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Minireviews</a></li>
</ul></li>
<li class="menu-939 menuparent  menu-path-node-1728  odd " role="menuitem"><a href="/content/submit-manuscript" data-hide-link-title="0" class="" data-icon-position="">For Authors</a><ul role="menu"><li class="menu-940 menu-path-node-1728 first odd " role="menuitem"><a href="/content/submit-manuscript" data-hide-link-title="0" class="" data-icon-position="">Submit a Manuscript</a></li>
<li class="menu-666 menu-path-node-1473  even " role="menuitem"><a href="/content/scope" data-hide-link-title="0" class="" data-icon-position="">Scope</a></li>
<li class="menu-667 menu-path-node-1467  odd " role="menuitem"><a href="/content/editorial-policy" data-hide-link-title="0" class="" data-icon-position="">Editorial Policy</a></li>
<li class="menu-668 menu-path-node-1468  even " role="menuitem"><a href="/content/submission-review-publication-processes" data-hide-link-title="0" class="" data-icon-position="">Submission, Review, &amp; Publication Processes</a></li>
<li class="menu-669 menu-path-node-1474  odd " role="menuitem"><a href="/content/organization-and-format" data-hide-link-title="0" class="" data-icon-position="">Organization and Format</a></li>
<li class="menu-676 menu-path-node-1  even " role="menuitem"><a href="/content/author-corrections-errata-retractions" data-hide-link-title="0" class="" data-icon-position="">Errata, Author Corrections, Retractions</a></li>
<li class="menu-671 menu-path-node-1475  odd " role="menuitem"><a href="/content/illustrations-and-tables" data-hide-link-title="0" class="" data-icon-position="">Illustrations and Tables</a></li>
<li class="menu-678 menu-path-node-1476  even " role="menuitem"><a href="/content/nomenclature" data-hide-link-title="0" class="" data-icon-position="">Nomenclature</a></li>
<li class="menu-672 menu-path-node-1477  odd " role="menuitem"><a href="/content/abbreviations-and-conventions" data-hide-link-title="0" class="" data-icon-position="">Abbreviations and Conventions</a></li>
<li class="menu-835 menu-path-node-1478  even " role="menuitem"><a href="/content/publication-fees" data-hide-link-title="0" class="" data-icon-position="">Publication Fees</a></li>
<li class="menu-948 menu-path-sjournalsasmorg-content-ethics-and-policies  odd last" role="menuitem"><a href="https://journals.asm.org/content/ethics-and-policies" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Ethics Resources and Policies </a></li>
</ul></li>
<li class="menu-664 menuparent  menu-path-node-17900  even " role="menuitem"><a href="/content/about-aac" data-hide-link-title="0" class="" data-icon-position="">About the Journal</a><ul role="menu"><li class="menu-1427 menu-path-node-17900 first odd " role="menuitem"><a href="/content/about-aac" data-hide-link-title="0" class="" data-icon-position="">About AAC</a></li>
<li class="menu-823 menu-path-node-8  even " role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" class="" data-icon-position="">Editor in Chief</a></li>
<li class="menu-824 menu-path-node-8  odd " role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Editorial Board</a></li>
<li class="menu-830 menu-path-sjournalsasmorg-content-reviewers  even " role="menuitem"><a href="https://journals.asm.org/content/reviewers" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Reviewers</a></li>
<li class="menu-833 menu-path-sasmorg-newsroom  odd " role="menuitem"><a href="https://www.asm.org/Newsroom" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For the Media</a></li>
<li class="menu-831 menu-path-sjournalsasmorg-content-institutions  even " role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Librarians</a></li>
<li class="menu-832 menu-path-sjournalsasmorg-content-advertising  odd " role="menuitem"><a href="https://journals.asm.org/content/advertising" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Advertisers</a></li>
<li class="menu-677 menu-path-sjournalsasmorg-alerts  even " role="menuitem"><a href="https://journals.asm.org/alerts" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Alerts</a></li>
<li class="menu-1516 menu-path-syoutubecom-playlistlistpl1dfmjfzvefiidg0t8jektditxxjrmdo5  odd " role="menuitem"><a href="https://www.youtube.com/playlist?list=PL1DFmJFZvefiidG0t8jEKTdITXxJrmdO5" data-hide-link-title="0" target="_blank" class="" data-icon-position="">AAC Podcast</a></li>
<li class="menu-829 menu-path-node-1471  even " role="menuitem"><a href="/content/rss" data-hide-link-title="0" class="" data-icon-position="">RSS</a></li>
<li class="menu-828 menu-path-node-1470  odd last" role="menuitem"><a href="/content/faq" data-hide-link-title="0" class="" data-icon-position="">FAQ</a></li>
</ul></li>
<li class="menu-1434 menuparent  menu-path-sjournalsasmorg-content-institutions  odd last" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Subscribe</a><ul role="menu"><li class="menu-1435 menu-path-sjournalsasmorg-content-members first odd " role="menuitem"><a href="https://journals.asm.org/content/members" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Members</a></li>
<li class="menu-1436 menu-path-sjournalsasmorg-content-institutions  even last" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Institutions</a></li>
</ul></li>
</ul></nav>
    </div>
  </div>
</div>  </div>
</div>
  </div>
  
  <div id="zone-header" class="zone zone-header clearfix container-30">
  	      </div>
</header>    
      <section id="section-content" class="section section-content">
    
  <div id="zone-content" class="zone zone-content clearfix container-30">    
        
    <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
  <div class="region-inner region-content-inner">
    <a id="main-content"></a>
                        <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panels-960-layout jcore-2col-layout" >
	  <div class="panel-row-wrapper panel-row-first clearfix">
		
		<div class="top-wrapper">
			<div class="panel-panel panel-region-top">
			  <div class="inside"><div class="panel-pane pane-highwire-article-citation article-page-title-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="81053" id="node81053--2" data-pisa="aac;47/3/923" data-pisa-master="aac;47/3/923" data-apath="/aac/47/3/923.atom" data-hw-author-tooltip-instance="highwire_author_tooltip"><div class="highwire-cite highwire-cite-highwire-article highwire-citation-asm-article-title clearfix has-author-tooltip highwire-citation-highwire-article-top-a">
  
  
  
      <div class="highwire-cite-overline">Susceptibility</div>
  
      <h1 class="highwire-cite-title" id="page-title">In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci</h1>  
    	<div class="highwire-cite-authors"><div class="highwire-citation-authors-type highwire-citation-authors-type-author"><span class="contributor-of-type"><em></em></span> <span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0">Takaji Fujimura</span>, <span class="highwire-citation-author" data-delta="1">Yoshinori Yamano</span>, <span class="highwire-citation-author" data-delta="2">Isamu Yoshida</span>, <span class="highwire-citation-author" data-delta="3">Jingoro Shimada</span>, <span class="highwire-citation-author" data-delta="4">Shogo Kuwahara</span></span></div></div>
  
  
  
  
  
</div>
<div id="hw-article-author-popups-node81053--2" style="display: none;"><div class="author-tooltip-0"><div class="author-tooltip-name">Takaji Fujimura </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'>
<span class='nlm-sup'>1</span>Discovery Research Laboratories, Shionogi & Co., Ltd., Toyonaka, Osaka 561-0825</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Takaji%2BFujimura%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Fujimura%20T&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3ATakaji%2BFujimura%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-corresp-email-link last"><span>For correspondence: 
<a href="mailto:takaji.fujimura@shionogi.co.jp" class="" data-icon-position="" data-hide-link-title="0">takaji.fujimura@shionogi.co.jp</a></span></li></ul></div><div class="author-tooltip-1"><div class="author-tooltip-name">Yoshinori Yamano </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'>
<span class='nlm-sup'>1</span>Discovery Research Laboratories, Shionogi & Co., Ltd., Toyonaka, Osaka 561-0825</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Yoshinori%2BYamano%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Yamano%20Y&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AYoshinori%2BYamano%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-2"><div class="author-tooltip-name">Isamu Yoshida </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'>
<span class='nlm-sup'>1</span>Discovery Research Laboratories, Shionogi & Co., Ltd., Toyonaka, Osaka 561-0825</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Isamu%2BYoshida%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Yoshida%20I&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AIsamu%2BYoshida%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-3"><div class="author-tooltip-name">Jingoro Shimada </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'>
<span class='nlm-sup'>2</span>St. Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Jingoro%2BShimada%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Shimada%20J&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AJingoro%2BShimada%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-4"><div class="author-tooltip-name">Shogo Kuwahara </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'>
<span class='nlm-sup'>3</span>Department of Microbiology, Toho University School of Medicine, Ota-ku, Tokyo 143-8540, Japan</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Shogo%2BKuwahara%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Kuwahara%20S&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AShogo%2BKuwahara%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1 article-page-header-doi" >
  
      
  
  <div class="pane-content">
    <div><strong>DOI:</strong>&nbsp;10.1128/AAC.47.3.923-931.2003</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	  
  <div class="panel-row-wrapper clearfix">
		
		<div class="main-content-wrapper grid-17 suffix-1 alpha">
			<div class="panel-panel panel-region-content">
			  <div class="inside"><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" >
  
      
  
  <div class="pane-content">
    <div class="item-list"><ul class="tabs inline panels-ajax-tab"><li class="first"><a href="/content/47/3/923" class="panels-ajax-tab-tab" data-panel-name="jnl_asm_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:81053" data-trigger="" data-url-enabled="1">Article</a><a href="/panels_ajax_tab/jnl_asm_tab_art/node:81053/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/47/3/923/figures-only" class="panels-ajax-tab-tab" data-panel-name="jnl_asm_tab_data" data-target-id="highwire_article_tabs" data-entity-context="node:81053" data-trigger="figures-only" data-url-enabled="1">Figures & Data</a><a href="/panels_ajax_tab/jnl_asm_tab_data/node:81053/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/47/3/923/article-info" class="panels-ajax-tab-tab" data-panel-name="jnl_asm_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:81053" data-trigger="article-info" data-url-enabled="1">Info & Metrics</a><a href="/panels_ajax_tab/jnl_asm_tab_info/node:81053/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li class="last"><a href="/content/aac/47/3/923.full.pdf" class="panels-ajax-tab-tab" data-panel-name="jnl_asm_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:81053" data-trigger="full-text.pdf" data-url-enabled="1"><i class="icon-file-alt"></i> PDF</a><a href="/panels_ajax_tab/jnl_asm_tab_pdf/node:81053/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li></ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" >
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="jnl_asm_tab_art" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://aac.asm.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-jnl_asm_tab_art"><div class="panel-display panel-1col clearfix" >
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-markup" >
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" id="content-block-markup" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article fulltext-view "><span class="highwire-journal-article-marker-start"></span><div class="section abstract" id="abstract-1"><h2 class="">ABSTRACT</h2><p id="p-1">The in vitro antibacterial activity of S-3578, a new parenteral cephalosporin, against clinical isolates was evaluated. The MICs of the drug at which 90% of the isolates were inhibited were 4 Ојg/ml for methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) and 2 Ојg/ml for methicillin-resistant <em>Staphylococcus epidermidis</em>, which were fourfold higher than and equal to those of vancomycin, respectively. The anti-MRSA activity of S-3578 was considered to be due to its high affinity for penicillin-binding protein 2a (50% inhibitory concentration, 4.5 Ојg/ml). In time-kill studies with 10 strains each of MRSA and methicillin-susceptible <em>S. aureus</em>, S-3578 caused more than a 4-log<sub>10</sub> decrease of viable cells on the average at twice the MIC after 24 h of exposure, indicating that it had potent bactericidal activity. Furthermore, in population analysis of MRSA strains with heterogeneous or homogeneous resistance to imipenem, no colonies emerged from about 10<sup>9</sup> cells on agar plates containing twice the MIC of S-3578, suggesting the low frequency of emergence of S-3578-resistant strains from MRSA. S-3578 was also highly active against penicillin-resistant <em>Streptococcus pneumoniae</em> (PRSP), with a MIC<sub>90</sub> of 1 Ојg/ml, which was comparable to that of ceftriaxone. S-3578 also had antibacterial activity against a variety of gram-negative bacteria including <em>Pseudomonas aeruginosa</em>, though its activity was not superior to that of cefepime. In conclusion, S-3578 exhibited a broad antibacterial spectrum and, particularly, had excellent activity against gram-positive bacteria including methicillin-resistant staphylococci and PRSP. Thus, S-3578 was considered to be worthy of further evaluation.</p></div><p id="p-2">Methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCNS) cause serious problems in nosocomial infection. The major factor in the mechanism of resistance to ОІ-lactams in MRSA and MRCNS is known to be the production of a penicillin-binding protein peculiar to them, designated PBP2вЂІ or PBP2a, which has low affinity for commercially available ОІ-lactams (<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>). Furthermore, most clinical isolates of MRSA and MRCNS have acquired resistance to not only ОІ-lactams but also various other antibiotics used in clinical settings. The worldwide spread and increased frequency of occurrence of these pathogens have caused difficulties in therapeutic treatment with antibiotics (<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>, <a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>).</p><p id="p-3">Some antibiotics such as vancomycin, linezolid, or dalfopristin-quinupristin show clinical efficacy against infections caused by methicillin-resistant staphylococci (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>, <a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>, <a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>) but have antibacterial activity against only gram-positive bacteria. Much effort has been spent on the development of ОІ-lactams with anti-MRSA activity in laboratories worldwide (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>, <a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>). Some compounds, for example, RWJ-54428 (MC-02479) or BMS-247243, have been reported elsewhere as anti-MRSA agents, but most of them also exhibit narrow-spectrum antibacterial activity (<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>, <a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>). On the other hand, broad-spectrum cephalosporins like ceftriaxone or cefepime have been useful against various infectious diseases but are not active against methicillin-resistant staphylococci. BAL9141 (formerly Ro-63-9141), which is under development, has been reported elsewhere to have satisfactory broad-spectrum activity with anti-MRSA activity (<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>). However, it does not have good water solubility and requires esterification to improve its solubility. With the aim of developing a broad-spectrum cephalosporin with anti-MRSA activity, we selected S-3578, 7ОІ-[2-(2-aminothiadiazol-4-yl)-2(<em>Z</em>)-ethoxyiminoacetamido]-3-(1-<em>N</em>-methylaminopropyl-1<em>H</em>-imidazo[4,5-<em>b</em>]pyridinium-4-yl)-methylcephalosporin, because of its antibacterial activities, aqueous solubility, and crystallinity (<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>).</p><p id="p-4">In this study, we evaluated the in vitro antibacterial activity of S-3578, particularly focusing on its anti-MRSA activity.</p><p id="p-5">(Part of this work was presented previously [Y. Yamano, H. Miwa, K. Motokawa, T. Yoshida, J. Shimada, and S. Kuwahara, Abstr. 41st Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-371, 2001; T. Fujimura, Y. Yamano, I. Yoshida, T. Yoshida, J. Shimada, and S. Kuwahara, Abstr. 41st Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-372, 2001].)</p><div class="section" id="sec-1"><h2 class="">MATERIALS AND METHODS</h2><div id="sec-2" class="subsection"><p id="p-6"><span class="inline-l2-heading">Antibiotics.</span>S-3578 was synthesized in the research laboratories of Shionogi &amp; Co., Ltd. (Osaka, Japan). Its chemical structure is shown in Fig. <a id="xref-fig-1-1" class="xref-fig" href="#F1">1</a>. Other compounds were purchased from commercial sources.</p><div id="F1" class="fig pos-float  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://aac.asm.org/content/aac/47/3/923/F1.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-495167613" data-figure-caption="" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG. 1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://aac.asm.org/content/aac/47/3/923/F1.medium.gif" width="440" height="104"/><noscript><img class="highwire-fragment fragment-image" alt="FIG. 1." src="https://aac.asm.org/content/aac/47/3/923/F1.medium.gif" width="440" height="104"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="new-tab first"><a href="https://aac.asm.org/content/aac/47/3/923/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/112807" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div><div class="fig-caption" xmlns:xhtml="http://www.w3.org/1999/xhtml"><span class="fig-label">FIG. 1.</span> <p id="p-30" class="first-child">Chemical structure of S-3578, 7ОІ-[2-(2-aminothiadiazol-4-yl)-2(<em>Z</em>)-ethoxyiminoacetamido]-3-(1-<em>N</em>-methylaminopropyl-1<em>H</em>-imidazo[4,5-<em>b</em>]pyridinium-4-yl)-methylcephalosporin.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-3" class="subsection"><p id="p-7"><span class="inline-l2-heading">Organisms.</span>Bacterial strains used in this study were clinical isolates collected from hospitals in various parts of Japan in 2000 and 2001 and strains from our laboratory collection. <em>S. aureus</em> SRM710, deficient in PBP2, was used in a binding affinity assay of PBP2a of MRSA (<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>).</p></div><div id="sec-4" class="subsection"><p id="p-8"><span class="inline-l2-heading">MIC determination.</span>MICs for aerobic bacteria were determined by a microdilution broth method as recommended by the NCCLS (<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>) with cation-adjusted Mueller-Hinton broth (CA-MHB) (Becton Dickinson, Sparks, Md.), which was supplemented with 15 Ојg of NAD/ml, 5% yeast extract (Becton Dickinson), and 5% lysed horse blood to support the growth of <em>Streptococcus pneumoniae</em> and <em>Haemophilus influenzae</em>. CA-MHB with 2% NaCl was used to determine MICs of oxacillin for staphylococci. MICs for <em>Neisseria gonorrhoeae</em> were determined by an agar dilution method with GC medium (Becton Dickinson) containing growth supplement after incubation at 35В°C for 20 h in the presence of 6% CO<sub>2</sub>. MICs for anaerobic bacteria were determined by an agar dilution method with Wilkins-Chalgren medium (Becton Dickinson) after anaerobic incubation at 35В°C for 48 h.</p></div><div id="sec-5" class="subsection"><p id="p-9"><span class="inline-l2-heading">Determination of minimum bactericidal concentration (MBC).</span>MBCs were determined by a macrodilution method with CA-MHB according to the NCCLS recommendations (<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>).</p></div><div id="sec-6" class="subsection"><p id="p-10"><span class="inline-l2-heading">Time-kill study.</span>The culture of a test strain at the early or mid-log phase was diluted to about 5 Г— 10<sup>5</sup> CFU/ml in 5 ml of fresh CA-MHB. Antibiotics at various concentrations were added to the diluted cultures. Viable cells were counted after shaking at 37В°C for 0, 1, 2.5, 4, and 6 h. In the studies of <em>S. aureus</em>, the additional counting was performed at 24 h.</p></div><div id="sec-7" class="subsection"><p id="p-11"><span class="inline-l2-heading">PBP binding affinity.</span>The affinities of antibiotics for PBPs were determined by a competition assay with [<sup>14</sup>C]benzylpenicillin (Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, England) as described previously (<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>, <a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>). The binding affinity of each compound was expressed as the concentration required to inhibit 50% of the binding of [<sup>14</sup>C]benzylpenicillin to each PBP (IC<sub>50</sub>).</p></div><div id="sec-8" class="subsection"><p id="p-12"><span class="inline-l2-heading">Population analysis and frequency of emergence of resistant colonies.</span>An overnight culture of <em>S. aureus</em> in CA-MHB was diluted with fresh medium to the appropriate bacterial density and spread onto a Mueller-Hinton agar plate containing serial twofold dilutions of antibiotics. The plates were incubated for 3 days at 37В°C, and the number of colonies was counted. The frequency of emergence of resistant colonies on an agar plate containing S-3578 was shown as their ratio to the number of colonies grown on an agar plate without antibiotics.</p></div><div id="sec-9" class="subsection"><p id="p-13"><span class="inline-l2-heading">ОІ-Lactamase stability.</span>ОІ-Lactamases were purified partially from bacterial membrane by ion-exchange chromatography as described previously (<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>). The stability of antibiotics against hydrolysis by ОІ-lactamases was assessed by determining the hydrolysis rate by a spectrophotometric assay method (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>). The kinetics parameters <em>K<sub>m</sub></em> and <em>V</em><sub>max</sub> were calculated from at least two independent experiments with the Michaelis-Menten formulation.</p></div></div><div class="section" id="sec-10"><h2 class="">RESULTS</h2><div id="sec-11" class="subsection"><p id="p-14"><span class="inline-l2-heading">MIC determination.</span>The antibacterial activity of S-3578 was compared with those of cefepime, ceftriaxone, ceftazidime, and imipenem. For gram-positive bacteria, vancomycin was also used as a comparator, as were oxacillin for staphylococci and penicillin G for <em>S. pneumoniae</em>. The results are shown in Table <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">1</a> as the MIC range, MIC<sub>50</sub> (the concentration at which the growth of 50% of the isolates was inhibited), and MIC<sub>90</sub>.</p><div id="T1" class="table pos-float"><div class="table-inline table-callout-links"><div class="callout"><span>View this table:</span><ul class="callout-links"><li class="view-inline first"><a href="##" class="table-expand-inline" data-table-url="/highwire/markup/112673/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a></li><li class="view-popup last"><a href="/highwire/markup/112673/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a></li></ul></div></div><div class="table-caption"><span class="table-label">TABLE 1.</span> <p id="p-37" class="first-child">In vitro antibacterial activities of S-3578 and reference compounds against clinical isolates</p><div class="sb-div caption-clear"></div></div></div><p id="p-15">S-3578 showed consistent antibacterial activity against staphylococci including methicillin-resistant strains and inhibited the growth of all clinical isolates of staphylococci at 8 Ојg/ml. The MIC<sub>90</sub>s of S-3578 for MRSA and methicillin-resistant <em>Staphylococcus epidermidis</em> (MRSE) were 4 and 2 Ојg/ml, respectively, whereas those of other ОІ-lactam compounds were 64 Ојg/ml or more. S-3578 was fourfold less active against MRSA than was vancomycin, but its activity against MRSE was equal to that of vancomycin. For methicillin-susceptible <em>S. aureus</em> (MSSA) and methicillin-susceptible <em>S. epidermidis</em>, the MIC<sub>90</sub>s of S-3578 were 2 and 0.5 Ојg/ml, respectively. It was characteristic that the MICs of S-3578 for methicillin-resistant staphylococcus strains were only two- to fourfold higher than those for methicillin-susceptible staphylococcus strains.</p><p id="p-16">S-3578 had activities against penicillin-susceptible, -intermediate, and -resistant <em>S. pneumoniae</em>, with MIC<sub>90</sub>s of 0.25, 1, and 1 Ојg/ml, respectively, which were comparable to those of ceftriaxone and cefepime. However, S-3578 was not as active against <em>Enterococcus faecalis</em> as were other cephalosporins, though it showed the lowest MIC<sub>50</sub> among the cephalosporins tested.</p><p id="p-17">S-3578 was also active against a variety of gram-negative bacteria, although its activity was not superior to those of cefepime and imipenem, except that imipenem was less active than was S-3578 against <em>H. influenzae</em>. The MIC<sub>90</sub>s of S-3578 for <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, and <em>Klebsiella oxytoca</em> were 1 Ојg/ml or less, which was comparable to those of ceftazidime but two- to eightfold higher than those of cefepime, ceftriaxone, and imipenem. Some S-3578-resistant strains of these species were also resistant to other cephalosporins. The MIC<sub>90</sub>s of S-3578 for <em>Enterobacter aerogenes</em>, <em>Citrobacter freundii</em>, <em>Serratia marcescens</em>, <em>Proteus mirabilis</em>, and <em>Providencia rettgeri</em> ranged from 2 to 8 Ојg/ml, and most strains of <em>Proteus vulgaris</em> were not susceptible to S-3578. S-3578 was active against <em>H. influenzae</em> except for ОІ-lactamase-negative ampicillin-resistant strains with a MIC<sub>90</sub> of 0.25 Ојg/ml, regardless of the ОІ-lactamase production. Its activity was comparable to those of cefepime and ceftazidime but lower than that of ceftriaxone. The activity of S-3578 against <em>Moraxella catarrhalis</em> (MIC<sub>90</sub>, 1 Ојg/ml) was higher than those of ceftriaxone and cefepime but fourfold lower than that of ceftazidime. S-3578 showed activity against <em>Pseudomonas aeruginosa</em> with a MIC<sub>50</sub> and a MIC<sub>90</sub> of 8 and 64 Ојg/ml, respectively, which were two- to fourfold higher than those of ceftazidime and cefepime. The activity of S-3578 against <em>Acinetobacter baumannii</em> was the highest among the cephalosporins tested, though its MIC<sub>50</sub> and MIC<sub>90</sub> were 1 and 16 Ојg/ml, respectively. S-3578, however, had the same potential against <em>N. gonorrhoeae</em> as did penicillin G, though other compounds were more active.</p><p id="p-18">The antibacterial activities against anaerobic pathogens were determined. S-3578 inhibited growth of all strains of <em>Peptostreptococcus</em> spp. at 8 Ојg/ml, which meant that it was as active as ceftriaxone was. <em>Bacteroides fragilis</em> was not susceptible to S-3578.</p></div><div id="sec-12" class="subsection"><p id="p-19"><span class="inline-l2-heading">Bactericidal activity.</span>We first determined MBCs for 20 clinical isolates each of MRSA and MSSA including ОІ-lactamase producers. The MBC/MIC ratios for S-3578 against all strains were 1 or 2 (Fig. <a id="xref-fig-2-1" class="xref-fig" href="#F2">2</a>). In particular, the number of MSSA strains showing the ratio of 1 for S-3578 was larger than the number of those showing the same ratio for cefepime and ceftriaxone, suggesting that S-3578 was more bactericidal than the reference agents were. The production of ОІ-lactamase did not have any influence on both MBCs and MICs of S-3578 as well as of the reference compounds.</p><div id="F2" class="fig pos-float  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://aac.asm.org/content/aac/47/3/923/F2.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-495167613" data-figure-caption="" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG. 2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://aac.asm.org/content/aac/47/3/923/F2.medium.gif" width="419" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="FIG. 2." src="https://aac.asm.org/content/aac/47/3/923/F2.medium.gif" width="419" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="new-tab first"><a href="https://aac.asm.org/content/aac/47/3/923/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/112678" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG. 2.</span> <p id="p-31" class="first-child">Distribution of MBCs and MICs for 20 clinical isolates each of MRSA (A) or MSSA (B). The activity of S-3578 was compared with those of cefepime and ceftriaxone against MSSA. Open and closed circles indicate ОІ-lactamase-producing and nonproducing strains, respectively.</p><div class="sb-div caption-clear"></div></div></div><p id="p-20">Next, we constructed the killing kinetics curves for MRSA and MSSA strains. S-3578 caused a time-dependent decrease of viable cells of the MSSA strain Smith at one or more times the MIC until 6 h, as did cefepime and ceftriaxone (Fig. <a id="xref-fig-3-1" class="xref-fig" href="#F3">3B</a>). Furthermore, the number of viable cells after 24-h exposure to S-3578 was significantly lower than the number after exposure to the reference compounds. S-3578 also showed similar bactericidal activity against the MRSA strain SR3637 at two or more times the MIC (Fig. <a id="xref-fig-3-2" class="xref-fig" href="#F3">3A</a>). Moreover, the decreases of viable cells with 10 clinical isolates each of MRSA or MSSA were compared after 24-h exposure to twice the MIC of each antibiotic. S-3578 caused more than a 4-log<sub>10</sub>-CFU/ml reduction on the average for both MRSA and MSSA, while cefepime and ceftriaxone demonstrated only less than a 2-log<sub>10</sub>-CFU/ml reduction for MSSA (Fig. <a id="xref-fig-4-1" class="xref-fig" href="#F4">4</a>). These results indicated that the bactericidal activity of S-3578 was more potent than those of cefepime and ceftriaxone against <em>S. aureus</em>, irrespective of methicillin resistance.</p><div id="F3" class="fig pos-float  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://aac.asm.org/content/aac/47/3/923/F3.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-495167613" data-figure-caption="" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG. 3." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://aac.asm.org/content/aac/47/3/923/F3.medium.gif" width="440" height="340"/><noscript><img class="highwire-fragment fragment-image" alt="FIG. 3." src="https://aac.asm.org/content/aac/47/3/923/F3.medium.gif" width="440" height="340"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="new-tab first"><a href="https://aac.asm.org/content/aac/47/3/923/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/112682" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG. 3.</span> <p id="p-32" class="first-child">Killing kinetics curves for S-3578 and reference compounds against <em>S. aureus</em> SR3637 (MRSA) (A) and Smith (MSSA) (B).</p><div class="sb-div caption-clear"></div></div></div><div id="F4" class="fig pos-float  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://aac.asm.org/content/aac/47/3/923/F4.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-495167613" data-figure-caption="" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG. 4." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://aac.asm.org/content/aac/47/3/923/F4.medium.gif" width="440" height="267"/><noscript><img class="highwire-fragment fragment-image" alt="FIG. 4." src="https://aac.asm.org/content/aac/47/3/923/F4.medium.gif" width="440" height="267"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="new-tab first"><a href="https://aac.asm.org/content/aac/47/3/923/F4.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/112668" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG. 4.</span> <p id="p-33" class="first-child">Decrease of viable cells in 10 clinical isolates each of MRSA or MSSA after 24-h exposure to twice the MIC of S-3578. Cefepime and ceftriaxone were used as comparators for MSSA. An open circle indicates decrease of viable cell counts of each strain compared to the initial inoculum, and a bar indicates the average of those of 10 strains.</p><div class="sb-div caption-clear"></div></div></div><p id="p-21">The MBCs of S-3578 for 20 clinical isolates of <em>E. coli</em> for which MICs were 0.13 to 1 Ојg/ml ranged from 0.25 to 1 Ојg/ml, while the MBCs and MICs of cefepime ranged from 0.25 to 2 Ојg/ml and from 0.13 to 2 Ојg/ml, respectively (Fig. <a id="xref-fig-5-1" class="xref-fig" href="#F5">5</a>). All strains tested were ОІ-lactamase producers, indicating that the activity of S-3578 was not affected by ОІ-lactamase. Furthermore, the killing kinetics curves for <em>E. coli</em> NIHJ JC-2 and <em>P. aeruginosa</em> SR24706 indicated that S-3578 also had time-dependent bactericidal activity against these species which was comparable to those of the reference compounds (Fig. <a id="xref-fig-6-1" class="xref-fig" href="#F6">6</a>).</p><div id="F5" class="fig pos-float  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://aac.asm.org/content/aac/47/3/923/F5.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-495167613" data-figure-caption="" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG. 5." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://aac.asm.org/content/aac/47/3/923/F5.medium.gif" width="440" height="362"/><noscript><img class="highwire-fragment fragment-image" alt="FIG. 5." src="https://aac.asm.org/content/aac/47/3/923/F5.medium.gif" width="440" height="362"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="new-tab first"><a href="https://aac.asm.org/content/aac/47/3/923/F5.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/112747" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG. 5.</span> <p id="p-34" class="first-child">Distribution of MBCs and MICs for 20 clinical isolates of <em>E. coli</em>. The activity of S-3578 was compared with that of cefepime. All strains produced ОІ-lactamases.</p><div class="sb-div caption-clear"></div></div></div><div id="F6" class="fig pos-float  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://aac.asm.org/content/aac/47/3/923/F6.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-495167613" data-figure-caption="" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG. 6." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://aac.asm.org/content/aac/47/3/923/F6.medium.gif" width="440" height="358"/><noscript><img class="highwire-fragment fragment-image" alt="FIG. 6." src="https://aac.asm.org/content/aac/47/3/923/F6.medium.gif" width="440" height="358"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="new-tab first"><a href="https://aac.asm.org/content/aac/47/3/923/F6.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/112745" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG. 6.</span> <p id="p-35" class="first-child">Killing kinetics curves for S-3578 and reference compounds against <em>E. coli</em> NIHJ JC-2 (A) and <em>P. aeruginosa</em> SR24706 (B).</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-13" class="subsection"><p id="p-22"><span class="inline-l2-heading">Binding affinity for PBPs.</span>S-3578 was found to have high affinity for PBP2a of MRSA, with an IC<sub>50</sub> of 4.5 Ојg/ml (Table <a id="xref-table-wrap-2-1" class="xref-table" href="#T2">2</a>). This characteristic seemed to reflect the anti-MRSA activity of S-3578. In contrast, cefepime, which was not active against MRSA, had a very low affinity for PBP2a. S-3578 also showed high affinities for PBP1 and -2 of <em>S. aureus</em> with IC<sub>50</sub>s of less than 0.5 Ојg/ml, as did ceftriaxone and cefepime.</p><div id="T2" class="table pos-float"><div class="table-inline table-callout-links"><div class="callout"><span>View this table:</span><ul class="callout-links"><li class="view-inline first"><a href="##" class="table-expand-inline" data-table-url="/highwire/markup/112733/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a></li><li class="view-popup last"><a href="/highwire/markup/112733/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a></li></ul></div></div><div class="table-caption"><span class="table-label">TABLE 2.</span> <p id="p-40" class="first-child">Binding affinity for PBPs of <em>S. aureus</em></p><div class="sb-div caption-clear"></div></div></div><p id="p-23">Cefepime had high affinities for PBP2 and -3 of <em>E. coli</em> with IC<sub>50</sub>s of less than 1 Ојg/ml, and ceftriaxone had affinities for PBP1A, -1B, -2, and -3 (Table <a id="xref-table-wrap-3-1" class="xref-table" href="#T3">3</a>). On the other hand, S-3578 had high affinity only for PBP3. Although the IC<sub>50</sub>s of S-3578 for PBP1A, -3, and -4 of <em>P. aeruginosa</em> ranged from 0.31 to 0.43 Ојg/ml (Table <a id="xref-table-wrap-4-1" class="xref-table" href="#T4">4</a>), its binding affinity was not as high as those of cefepime and ceftazidime, the IC<sub>50</sub>s of which for PBP3 were 10-fold less than that of S-3578.</p><div id="T3" class="table pos-float"><div class="table-inline table-callout-links"><div class="callout"><span>View this table:</span><ul class="callout-links"><li class="view-inline first"><a href="##" class="table-expand-inline" data-table-url="/highwire/markup/112739/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a></li><li class="view-popup last"><a href="/highwire/markup/112739/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a></li></ul></div></div><div class="table-caption"><span class="table-label">TABLE 3.</span> <p id="p-43" class="first-child">Binding affinity for PBPs of <em>E. coli</em></p><div class="sb-div caption-clear"></div></div></div><div id="T4" class="table pos-float"><div class="table-inline table-callout-links"><div class="callout"><span>View this table:</span><ul class="callout-links"><li class="view-inline first"><a href="##" class="table-expand-inline" data-table-url="/highwire/markup/112851/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a></li><li class="view-popup last"><a href="/highwire/markup/112851/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a></li></ul></div></div><div class="table-caption"><span class="table-label">TABLE 4.</span> <p id="p-45" class="first-child">Binding affinity for PBPs of <em>P. aeruginosa</em></p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-14" class="subsection"><p id="p-24"><span class="inline-l2-heading">Frequency of emergence of resistant colonies.</span>In order to estimate the frequency of resistance development, we first carried out population analysis on two clinical isolates of MRSA, the low-level-methicillin-resistant strain SR19754 and the high-level-methicillin-resistant strain SR19760. As shown in Fig. <a id="xref-fig-7-1" class="xref-fig" href="#F7">7</a>, strain SR19754 had a subpopulation resistant to imipenem at a frequency of about 10<sup>в€’6</sup> in spite of the low MIC of imipenem for this strain, that is, it exhibited a heteroresistance profile. In contrast, the viabilities of both strains against S-3578 sharply decreased with increase of the antibiotic concentration. In particular, it was notable that no colonies emerged on agar plates containing twice the MIC of S-3578. Furthermore, about 10<sup>9</sup> bacterial cells each of 20 clinical isolates of MRSA were spread on agar plates containing S-3578 and incubated for 3 days at 35В°C. For all isolates, no colonies appeared on the plates at twice the MIC, and emergence from an isolate for which the MIC was 8 Ојg/ml did not occur even at the MIC (data not shown). From these results, the frequency at which resistant colonies emerged was estimated to be below 10<sup>в€’9</sup>.</p><div id="F7" class="fig pos-float  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://aac.asm.org/content/aac/47/3/923/F7.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-495167613" data-figure-caption="" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG. 7." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://aac.asm.org/content/aac/47/3/923/F7.medium.gif" width="440" height="190"/><noscript><img class="highwire-fragment fragment-image" alt="FIG. 7." src="https://aac.asm.org/content/aac/47/3/923/F7.medium.gif" width="440" height="190"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="new-tab first"><a href="https://aac.asm.org/content/aac/47/3/923/F7.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/112798" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG. 7.</span> <p id="p-36" class="first-child">Population analysis profiles of two clinical isolates of MRSA. Strains SR19754 (A) and SR19760 (B) are low-level- and high-level-methicillin-resistant strains, respectively. The MICs of S-3578 and imipenem for each strain are indicated in the figure. Closed circles and open triangles indicate viable cell counts on plates containing S-3578 or imipenem, respectively.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-15" class="subsection"><p id="p-25"><span class="inline-l2-heading">ОІ-Lactamase stability.</span>The hydrolysis of S-3578 and cefepime by a ОІ-lactamase purified from <em>S. aureus</em> SR5644 was not detected at 100 Ојg of the compounds per ml (data not shown), indicating that S-3578 was stable against hydrolysis by the ОІ-lactamase from <em>S. aureus</em>. S-3578, as well as cefepime, was stable against TEM-1 and a class A ОІ-lactamase from <em>K. pneumoniae</em> GN69 (<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>) because their hydrolysis rates were less than 0.1% of that of ampicillin at the substrate concentration of 100 Ојg/ml (data not shown). Although the <em>K<sub>m</sub></em> values of S-3578 against various AmpC enzymes from <em>C. freundii</em>, <em>Enterobacter cloacae</em>, and <em>P. aeruginosa</em> were lower than those of cefepime, its relative <em>V</em><sub>max</sub>/<em>K<sub>m</sub></em> values were comparable to those of cefepime. These results indicated that S-3578 had higher affinity for AmpC enzymes but was as stable as cefepime was against hydrolysis (Table <a id="xref-table-wrap-5-1" class="xref-table" href="#T5">5</a>). On the other hand, S-3578 was not as stable as cefepime was against a Toho-1-like extended-spectrum ОІ-lactamase and a class B IMP-1-like enzyme (data not shown).</p><div id="T5" class="table pos-float"><div class="table-inline table-callout-links"><div class="callout"><span>View this table:</span><ul class="callout-links"><li class="view-inline first"><a href="##" class="table-expand-inline" data-table-url="/highwire/markup/112741/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a></li><li class="view-popup last"><a href="/highwire/markup/112741/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a></li></ul></div></div><div class="table-caption"><span class="table-label">TABLE 5.</span> <p id="p-47" class="first-child">Stability of S-3578 against AmpC ОІ-lactamases</p><div class="sb-div caption-clear"></div></div></div></div></div><div class="section" id="sec-16"><h2 class="">DISCUSSION</h2><p id="p-26">One of the most striking features of S-3578 was its activity against methicillin-resistant staphylococci. S-3578 inhibited growth of all clinical isolates of <em>Staphylococcus</em> spp. including methicillin-resistant strains at 8 Ојg/ml, although other ОІ-lactam compounds including imipenem were not active against most strains of methicillin-resistant staphylococci. We further characterized the anti-MRSA activity of S-3578 as follows. First, this activity of S-3578, like those of other anti-MRSA ОІ-lactams (<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-9-2" class="xref-bibr" href="#ref-9">9</a>, <a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>), was considered to be due to the high affinity for PBP2a. This was consistent with reports of a correlation between the affinity for PBP2a and the MIC for MRSA strains with a high level of resistance to ОІ-lactams (<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>, <a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>). Second, S-3578 showed potent bactericidal activity against MSSA and MRSA strains. The superiority of S-3578 over cefepime and ceftriaxone in bactericidal activity against MSSA was represented by a significant decrease of viable cells after 24-h exposure to S-3578. The results in Fig. <a id="xref-fig-3-3" class="xref-fig" href="#F3">3</a> and <a id="xref-fig-4-2" class="xref-fig" href="#F4">4</a> indicate that S-3578 had potent bactericidal activity against not only MSSA but also MRSA. Third, the frequency of emergence of resistant colonies from MRSA strains was extremely low. Moreover, S-3578 showed remarkable reduction of the viability of the heteroresistant strain in contrast with imipenem, which easily selected its resistant subpopulation (Fig. <a id="xref-fig-7-2" class="xref-fig" href="#F7">7</a>). These results suggested that S-3578-resistant strains would rarely emerge during antibiotic treatment. The two latter features would contribute to in vivo therapeutic efficacy against MRSA infection.</p><p id="p-27">In addition to the activity against methicillin-resistant staphylococci, S-3578 was highly active against streptococci including penicillin-resistant <em>S. pneumoniae</em>, though most <em>E. faecalis</em> strains were not susceptible to this compound. On the other hand, S-3578 was not as active against gram-negative bacteria as cefepime was, but it showed antibacterial activity comparable to that of ceftazidime against most members of the family <em>Enterobacteriaceae</em>, <em>H. influenzae</em>, and <em>M. catarrhalis</em>. The antipseudomonal activity of S-3578, with a MIC<sub>50</sub> of 8 Ојg/ml, was two- to fourfold less than those of ceftazidime and cefepime.</p><p id="p-28">In conclusion, S-3578 is a novel parenteral broad-spectrum cephalosporin antibiotic with high activity against methicillin-resistant staphylococci. It should be noted that S-3578 is soluble in water at more than 100 mg/ml (<a id="xref-ref-26-2" class="xref-bibr" href="#ref-26">26</a>). This water solubility is a great advantage because most anti-MRSA cephalosporins have been reported elsewhere to be insoluble in water (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>, <a id="xref-ref-9-3" class="xref-bibr" href="#ref-9">9</a>). The pharmacokinetic profile of S-3578 in mice is similar to that of cefepime, and S-3578 shows good therapeutic efficacy in murine models of infection by MRSA, penicillin-resistant <em>S. pneumoniae</em>, or <em>P. aeruginosa</em> (M. Tsuji, M. Takema, H. Miwa, J. Shimada, and S. Kuwahara, submitted for publication). Thus, S-3578 is considered to be a promising compound for further evaluation as an anti-MRSA broad-spectrum cephalosporin antibiotic.</p></div><div class="section ack" id="ack-1"><h2>ACKNOWLEDGMENTS</h2><p id="p-29">We are grateful to M. Doi, Y. Jinushi, Y. Kimura, H. Motoyama, K. Motokawa, T. Munekage, and K. Uotani for their superb technical assistance.</p></div><div class="section fn-group" id="fn-group-1"><h2>FOOTNOTES</h2><ul><ul class="history-list"><li xmlns:hwp="http://schema.highwire.org/Journal" class="received" hwp:start="2002-07-05"><span class="received-label">Received </span>5 July 2002.</li><li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd" hwp:start="2002-10-01"><span class="rev-recd-label">Returned for modification </span>1 October 2002.</li><li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted" hwp:start="2002-12-10"><span class="accepted-label">Accepted </span>10 December 2002.</li></ul></ul></div><ul class="copyright-statement"><li class="fn" id="copyright-statement-1">Copyright В© 2003 American Society for Microbiology</li></ul><div class="section ref-list" id="ref-list-1"><h2 class="">REFERENCES</h2><ol class="cit-list ref-use-labels"><li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text" id="ref-1">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.1"><div class="cit-metadata"><cite><strong>Antony, S. J., E. Diaz-Vasquez, and C. Stratton.</strong>
<span class="cit-pub-date">2001</span>. Clinical experience with linezolid in the treatment of resistant gram-positive infections. <span class="cit-source">J. Natl. Med. Assoc.</span><span class="cit-vol">93</span><strong>:</strong><span class="cit-fpage">386</span>-391.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bthe%2BNational%2BMedical%2BAssociation%26rft.stitle%253DJ%2BNatl%2BMed%2BAssoc%26rft.aulast%253DAntony%26rft.auinit1%253DS.%2BJ.%26rft.volume%253D93%26rft.issue%253D10%26rft.spage%253D386%26rft.epage%253D391%26rft.atitle%253DClinical%2Bexperience%2Bwith%2Blinezolid%2Bin%2Bthe%2Btreatment%2Bof%2Bresistant%2Bgram-positive%2Binfections.%26rft_id%253Dinfo%253Apmid%252F11688919%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=11688919&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">2.</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text" id="ref-2">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.2" data-doi="10.1093/infdis/161.6.1170"><div class="cit-metadata"><cite><strong>Chambers, H. F., and M. Sachdeva.</strong>
<span class="cit-pub-date">1990</span>. Binding of ОІ-lactam antibiotics to penicillin-binding proteins in methicillin-resistant <em>Staphylococcus aureus</em>. <span class="cit-source">J. Infect. Dis.</span><span class="cit-vol">161</span><strong>:</strong><span class="cit-fpage">1170</span>-1176.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BInfect.%2BDis.%26rft_id%253Dinfo%253Adoi%252F10.1093%252Finfdis%252F161.6.1170%26rft_id%253Dinfo%253Apmid%252F2345297%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/infdis/161.6.1170&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=2345297&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1990DG05100019&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text" id="ref-3">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.3" data-doi="10.1128/AAC.39.2.462"><div class="cit-metadata"><cite><strong>Chambers, H. F.</strong>
<span class="cit-pub-date">1995</span>. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">39</span><strong>:</strong><span class="cit-fpage">462</span>-466.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DChambers%26rft.auinit1%253DH.%2BF.%26rft.volume%253D39%26rft.issue%253D2%26rft.spage%253D462%26rft.epage%253D466%26rft.atitle%253DIn%2Bvitro%2Band%2Bin%2Bvivo%2Bantistaphylococcal%2Bactivities%2Bof%2BL-695%252C256%252C%2Ba%2Bcarbapenem%2Bwith%2Bhigh%2Baffinity%2Bfor%2Bthe%2Bpenicillin-binding%2Bprotein%2BPBP%2B2a.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.39.2.462%26rft_id%253Dinfo%253Apmid%252F7726516%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjg6IjM5LzIvNDYyIjtzOjQ6ImF0b20iO3M6MTg6Ii9hYWMvNDcvMy85MjMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text" id="ref-4">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.4" data-doi="10.1016/S0960-894X(00)00603-X"><div class="cit-metadata"><cite><strong>Cho, A., T. W. Glinka, M. Ludwikow, A. T. Fan, M. Wang, and S. J. Hecker.</strong>
<span class="cit-pub-date">2001</span>. New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position. <span class="cit-source">Bioorg. Med. Chem. Lett.</span><span class="cit-vol">11</span><strong>:</strong><span class="cit-fpage">137</span>-140.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBioorganic%2B%2526%2BMedicinal%2BChemistry%2BLetters%26rft.stitle%253DBioorganic%2B%2526%2BMedicinal%2BChemistry%2BLetters%26rft.aulast%253DCho%26rft.auinit1%253DA.%26rft.volume%253D11%26rft.issue%253D2%26rft.spage%253D137%26rft.epage%253D140%26rft.atitle%253DNew%2Banti-MRSA%2Bcephalosporins%2Bwith%2Ba%2Bbasic%2Baminopyridine%2Bat%2Bthe%2BC-7%2Bposition.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0960-894X%252800%252900603-X%26rft_id%253Dinfo%253Apmid%252F11206444%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0960-894X(00)00603-X&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=11206444&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text" id="ref-5">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.5"><div class="cit-metadata"><cite><strong>Diekema, D. J., M. A. Pfaller, J. Turnidge, J. Verhoef, J. Bell, A. C. Fluit, G. V. Doern, R. N. Jones, and the SENTRY Participants Group.</strong>
<span class="cit-pub-date">2000</span>. Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant <em>Staphylococcus aureus</em> bloodstream isolates from SENTRY antimicrobial resistance surveillance centers worldwide, 1998. <span class="cit-source">Microb. Drug Resist.</span><span class="cit-vol">6</span><strong>:</strong><span class="cit-fpage">213</span>-221.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DMicrobial%2Bdrug%2Bresistance%2B%2528Larchmont%252C%2BN.Y.%2529%26rft.stitle%253DMicrob%2BDrug%2BResist%26rft.aulast%253DDiekema%26rft.auinit1%253DD.%2BJ.%26rft.volume%253D6%26rft.issue%253D3%26rft.spage%253D213%26rft.epage%253D221%26rft.atitle%253DGenetic%2Brelatedness%2Bof%2Bmultidrug-resistant%252C%2Bmethicillin%2B%2528oxacillin%2529-resistant%2BStaphylococcus%2Baureus%2Bbloodstream%2Bisolates%2Bfrom%2BSENTRY%2BAntimicrobial%2BResistance%2BSurveillance%2BCenters%2Bworldwide%252C%2B1998.%26rft_id%253Dinfo%253Apmid%252F11144421%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=11144421&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000165784600004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text" id="ref-6">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.6" data-doi="10.1093/jac/46.5.775"><div class="cit-metadata"><cite><strong>Drew, R. H., J. R. Perfect, L. Srinath, E. Kurkimilis, M. Dowzicky, and G. H. Talbot.</strong>
<span class="cit-pub-date">2000</span>. Treatment of methicillin-resistant <em>Staphylococcus aureus</em> infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. <span class="cit-source">J. Antimicrob. Chem.</span><span class="cit-vol">46</span><strong>:</strong><span class="cit-fpage">775</span>-784.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BAntimicrobial%2BChemotherapy%26rft.stitle%253DJ%2BAntimicrob%2BChemother%26rft.aulast%253DDrew%26rft.auinit1%253DR.%2BH.%26rft.volume%253D46%26rft.issue%253D5%26rft.spage%253D775%26rft.epage%253D784%26rft.atitle%253DTreatment%2Bof%2Bmethicillin-resistant%2BStaphylococcus%2Baureus%2Binfections%2Bwith%2Bquinupristin-dalfopristin%2Bin%2Bpatients%2Bintolerant%2Bof%2Bor%2Bfailing%2Bprior%2Btherapy%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fjac%252F46.5.775%26rft_id%253Dinfo%253Apmid%252F11062197%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/jac/46.5.775&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=11062197&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000165510200016&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">7.</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text" id="ref-7">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.7" data-doi="10.1128/AAC.46.4.971-976.2002"><div class="cit-metadata"><cite><strong>Fung-Tomc, J. C., J. Clark, B. Minassian, M. Pucci, Y. Tsai, E. Gradelski, L. Lamb, I. Media, E. Huczko, B. Kolek, S. Chaniewski, C. Ferraro, T. Washo, and D. P. Bonner.</strong>
<span class="cit-pub-date">2002</span>. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and susceptible staphylococci. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">46</span><strong>:</strong><span class="cit-fpage">971</span>-976.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DFung-Tomc%26rft.auinit1%253DJ.%2BC.%26rft.volume%253D46%26rft.issue%253D4%26rft.spage%253D971%26rft.epage%253D976%26rft.atitle%253DIn%2BVitro%2Band%2BIn%2BVivo%2BActivities%2Bof%2Ba%2BNovel%2BCephalosporin%252C%2BBMS-247243%252C%2Bagainst%2BMethicillin-Resistant%2Band%2B-Susceptible%2BStaphylococci%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.46.4.971-976.2002%26rft_id%253Dinfo%253Apmid%252F11897577%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjg6IjQ2LzQvOTcxIjtzOjQ6ImF0b20iO3M6MTg6Ii9hYWMvNDcvMy85MjMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">8.</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text" id="ref-8">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.8" data-doi="10.1128/JB.158.2.513-516.1984"><div class="cit-metadata"><cite><strong>Hartman, B. J., and A. Tomasz.</strong>
<span class="cit-pub-date">1984</span>. Low-affinity penicillin-binding protein associated with ОІ-lactam resistance in <em>Staphylococcus aureus</em>. <span class="cit-source">J. Bacteriol.</span><span class="cit-vol">158</span><strong>:</strong><span class="cit-fpage">513</span>-516.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BBacteriology%26rft.stitle%253DJ.%2BBacteriol.%26rft.aulast%253DHartman%26rft.auinit1%253DB%2BJ%26rft.volume%253D158%26rft.issue%253D2%26rft.spage%253D513%26rft.epage%253D516%26rft.atitle%253DLow-affinity%2Bpenicillin-binding%2Bprotein%2Bassociated%2Bwith%2Bbeta-lactam%2Bresistance%2Bin%2BStaphylococcus%2Baureus.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJB.158.2.513-516.1984%26rft_id%253Dinfo%253Apmid%252F6563036%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MjoiamIiO3M6NToicmVzaWQiO3M6OToiMTU4LzIvNTEzIjtzOjQ6ImF0b20iO3M6MTg6Ii9hYWMvNDcvMy85MjMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">9.</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text" id="ref-9">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.9" data-doi="10.1128/AAC.45.3.825-836.2001"><div class="cit-metadata"><cite><strong>Hebeisen, P., I. Heinze-Krauss, P. Angehrn, P. Hohl, M. G. P. Page, and R. L. Then.</strong>
<span class="cit-pub-date">2001</span>. In vitro and in vivo properties of Ro63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">45</span><strong>:</strong><span class="cit-fpage">825</span>-836.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DHebeisen%26rft.auinit1%253DP.%26rft.volume%253D45%26rft.issue%253D3%26rft.spage%253D825%26rft.epage%253D836%26rft.atitle%253DIn%2BVitro%2Band%2BIn%2BVivo%2BProperties%2Bof%2BRo%2B63-9141%252C%2Ba%2BNovel%2BBroad-Spectrum%2BCephalosporin%2Bwith%2BActivity%2Bagainst%2BMethicillin-Resistant%2BStaphylococci%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.45.3.825-836.2001%26rft_id%253Dinfo%253Apmid%252F11181368%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjg6IjQ1LzMvODI1IjtzOjQ6ImF0b20iO3M6MTg6Ii9hYWMvNDcvMy85MjMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">10.</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text" id="ref-10">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.10" data-doi="10.1021/jm950886v"><div class="cit-metadata"><cite><strong>Heinze-Krauss, I., P. Angehrn, P. Guerry, P. Hebeisen, C. Hubschwerlen, I. Kompis, M. G. P. Page, H. G. F. Richter, V. Runtz, H. Stalder, U. Weiss, and C. Wei.</strong>
<span class="cit-pub-date">1996</span>. Synthesis and structure-activity relationship of (lactamylvinyl)cephalosporins exhibiting activity against staphylococci, pneumococci, and enterococci. <span class="cit-source">J. Med. Chem.</span><span class="cit-vol">39</span><strong>:</strong><span class="cit-fpage">1864</span>-1871.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bmedicinal%2Bchemistry%26rft.stitle%253DJ%2BMed%2BChem%26rft.aulast%253DHeinze-Krauss%26rft.auinit1%253DI.%26rft.volume%253D39%26rft.issue%253D9%26rft.spage%253D1864%26rft.epage%253D1871%26rft.atitle%253DSynthesis%2Band%2Bstructure-activity%2Brelationship%2Bof%2B%2528lactamylvinyl%2529cephalosporins%2Bexhibiting%2Bactivity%2Bagainst%2Bstaphylococci%252C%2Bpneumococci%252C%2Band%2Benterococci.%26rft_id%253Dinfo%253Adoi%252F10.1021%252Fjm950886v%26rft_id%253Dinfo%253Apmid%252F8627610%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1021/jm950886v&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=8627610&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1996UJ11200015&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">11.</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11. in text" id="ref-11">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.11" data-doi="10.1159/000007163"><div class="cit-metadata"><cite><strong>Higashi, Y., A. Wakabayashi, Y. Matsumoto, Y. Watanabe, and A. Ohno.</strong>
<span class="cit-pub-date">1999</span>. Role of inhibition of penicillin binding proteins and cell wall cross-linking by beta-lactam antibiotics in low- and high-level methicillin resistance of <em>Staphylococcus aureus</em>. <span class="cit-source">Chemotherapy</span><span class="cit-vol">45</span><strong>:</strong><span class="cit-fpage">37</span>-47.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DChemotherapy%26rft.stitle%253DChemotherapy%26rft.aulast%253DHigashi%26rft.auinit1%253DY.%26rft.volume%253D45%26rft.issue%253D1%26rft.spage%253D37%26rft.epage%253D47%26rft.atitle%253DRole%2Bof%2Binhibition%2Bof%2Bpenicillin%2Bbinding%2Bproteins%2Band%2Bcell%2Bwall%2Bcross-linking%2Bby%2Bbeta-lactam%2Bantibiotics%2Bin%2Blow-%2Band%2Bhigh-level%2Bmethicillin%2Bresistance%2Bof%2BStaphylococcus%2Baureus.%26rft_id%253Dinfo%253Adoi%252F10.1159%252F000007163%26rft_id%253Dinfo%253Apmid%252F9876208%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1159/000007163&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=9876208&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">12.</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text" id="ref-12">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.12"><div class="cit-metadata"><cite><strong>Ishikawa, T., K. Kamiyama, Y. Nakayama, Y. Iizawa, K. Okonogi, and A. Miyake.</strong>
<span class="cit-pub-date">2001</span>. Studies on anti-MRSA parenteral cephalosporins. III. Synthesis and antibacterial activity of 7ОІ-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(<em>Z</em>)-alkoxyiminoacetamido]-3-[(<em>E</em>)-2-(1-alkylimidazo[1,2-<em>b</em>]pyridazinium-6-yl)thiovinyl]-3-cephem-4-carboxylates and related compounds. <span class="cit-source">J. Antibiot.</span><span class="cit-vol">54</span><strong>:</strong><span class="cit-fpage">257</span>-277.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DThe%2BJournal%2Bof%2Bantibiotics%26rft.stitle%253DJ%2BAntibiot%2B%2528Tokyo%2529%26rft.aulast%253DIshikawa%26rft.auinit1%253DT.%26rft.volume%253D54%26rft.issue%253D3%26rft.spage%253D257%26rft.epage%253D277%26rft.atitle%253DStudies%2Bon%2Banti-MRSA%2Bparenteral%2Bcephalosporins.%2BIII.%2BSynthesis%2Band%2Bantibacterial%2Bactivity%2Bof%2B7beta-%255B2-%25285-amino-1%252C2%252C4-thiadiazol-3-yl%2529-2%2528Z%2529-alkoxyiminoacetamido-3.%26rft_id%253Dinfo%253Apmid%252F11372783%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=11372783&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">13.</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text" id="ref-13">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.13" data-doi="10.1128/AAC.46.2.321-326.2002"><div class="cit-metadata"><cite><strong>Johnson, A. P., M. Warner, M. Carter, and D. M. Livermore.</strong>
<span class="cit-pub-date">2002</span>. In vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocci. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">46</span><strong>:</strong><span class="cit-fpage">321</span>-326.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DJohnson%26rft.auinit1%253DA.%2BP.%26rft.volume%253D46%26rft.issue%253D2%26rft.spage%253D321%26rft.epage%253D326%26rft.atitle%253DIn%2BVitro%2BActivity%2Bof%2BCephalosporin%2BRWJ-54428%2B%2528MC-02479%2529%2Bagainst%2BMultidrug-Resistant%2BGram-Positive%2BCocci%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.46.2.321-326.2002%26rft_id%253Dinfo%253Apmid%252F11796337%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjg6IjQ2LzIvMzIxIjtzOjQ6ImF0b20iO3M6MTg6Ii9hYWMvNDcvMy85MjMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">14.</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14. in text" id="ref-14">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.14" data-doi="10.1056/NEJM199808203390806"><div class="cit-metadata"><cite><strong>Lowy, F.</strong>
<span class="cit-pub-date">1998</span>. <em>Staphylococcus aureus</em> infections. <span class="cit-source">N. Engl. J. Med.</span><span class="cit-vol">339</span><strong>:</strong><span class="cit-fpage">520</span>-532.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DLowy%26rft.auinit1%253DF.%2BD.%26rft.volume%253D339%26rft.issue%253D8%26rft.spage%253D520%26rft.epage%253D532%26rft.atitle%253DStaphylococcus%2Baureus%2BInfections%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM199808203390806%26rft_id%253Dinfo%253Apmid%252F9709046%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJM199808203390806&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=9709046&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000075447000006&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">15.</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15. in text" id="ref-15">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.15" data-doi="10.1128/AAC.42.11.2943"><div class="cit-metadata"><cite><strong>Matsumoto, M., H. Tamaoka, H. Ishikawa, and M. Kikuchi.</strong>
<span class="cit-pub-date">1998</span>. In vitro and in vivo antibacterial activities of OPC-20011, a novel parenteral broad-spectrum 2-oxaisocephem antibiotic. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">42</span><strong>:</strong><span class="cit-fpage">2943</span>-2949.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DMatsumoto%26rft.auinit1%253DM.%26rft.volume%253D42%26rft.issue%253D11%26rft.spage%253D2943%26rft.epage%253D2949%26rft.atitle%253DIn%2BVitro%2Band%2BIn%2BVivo%2BAntibacterial%2BActivities%2Bof%2BOPC-20011%252C%2Ba%2BNovel%2BParenteral%2BBroad-Spectrum%2B2-Oxaisocephem%2BAntibiotic%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.42.11.2943%26rft_id%253Dinfo%253Apmid%252F9797230%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjEwOiI0Mi8xMS8yOTQzIjtzOjQ6ImF0b20iO3M6MTg6Ii9hYWMvNDcvMy85MjMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">16.</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16. in text" id="ref-16">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.16" data-doi="10.1128/AAC.27.5.727"><div class="cit-metadata"><cite><strong>Murakami, K., and T. Yoshida.</strong>
<span class="cit-pub-date">1985</span>. Covalent binding of moxalactam to cephalosporinase of <em>Citrobacter freundii</em>. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">27</span><strong>:</strong><span class="cit-fpage">727</span>-732.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DMurakami%26rft.auinit1%253DK.%26rft.volume%253D27%26rft.issue%253D5%26rft.spage%253D727%26rft.epage%253D732%26rft.atitle%253DCovalent%2Bbinding%2Bof%2Bmoxalactam%2Bto%2Bcephalosporinase%2Bof%2BCitrobacter%2Bfreundii.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.27.5.727%26rft_id%253Dinfo%253Apmid%252F3874595%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjg6IjI3LzUvNzI3IjtzOjQ6ImF0b20iO3M6MTg6Ii9hYWMvNDcvMy85MjMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">17.</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17. in text" id="ref-17">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.17" data-doi="10.1128/AAC.31.9.1307"><div class="cit-metadata"><cite><strong>Murakami, K., K. Nomura, M. Doi, and T. Yoshida.</strong>
<span class="cit-pub-date">1987</span>. Production of low-affinity penicillin-binding protein by low-and high-resistance groups of methicillin-resistant <em>Staphylococcus aureus</em>. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">31</span><strong>:</strong><span class="cit-fpage">1307</span>-1311.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DMurakami%26rft.auinit1%253DK.%26rft.volume%253D31%26rft.issue%253D9%26rft.spage%253D1307%26rft.epage%253D1311%26rft.atitle%253DProduction%2Bof%2Blow-affinity%2Bpenicillin-binding%2Bprotein%2Bby%2Blow-%2Band%2Bhigh-resistance%2Bgroups%2Bof%2Bmethicillin-resistant%2BStaphylococcus%2Baureus.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.31.9.1307%26rft_id%253Dinfo%253Apmid%252F3499861%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjk6IjMxLzkvMTMwNyI7czo0OiJhdG9tIjtzOjE4OiIvYWFjLzQ3LzMvOTIzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">18.</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18. in text" id="ref-18">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.18" data-doi="10.1128/AAC.31.9.1423"><div class="cit-metadata"><cite><strong>Murakami, K., K. Nomura, M. Doi, and T. Yoshida.</strong>
<span class="cit-pub-date">1987</span>. Increased susceptibility to cephamycin-type antibiotics of methicillin-resistant <em>Staphylococcus aureus</em> defective in penicillin-binding protein 2. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">31</span><strong>:</strong><span class="cit-fpage">1423</span>-1425.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DMurakami%26rft.auinit1%253DK.%26rft.volume%253D31%26rft.issue%253D9%26rft.spage%253D1423%26rft.epage%253D1425%26rft.atitle%253DIncreased%2Bsusceptibility%2Bto%2Bcephamycin-type%2Bantibiotics%2Bof%2Bmethicillin-resistant%2BStaphylococcus%2Baureus%2Bdefective%2Bin%2Bpenicillin-binding%2Bprotein%2B2.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.31.9.1423%26rft_id%253Dinfo%253Apmid%252F3499862%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjk6IjMxLzkvMTQyMyI7czo0OiJhdG9tIjtzOjE4OiIvYWFjLzQ3LzMvOTIzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">19.</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19. in text" id="ref-19">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.19"><div class="cit-metadata"><cite><strong>National Committee for Clinical Laboratory Standards.</strong>
<span class="cit-pub-date">1999</span>. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. M26-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">20.</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20. in text" id="ref-20">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.20"><div class="cit-metadata"><cite><strong>National Committee for Clinical Laboratory Standards.</strong>
<span class="cit-pub-date">2000</span>. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard, 5th ed. M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">21.</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text" id="ref-21">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.21"><div class="cit-metadata"><cite><strong>O'Callaghan, C. H., P. W. Muggleton, and G. W. Ross.</strong> 1969. Effects of ОІ-lactamase from gram-negative organisms on cephalosporins and penicillins, p. <span class="cit-fpage">57</span>-63. Antimicrob. Agents Chemother. 1968.</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">22.</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22. in text" id="ref-22">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.22"><div class="cit-metadata"><cite><strong>Sawai, T., S. Yamagishi, and S. Mitsuhashi.</strong>
<span class="cit-pub-date">1973</span>. Penicillinases of <em>Klebsiella pneumoniae</em> and their phylogenetic relationship to penicillinases mediated by R factors. <span class="cit-source">J. Bacteriol.</span><span class="cit-vol">115</span><strong>:</strong><span class="cit-fpage">1045</span>-1054.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BBacteriology%26rft.stitle%253DJ.%2BBacteriol.%26rft.aulast%253DSawai%26rft.auinit1%253DT.%26rft.volume%253D115%26rft.issue%253D3%26rft.spage%253D1045%26rft.epage%253D1054%26rft.atitle%253DPenicillinases%2Bof%2BKlebsiella%2Bpneumoniae%2Band%2BTheir%2BPhylogenetic%2BRelationship%2Bto%2BPenicillinases%2BMediated%2Bby%2BR%2BFactors%26rft_id%253Dinfo%253Apmid%252F4199503%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MjoiamIiO3M6NToicmVzaWQiO3M6MTA6IjExNS8zLzEwNDUiO3M6NDoiYXRvbSI7czoxODoiL2FhYy80Ny8zLzkyMy5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">23.</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23. in text" id="ref-23">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.23" data-doi="10.1111/j.1432-1033.1977.tb11258.x"><div class="cit-metadata"><cite><strong>Spratt, B. G.</strong>
<span class="cit-pub-date">1977</span>. Properties of the penicillin-binding proteins of <em>Escherichia coli</em> K12. <span class="cit-source">Eur. J. Biochem.</span><span class="cit-vol">72</span><strong>:</strong><span class="cit-fpage">341</span>-352.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DFEBS%2BJournal%26rft.stitle%253DFEBS%2BJ%26rft.aulast%253DSpratt%26rft.auinit1%253DB.%26rft.volume%253D72%26rft.issue%253D2%26rft.spage%253D341%26rft.epage%253D352%26rft.atitle%253DProperties%2Bof%2Bthe%2Bpenicillin-binding%2Bproteins%2Bof%2BEscherichia%2Bcoli%2BK12%252C.%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fj.1432-1033.1977.tb11258.x%26rft_id%253Dinfo%253Apmid%252F319999%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1111/j.1432-1033.1977.tb11258.x&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=319999&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1977CU37400017&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">24.</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24. in text" id="ref-24">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.24" data-doi="10.1016/S0960-894X(01)00060-9"><div class="cit-metadata"><cite><strong>Springer, D. M., B. Luh, and J. J. Bronson.</strong>
<span class="cit-pub-date">2001</span>. Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives. <span class="cit-source">Bioorg. Med. Chem. Lett.</span><span class="cit-vol">11</span><strong>:</strong><span class="cit-fpage">797</span>-801.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBioorganic%2B%2526%2BMedicinal%2BChemistry%2BLetters%26rft.stitle%253DBioorganic%2B%2526%2BMedicinal%2BChemistry%2BLetters%26rft.aulast%253DSpringer%26rft.auinit1%253DD.%2BM.%26rft.volume%253D11%26rft.issue%253D6%26rft.spage%253D797%26rft.epage%253D801%26rft.atitle%253DAnti-MRSA%2Bcephems.%2BPart%2B1%253A%2BC-3%2Bsubstituted%2Bthiopyridinium%2Bderivatives.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0960-894X%252801%252900060-9%26rft_id%253Dinfo%253Apmid%252F11277523%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0960-894X(01)00060-9&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=11277523&amp;link_type=MED&amp;atom=%2Faac%2F47%2F3%2F923.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">25.</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25. in text" id="ref-25">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.25"><div class="cit-metadata"><cite><strong>Witte, W.</strong>
<span class="cit-pub-date">1999</span>. Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. <span class="cit-source">J. Antimicrob. Chemother.</span><span class="cit-vol">44</span><strong>:</strong><span class="cit-fpage">A1</span>-A9.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BAntimicrob.%2BChemother.%26rft.volume%253D44%26rft.spage%253DA1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">26.</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26. in text" id="ref-26">в†µ</a><div class="cit ref-cit ref-other" id="cit-47.3.923.26"><div class="cit-metadata"><cite><strong>Yoshizawa, H., H. Itani, K. Ishikura, T. Irie, K. Yokoo, T. Kubota, K. Minami, T. Iwaki, H. Miwa and Y. Nishitani.</strong>
<span class="cit-pub-date">2002</span>. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) and <em>Pseudomonas aeruginosa</em>: synthesis and structure-activity relationships. J. Antibiot., <strong>55:</strong>975-992.</cite></div><div class="cit-extra"></div></div></li></ol></div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div><a href="https://aac.asm.org/content/47/3/923.abstract" class="hw-link hw-link-article-abstract" data-icon-position="" data-hide-link-title="0">View Abstract</a></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-node-pager" >
  
      
  
  <div class="pane-content">
    <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager"><span class="pager-prev"><a href="/content/47/3/917" title="Clinical Concentrations of Thioridazine Kill Intracellular Multidrug-Resistant Mycobacterium tuberculosis" rel="prev" class="pager-link-prev link-icon"><i class="icon-circle-arrow-left"></i> <span class="title">Previous</span></a></span><span class="pager-next"><a href="/content/47/3/1068" title="In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant Isolates" rel="next" class="pager-link-next link-icon-right link-icon"><span class="title">Next</span> <i class="icon-circle-arrow-right"></i></a></span></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-back-to-top" >
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0"><i class="icon-chevron-up"></i> Back to top</a>  </div>

  
  </div>
</div>
			</div>
		</div>
		
		<div class="sidebar-right-wrapper grid-10 omega">
			<div class="panel-panel panel-region-sidebar-right">
			  <div class="inside"><div class="panel-pane pane-add-to-cart" >
  
      
  
  <div class="pane-content">
    <span  data-font-icon="icon-shopping-cart" data-text="Add to Cart (%short-price)" data-apath="/aac/47/3/923.atom" data-type="link" data-parent-id="66558" class="highwire-foxycart-add-to-cart-ahah"></span>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-jnl-asm-art-tools  pane-style-alt-content" >
  
      
  
  <div class="pane-content">
    <div id="mini-panel-jnl_asm_art_tools" class="highwire-2col-stacked panel-display">
	  
  <div class="panel-row-wrapper clearfix">
		<div class="content-left-wrapper content-column">
          <div class="panel-panel panel-region-content-left">
            <div class="inside"><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/aac/47/3/923.full-text.pdf" target="_blank" class="link-icon"><i class="icon-download"></i> <span class="title">Download PDF</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-jnl-asm-cite-tool" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/highwire/citation/81053/download" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title=""><i class="icon-globe"></i> <span class="title">Citation Tools</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_cite_tool">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-citation-export" >
  
      
  
  <div class="pane-content">
    <div class="highwire-citation-export">  
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="81053" id="node81053" data-pisa="aac;47/3/923" data-pisa-master="aac;47/3/923" data-apath="/aac/47/3/923.atom"><div class="highwire-cite highwire-cite-highwire-article highwire-citation-asm-article-toolbox-citation clearfix">
  
  
  
  
      <div class="highwire-cite-title">In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci</div>  
    	<div class="highwire-cite-authors"><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Takaji</span> <span class="nlm-surname">Fujimura</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Yoshinori</span> <span class="nlm-surname">Yamano</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Isamu</span> <span class="nlm-surname">Yoshida</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Jingoro</span> <span class="nlm-surname">Shimada</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Shogo</span> <span class="nlm-surname">Kuwahara</span></span></span></div>
  
    	<div class="highwire-cite-metadata"><span  class="highwire-cite-metadata-journal highwire-cite-metadata">Antimicrobial Agents and Chemotherapy </span><span  class="highwire-cite-metadata-date highwire-cite-metadata">Mar 2003, </span><span  class="highwire-cite-metadata-volume highwire-cite-metadata">47 </span><span  class="highwire-cite-metadata-issue highwire-cite-metadata">(3) </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">923-931; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">DOI:</span> 10.1128/AAC.47.3.923-931.2003 </span></div>
  
  
  
</div>
</div>  </div>
  <div class="highwire-citation-formats">
  	      <h2>Citation Manager Formats</h2>
        <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage=923&amp;rft.epage=931&amp;rft.atitle=In%20Vitro%20Activity%20of%20S-3578%2C%20a%20New%20Broad-Spectrum%20Cephalosporin%20Active%20against%20Methicillin-Resistant%20Staphylococci&amp;rft.volume=47&amp;rft.issue=3&amp;rft.date=2003-03-01%2000%3A00%3A00&amp;rft.stitle&amp;rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&amp;rft.au=Fujimura%2C+Takaji&amp;rft.au=Yamano%2C+Yoshinori&amp;rft.au=Yoshida%2C+Isamu&amp;rft.au=Shimada%2C+Jingoro&amp;rft.au=Kuwahara%2C+Shogo"></span><ul class="hw-citation-links inline button button-alt button-grid clearfix"><li class="bibtext first"><a href="/highwire/citation/81053/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">BibTeX</a></li><li class="bookends"><a href="/highwire/citation/81053/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Bookends</a></li><li class="easybib"><a href="/highwire/citation/81053/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EasyBib</a></li><li class="endnote-tagged"><a href="/highwire/citation/81053/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote (tagged)</a></li><li class="endnote-8-xml"><a href="/highwire/citation/81053/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote 8 (xml)</a></li><li class="medlars"><a href="/highwire/citation/81053/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Medlars</a></li><li class="mendeley"><a href="/highwire/citation/81053/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Mendeley</a></li><li class="papers"><a href="/highwire/citation/81053/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Papers</a></li><li class="refworks-tagged"><a href="/highwire/citation/81053/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RefWorks Tagged</a></li><li class="reference-manager"><a href="/highwire/citation/81053/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Ref Manager</a></li><li class="ris"><a href="/highwire/citation/81053/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RIS</a></li><li class="zotero last"><a href="/highwire/citation/81053/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Zotero</a></li></ul>    </div>
  </div>
</div>
  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/aac/47/3/923.full-text.pdf" target="_blank" rel="nofollow" class="link-icon"><i class="icon-print"></i> <span class="title">Print</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-ajax-pane-content pane-highwire-permission-link" >
  
        <h2 class="pane-title"><span class='panels-ajax-pane-title' data-pid='new-20'></span></h2>
    
  
  <div class="pane-content">
    <div class='panels-ajax-pane panels-ajax-pane-new-20' data-pid='new-20'></div>  </div>

  
  </div>
</div>
          </div>
        </div>
        
        <div class="content-right-wrapper content-column">
          <div class="panel-panel panel-region-content-right">
            <div class="inside"><div class="panel-pane pane-minipanel-dialog-link pane-jnl-asm-art-alert" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title=""><i class="icon-bullhorn"></i> <span class="title">Alerts</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_art_alert">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-article-add-form" >
  
      
  
  <div class="pane-content">
    <div id = "alerts-form-wrapper"><form action="/content/47/3/923.full" method="post" id="highwire-user-opportunity-login" accept-charset="UTF-8"><div><div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name">User Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name" name="name" value="" size="60" maxlength="128" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-password form-item-pass">
  <label for="edit-pass">Password <span class="form-required" title="This field is required.">*</span></label>
 <input type="password" id="edit-pass" name="pass" size="60" maxlength="128" class="form-text required" />
</div>
<div id="alerts_email">Sign In to Email Alerts with your Email Address</div><div class="form-item form-item-label-before form-type-textfield form-item-highwire-alerts-email">
  <label for="edit-highwire-alerts-email">Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-highwire-alerts-email" name="highwire_alerts_email" value="" size="60" maxlength="128" class="form-text required" />
</div>
<input type="submit" id="edit-submit--3" name="op" value="Submit" class="form-submit" /><input type="hidden" name="form_build_id" value="form-JbfrCSu0nEICqpxrMSzv7aAQouAFVTPkslf3gMR3WPU" />
<input type="hidden" name="form_id" value="highwire_alerts_article_sign_up_form" />
<input type="hidden" name="current_path" value="content/47/3/923.full" />
</div></form></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-jnl-asm-art-email" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="" data-icon-position="" data-hide-link-title="0"><i class = 'icon-envelope'></i> Email</a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_art_email">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-block pane-forward-form pane-forward" >
  
      
  
  <div class="pane-content">
    <form action="/content/47/3/923.full" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-item form-item-label-before form-type-item">
 <p>Thank you for sharing this Antimicrobial Agents and Chemotherapy article.</p><p>NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.</p>
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-email">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name--2">Your Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name--2" name="name" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-recipients">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea></div>
<div class="description">Enter multiple addresses on separate lines or separate them with commas.</div>
</div>
<div id="edit-page" class="form-item form-item-label-before form-type-item">
  <label for="edit-page">You are going to email the following </label>
 <a href="/content/47/3/923" class="active" data-icon-position="" data-hide-link-title="0">In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci</a>
</div>
<div id="edit-subject" class="form-item form-item-label-before form-type-item">
  <label for="edit-subject">Message Subject </label>
 (Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
</div>
<div id="edit-body" class="form-item form-item-label-before form-type-item">
  <label for="edit-body">Message Body </label>
 (Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-message">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea></div>
</div>
<input type="hidden" name="path" value="node/81053" />
<input type="hidden" name="path_cid" value="" />
<input type="hidden" name="forward_footer" value=" " />
<input type="hidden" name="form_build_id" value="form-wxG7SNnpEAAfudw3FPKYonY3cKm2q8SepDhdVWFRfOg" />
<input type="hidden" name="form_id" value="forward_form" />
<fieldset class="captcha form-wrapper"><legend><span class="fieldset-legend">CAPTCHA</span></legend><div class="fieldset-wrapper"><div class="fieldset-description">This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.</div><input type="hidden" name="captcha_sid" value="13388239" />
<input type="hidden" name="captcha_token" value="8ecf495c8939aa3de7f938883b1bd8f2" />
<input type="hidden" name="captcha_response" value="Google no captcha" />
<div class="g-recaptcha" data-sitekey="6LfnJVIUAAAAAE-bUOMg0MJGki4lqSvDmhJp19fN" data-theme="light" data-type="image"></div></div></fieldset>
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit--4" name="op" value="Send Message" class="form-submit" /></div></div></form>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax"  id="shareit">
  
      
  
  <div class="pane-content">
    <a href="/" class="link-icon"><i class="icon-share-alt"></i> <span class="title">Share</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-jnl-asm-share highwire_clipboard_form_ajax_shareit" >
  
      
  
  <div class="pane-content">
    
<div class="panel-display omega-12-onecol" id="mini-panel-jnl_asm_share">

		  <div class="panel-panel grid-12 panel-region-preface">
		  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="81053" id="node81053" data-pisa="aac;47/3/923" data-pisa-master="aac;47/3/923" data-apath="/aac/47/3/923.atom"><div class="highwire-cite highwire-cite-highwire-article highwire-citation-asm-article-toolbox-citation clearfix">
  
  
  
  
      <div class="highwire-cite-title">In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci</div>  
    	<div class="highwire-cite-authors"><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Takaji</span> <span class="nlm-surname">Fujimura</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Yoshinori</span> <span class="nlm-surname">Yamano</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Isamu</span> <span class="nlm-surname">Yoshida</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Jingoro</span> <span class="nlm-surname">Shimada</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Shogo</span> <span class="nlm-surname">Kuwahara</span></span></span></div>
  
    	<div class="highwire-cite-metadata"><span  class="highwire-cite-metadata-journal highwire-cite-metadata">Antimicrobial Agents and Chemotherapy </span><span  class="highwire-cite-metadata-date highwire-cite-metadata">Mar 2003, </span><span  class="highwire-cite-metadata-volume highwire-cite-metadata">47 </span><span  class="highwire-cite-metadata-issue highwire-cite-metadata">(3) </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">923-931; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">DOI:</span> 10.1128/AAC.47.3.923-931.2003 </span></div>
  
  
  
</div>
</div>  </div>

  
  </div>
</div>
	  </div>
	
  <div class="panel-panel grid-12 panel-region-content">
  	<div class="inside"><div class="panel-pane pane-highwire-article-clipboard-copy" >
  
      
  
  <div class="pane-content">
    <div class = "clipboard-copy">
  <span class="label-url">
    <label for="dynamic">Share This Article:</label>
  </span>
  <span class="input-text-url">
    <input type="text" id="dynamic" value="https://aac.asm.org/content/47/3/923" size="50"/>
  </span>
  <span class="copy-button button">
    <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">Copy</button>
  </span>
</div>
  </div>

  
  </div>
</div>
  </div>
	
		  <div class="panel-panel grid-12 panel-region-postscript">
	    <div class="inside"><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><a href="http://del.icio.us/post?url=https%3A//aac.asm.org/content/47/3/923&amp;title=In%20Vitro%20Activity%20of%20S-3578%2C%20a%20New%20Broad-Spectrum%20Cephalosporin%20Active%20against%20Methicillin-Resistant%20Staphylococci" id="delicious" title="Bookmark this post on del.icio.us" class="service-links-delicious" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/delicious-32.png" alt="del.icio.us logo" /></a> <a href="http://digg.com/submit?phase=2&amp;url=https%3A//aac.asm.org/content/47/3/923&amp;title=In%20Vitro%20Activity%20of%20S-3578%2C%20a%20New%20Broad-Spectrum%20Cephalosporin%20Active%20against%20Methicillin-Resistant%20Staphylococci" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo" /></a> <a href="http://reddit.com/submit?url=https%3A//aac.asm.org/content/47/3/923&amp;title=In%20Vitro%20Activity%20of%20S-3578%2C%20a%20New%20Broad-Spectrum%20Cephalosporin%20Active%20against%20Methicillin-Resistant%20Staphylococci" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo" /></a> <a href="http://twitter.com/share?url=https%3A//aac.asm.org/content/47/3/923&amp;text=In%20Vitro%20Activity%20of%20S-3578%2C%20a%20New%20Broad-Spectrum%20Cephalosporin%20Active%20against%20Methicillin-Resistant%20Staphylococci" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo" /></a> <a href="http://www.citeulike.org/posturl?url=https%3A//aac.asm.org/content/47/3/923&amp;title=In%20Vitro%20Activity%20of%20S-3578%2C%20a%20New%20Broad-Spectrum%20Cephalosporin%20Active%20against%20Methicillin-Resistant%20Staphylococci" id="citeulike" title="Share on CiteULike" class="service-links-citeulike" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/citeyoulike.png" alt="CiteULike logo" /></a> <a href="http://www.facebook.com/sharer.php?u=https%3A//aac.asm.org/content/47/3/923&amp;t=In%20Vitro%20Activity%20of%20S-3578%2C%20a%20New%20Broad-Spectrum%20Cephalosporin%20Active%20against%20Methicillin-Resistant%20Staphylococci" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo" /></a> <a href="http://www.google.com/bookmarks/mark?op=add&amp;bkmk=https%3A//aac.asm.org/content/47/3/923&amp;title=In%20Vitro%20Activity%20of%20S-3578%2C%20a%20New%20Broad-Spectrum%20Cephalosporin%20Active%20against%20Methicillin-Resistant%20Staphylococci" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo" /></a> <a href="http://www.mendeley.com/import/?url=https%3A//aac.asm.org/content/47/3/923&amp;title=In%20Vitro%20Activity%20of%20S-3578%2C%20a%20New%20Broad-Spectrum%20Cephalosporin%20Active%20against%20Methicillin-Resistant%20Staphylococci" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo" /></a></div>  </div>

  
  </div>
</div>
	  </div>
	
</div>
  </div>

  
  </div>
</div>
          </div>
        </div>
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-nav mobile-hidden  pane-style-alt-content" >
  
      
  
  <div class="pane-content">
    <div class="highwire-list-wrapper highwire-article-nav highwire-nav-float"><div class="highwire-list"><ul data-highwire-float="1" data-highwire-float-class="grid-10 alpha omega"><li class="first odd"><a href="#skip-link" class="" data-icon-position="" data-hide-link-title="0">Top</a></li><li class="parent even"><a href="/content/47/3/923" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-is-tab-link="true" data-icon-position="" data-hide-link-title="0">Article</a><div class="highwire-list"><ul><li class="first odd"><a href="#abstract-1" class="highwire-article-nav-jumplink first" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">ABSTRACT</a></li><li class="even"><a href="#sec-1" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">MATERIALS AND METHODS</a></li><li class="odd"><a href="#sec-10" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">RESULTS</a></li><li class="even"><a href="#sec-16" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">DISCUSSION</a></li><li class="odd"><a href="#ack-1" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">ACKNOWLEDGMENTS</a></li><li class="even"><a href="#fn-group-1" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">FOOTNOTES</a></li><li class="last odd"><a href="#ref-list-1" class="highwire-article-nav-jumplink last" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">REFERENCES</a></li></ul></div></li><li class="odd"><a href="/content/47/3/923/figures-only" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_data" data-is-tab-link="true" data-icon-position="" data-hide-link-title="0">Figures & Data</a></li><li class="even"><a href="/content/47/3/923/article-info" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_info" data-is-tab-link="true" data-icon-position="" data-hide-link-title="0">Info & Metrics</a></li><li class="last odd"><a href="/content/47/3/923.full.pdf" class="highwire-article-nav-jumplink" data-icon-position="" data-hide-link-title="0"><i class="icon-file-alt"></i> PDF</a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-entity-field pane-node-field-highwire-article-keyword  pane-style-alt-content" >
  
        <h2 class="pane-title">KEYWORDS</h2>
    
  
  <div class="pane-content">
    <div class="field field-name-field-highwire-article-keyword field-type-taxonomy-term-reference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="/keyword/bacterial-proteins" class="" data-icon-position="" data-hide-link-title="0">Bacterial Proteins</a></div><div class="field-item odd"><a href="/keyword/cephalosporins" class="" data-icon-position="" data-hide-link-title="0">cephalosporins</a></div><div class="field-item even"><a href="/keyword/hexosyltransferases" class="" data-icon-position="" data-hide-link-title="0">Hexosyltransferases</a></div><div class="field-item odd"><a href="/keyword/methicillin-resistance" class="" data-icon-position="" data-hide-link-title="0">methicillin resistance</a></div><div class="field-item even"><a href="/keyword/peptidyl-transferases" class="" data-icon-position="" data-hide-link-title="0">Peptidyl Transferases</a></div><div class="field-item odd"><a href="/keyword/staphylococcus" class="" data-icon-position="" data-hide-link-title="0">Staphylococcus</a></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-jnl-asm-accordion" >
  
      
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_accordion">
  <div class="panel-panel panel-col">
    <div><div id="highwire_article_accordion_container"><h3 ><i class="icon-file"></i> Related Articles</h3><div><div class='panels-ajax-pane panels-ajax-pane-new-1' data-pid='new-1'></div></div><h3 ><i class="icon-retweet"></i> Cited By...</h3><div><div class='panels-ajax-pane panels-ajax-pane-new-2' data-pid='new-2'></div></div></div></div>
  </div>
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-trendmd" >
  
      
  
  <div class="pane-content">
    <div id="trendmd-suggestions"></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-asm-box-ads rtecenter" >
  
      
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-asm_box_ads">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-dfp-pane rtecenter" >
  
      
  
  <div class="pane-content">
    <div id="dfp-ad-asm_box-wrapper" class="dfp-tag-wrapper">

<div  id="dfp-ad-asm_box" class="dfp-tag-wrapper">
  <script type="text/javascript">
    googletag.cmd.push(function() {
      googletag.display("dfp-ad-asm_box");
    });
  </script>
</div>
</div>  </div>

  
  </div>
</div>
  </div>
</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

    </div>
  </div>
</div>      </div>
</div>  </div>
</section>    
  
      <footer id="section-footer" class="section section-footer">
    
  <div id="zone-postscript" class="zone zone-postscript clearfix container-30">
    <div class="grid-7 prefix-1 region region-postscript-first" id="region-postscript-first">
  <div class="region-inner region-postscript-first-inner">
    <section class="block block-menu block-menu-about-the-journal block-menu-menu-about-the-journal odd" id="block-menu-menu-about-the-journal">
  <div class="block-inner clearfix">
              <h2 class="block-title">About</h2>
            
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/content/about-aac" data-hide-link-title="0" target="_blank" class="" data-icon-position="">About AAC</a></li>
<li class="leaf" role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" class="" data-icon-position="">Editor in Chief</a></li>
<li class="leaf" role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Editorial Board</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/ethics-and-policies" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Policies</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/reviewers" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Reviewers</a></li>
<li class="leaf" role="menuitem"><a href="https://www.asm.org/Newsroom" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For the Media</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Librarians</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/advertising" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Advertisers</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/alerts" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Alerts</a></li>
<li class="leaf" role="menuitem"><a href="https://www.youtube.com/playlist?list=PL1DFmJFZvefiidG0t8jEKTdITXxJrmdO5" data-hide-link-title="0" target="_blank" class="" data-icon-position="">AAC Podcast</a></li>
<li class="leaf" role="menuitem"><a href="/content/rss" data-hide-link-title="0" class="" data-icon-position="">RSS</a></li>
<li class="leaf" role="menuitem"><a href="/content/faq" data-hide-link-title="0" class="" data-icon-position="">FAQ</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/permissions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Permissions</a></li>
<li class="last leaf" role="menuitem"><a href="https://journals.asm.org/content/journal-announcements" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Journal Announcements</a></li>
</ul></nav>    </div>
  </div>
</section>  </div>
</div><div class="grid-7 region region-postscript-second" id="region-postscript-second">
  <div class="region-inner region-postscript-second-inner">
    <section class="block block-menu block-menu-for-authors block-menu-menu-for-authors odd" id="block-menu-menu-for-authors">
  <div class="block-inner clearfix">
              <h2 class="block-title">Authors</h2>
            
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="https://journals.asm.org/content/asm-author-center" data-hide-link-title="0" target="_blank" class="" data-icon-position="">ASM Author Center</a></li>
<li class="leaf" role="menuitem"><a href="/content/submit-manuscript" data-hide-link-title="0" class="" data-icon-position="">Submit a Manuscript</a></li>
<li class="leaf" role="menuitem"><a href="http://bit.ly/AACArticleTypes" data-hide-link-title="0" class="" data-icon-position="">Article Types</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/ethics" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Ethics</a></li>
<li class="last leaf" role="menuitem"><a href="https://journals.asm.org/content/contact-us" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Contact Us</a></li>
</ul></nav>    </div>
  </div>
</section>  </div>
</div><div class="grid-7 region region-postscript-third" id="region-postscript-third">
  <div class="region-inner region-postscript-third-inner">
    <div class="block block-panels-mini block-snippet-for-social-icons block-panels-mini-snippet-for-social-icons odd block-without-title" id="block-panels-mini-snippet-for-social-icons">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-snippet_for_social_icons">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-snippet pane-snippet-for-social-icons" >
  
      
  
  <div class="pane-content">
    <div class="snippet snippet-for-social-icons" id="snippet-for-social-icons">
  
      
  <div class="snippet-content">
    <p style="color:#FFF;"><strong>Follow #AACJournal</strong></p>

<p style="color:#FFF;"><strong>@ASMicrobiology</strong></p>

<p><a href="http://www.facebook.com/asmfan"><img alt="" src="/sites/default/files/additional-assets/icn-facebook.png" style="width: 32px; height: 32px;" /></a>&nbsp;&nbsp; <a href="https://twitter.com/asmicrobiology"><img alt="" src="/sites/default/files/additional-assets/icn-twitter.png" style="width: 32px; height: 32px;" /></a> &nbsp;&nbsp;<!--<a href="https://www.asm.org/index.php/mbiosphere"><img alt="podcast" src="/sites/default/files/additional-assets/blog.png" style="width: 32px; height: 32px;" /></a>-->&nbsp;&nbsp; <a href="/content/rss"><img alt="" src="/sites/default/files/additional-assets/icn-rss.png" style="width: 32px; height: 32px;" /></a></p>
  </div>

</div>
  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div><div class="grid-7 suffix-1 region region-postscript-fourth" id="region-postscript-fourth">
  <div class="region-inner region-postscript-fourth-inner">
    <div class="block block-panels-mini block-snippet-about-asa block-panels-mini-snippet-about-asa odd block-without-title" id="block-panels-mini-snippet-about-asa">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-snippet_about_asa">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-snippet pane-snippet-about-asa" >
  
      
  
  <div class="pane-content">
    <div class="snippet snippet-about-asa" id="snippet-about-asa">
  
      
  <div class="snippet-content">
    <p><a href="http://journals.asm.org" target="_blank"><img alt="ASM Journals" src="/sites/default/files/additional_assets/footer/logo-footer-JournalsASMorg2x.png" style="width: 225px; height: auto;" /></a></p>

<p style="color: #ccc;">ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.</p>

<p><a href="https://www.asm.org/about-asm" target="_blank">About ASM</a> <span style="color: #ccc;">|</span> <a href="https://journals.asm.org/content/contact-us
">Contact Us</a> <span style="color: #ccc;">|</span> <a href="https://www.asm.org/Browse-By-Audience/Press" target="_blank">Press Room</a></p>

<p>&nbsp;</p>

<p>ASM is a member of</p>

<p><a href="https://byscientistsforscience.org/" target="_blank"><img alt="Scientific Society Publisher Alliance" src="/sites/default/files/additional_assets/footer/logo-footer-sspa2x.png" style="width: 175px; height: auto;" /></a></p>

<p>&nbsp;</p>

<p>American Society for Microbiology<br/>
1752 N St. NW<br/>
Washington, DC 20036<br/>
Phone: (202) 737-3600</p>
  </div>

</div>
  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-footer" class="zone zone-footer clearfix container-30">
    <div class="grid-28 suffix-1 prefix-1 region region-footer-second" id="region-footer-second">
  <div class="region-inner region-footer-second-inner">
    <div class="block block-panels-mini block-footer-bottom block-panels-mini-footer-bottom odd block-without-title" id="block-panels-mini-footer-bottom">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-footer_bottom">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-snippet pane-copyright-footer" >
  
      
  
  <div class="pane-content">
    <div class="snippet copyright-footer" id="copyright-footer">
  
      
  <div class="snippet-content">
    <p class="rtecenter" style="font-size:small;"><a href="https://journals.asm.org/content/copyright-notice-and-license-information" target="_blank">Copyright &copy; 2020</a> <a href="https://www.asm.org/" target="_blank"><span style="white-space:nowrap;"> American Society for Microbiology</span></a> | <a href="https://www.asm.org/cookie-policy" target="_blank">Privacy Policy</a> | <a href="/feedback">Website feedback</a></p>

<p class="rtecenter" style="font-size:small;">Print ISSN: 0066-4804; Online ISSN: 1098-6596</p>
  </div>

</div>
  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
</footer>  </div>    <div class="region region-page-bottom" id="region-page-bottom">
  <div class="region-inner region-page-bottom-inner">
      </div>
</div><script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__bnwyEQSuZLC-kZnFqCi5iE02nOCzM7DjY7zYxcN9nsQ__VBiBT_qq_eHMMO2Q1rXK1u-hHff31XLUkmi9dgjuPeY__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__GM3GJPR36rRIz0TRkjC5OQwrioSyN9aoYRivDhCO_AM__qAl84FcCv2jyN22yFGS5Oc85cjd9zKX6p_cFNLGhe-M__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js" async="async"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__oG4YIK4vOM0kZaFGZ9tW8cW21AH_tz72H9yFAn40-3c__LYiQGqUNwCwMgKPn4rDHxT7k2cpaEGGK9difJ3_Pdwo__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__2WRbxlwOW0MEUc_hSWU5MBepQg6Lch6O5SZwefpJ6IE__HCL0YQJqLkOhrLPZZYGqosGvtFsEHMGghHIkSx4y9vA__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js" defer="defer"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__7wIZ-Fggxuz1XBq4W-gV9zVqSKOKMJ9F8HRNs4UfDbQ__LYpq6x97AHkV6nczZd2iqB4USQvZg7peOb7zH4R__4U__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
function euCookieComplianceLoadScripts() {}
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
<script type="text/javascript" defer="defer" src="https://aac.asm.org/sites/all/modules/highwire/highwire/highwire_foxycart/highwire_foxycart.js?qjdf71"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__WcTpt-w0y1FyXrxZNriX8Ts1KjsFTDpdvZaw9yhRn24__aFJpdvsZPb1v9rWrq-WXbz_WQ9IThQN-mFTCdm1cfXc__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
  </body>
</html>
